var title_f21_59_22448="Acoustic neuroma";
var content_f21_59_22448=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61242&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acoustic neuroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 301px; height: 339px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFTAS0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5ncncx9/WmZ5pz/eOPWmjrWB6wlLSGigQtFFFAwoyaKKACiiigApaSgUhi0UUUAd18F7jRbDx1BqfiK7itrXToJbyHzV3CSdFzGuPXPI91xXokfiXRV+N/hLxLpXiC0jiurGCbWLh8QKsm0rKrg5+ZgoJHXnr3rwGlq1OysZSo88ua57X4c8S6HpklxYXV1aebbeK4Nbe4Vw0c1pHu3BHH325GE75+tb/AIG8faL/AGlBqOqz6bb6XYX+rXNnm4eK6tkuAxAaALtl3FgBtPHPpXB/Bz4a3HjfUwZf3dkvJYg89favdJ9F+HXgkLBe2KXkq8E5XrXRTUmubY5a3JF8qu2fIMmS7HBGeeaZX2ba6R8O/HA+zWOnx2kxHDfKBXiXxq+Etx4Kf7ZaYm09udyg8Disp0WldHTSxUZvlaszx+loorA6gooooGFLSUUAKKKSlpDQtIaKWgYlLRS0DsJRS1u+EbDT9S1L7NqK3srSDbDBaSRxMzYJLF5PlAAHTqcimld2FJ8quzBpa7Ky8N6XPaa3CLq7lvrDzm+0LtSBFj3bQ0Z/eMX2dV+7uGehrM8CaLD4i8X6VpNy8scF1LscxFQ+ME4BbgHjGTxTcGrLuSqkbN9jAorf8ZafY6XqwtbC2vbbbErSJd3UNw248ghogFxjHHWum8HeDtN1PwpDql7a6ndzS3c0G211C1tVRUWMjPnAlifMPTgYFCpty5QdWMYqb6nmr8M31pO9Of7zfWmd6bMgopKWgkKKKPpSGFFJS0wCl7UlFIBaKSloGgooooGLUkEbTTJGgyzkAVHXe/Cvw4+p6i2pTIfsVmcsx6FsVUY8zsKclCLkz6F8ILN4E8IWSRKsZuosZxya8V8ePLqUst1HIymN8MCe9eo+P/FZ1u48L6ZG0XyPgiP0x/8AWrgNW0xJfGuq6ZKcfu96j3rsnqrI86jo+Z7mV4C/tK1v2nSdvJjAZirV9FJdDxv4bi0q6RJUnXC7uWFeD26zaX4Ym8sbXupxCOO3Suw1LXn+HfiTw/MD+6EI37uhyMf1og+VahVTnK63PC/Hfh248L+JrzTLhGXy2+XI6iuer6O+JtzafFIG4itFsr6FMxSg5EuBwCa+e9RsLnTrp7e8iaKVDggiuWrDld1sd9Crzxs90VaKMU9Inc4RSx9hWRvYZRVtdPum6QPz7U17G5T70En5UWYFeinGNl6qRj2puKQwpaKKBhS0lFAxa0dG1GCweUXemWepQyY/d3BddrDOCGRlYdTkZwe44FZ1FCdtQaurM6SPxXOpvbh7GyfVLlpyL/ayyoJgwkGAQrZDsAWBIzx0FZnh/Vp9D1i11KzWJ57cllWVSynII5AI7Gs4UU+ZiUIpNW3FGAPQVcuNRln0i0051j8i1mlmjIX5i0gQNk+n7tcfjW58LYZp/iL4cjtrQXchvosxGLzBt3Dc23pwMnJ4GM13fww0+2tJdfttVtYYb6G82PFcoFdAM4BB6c5q6cHLZmVWqobrY8auI3hnkinR45kYq6OMMpBwQR2Oas3Gkajbabb6jcWNzFYTttiuHjIRz7Gu11rXfChg8WxR6TcXlxeXxks7uW5O4rvkO44XAxuHA+9msrxQkd1ajVbbVrXyLi2tYBZpNmZ2jiRW3xj7oBViCevGOtaOmlfU51UbaurHIUUUViahRRRQAtKBSUooKQYqeCzmm5RcD1PAqzYWPnOgzulYjZGOprvLDw6tnEkl8u+5PIjH3UHvWsad9yJ1FE4iDRJ5QTnCj+LHFK+kBCB5xY9wq11l9cRws25kPONq1nS6tHEQY0Uj1Ip8iRCnJ7GRHowkyQ0i+mVpw8PyucJJ+a1px60WlBVE49q7DQL20uZR50IRj/FjimoRYSqTictpXggzgNeXJQf3VXrXd6P4ifwXG9pYWCzWyodwk/iOOtdpp2hR6sghtW2ylfkIH3jWFqfh6az+3adfwst8ynBbvWyp8uqOSVb2jtI8+8DazPrPxOsruZFUSS7ljHReO1dp4xXf8a2CqyK8OD+tcl8F9Ckm+Ikccq7RaklieAK7fxPNb3nxgMls4eOOLBYVML8t33NKrSqWj2JPEFiF0zSkXJC3QJ496v8A7SultLoOm3yDKpEBkD6VZ1vDWGnnG1BKOfWt/wCMKnUPh1EtnifYo3FfmI5FauN4yRzwm1OL8zxP4fa3ql5oNzpaRJNDECVbo61rTaMuoQRvrMC3Eg+VSeCPbisH4P2Ny+v3OwMFReV9ea9v8G6BDqur3NxI2FiUnDD5c1nSi5RVzorzVObseTT+DNKUErCYjjPUmsy50q1tGDblUAce9ekeNroWU0qSBAC2Ayr0ryTVroGSRVkLN70ppR0RVKUp7ssSvbsDyCPY1VQQM+IpCD25rnJrqQsdj4A4qOBpDNu34Ye/FZXOtUtNzt4rMSx4uoDLH/fj4ZazNa8MeVF9ptz50BH3kHKf7wqTw7qzqVIYlVbDA+len6LYQ3XlOi/upuCR0yfWrUVIwlUlSZ8/zxeVJtDBgO9RE1618R/h/NptzLPbW7bPvsqjqPUcV5TOgRyAelYVKbiddKqqsbxI6KSiszQWjNFFAB2paSikA5WKsGVirDoQcUhJYksSSepPOaMHGccetFAyOT77fWmd6dIfnbPqabxWjOUSijFBpCCiiigBafEpY8CmV0ngXRJde1xLdFJiT55T6LVQV3YHJRXMzufhf4Tm+yS6zdQE4GIy3QDHWrXirUDY2pjTmaQ5LdwK9e0i6tovBstlDEFjQhcgegryDx1ZZuHdVzxxjtXZKPLHQ86NR1JtyPNb6VieDkscEGqxJMOwAFs96tyoRKQ3DDpUSRLuyuSx9awPRi0kPtIWRctyc9a6XQ2kBKKcljWHGCRjtXoHw70R9Q1KJVTcd3AxVRTbMa07K7Pf/hJ4fYQW08hPCh+fwrX+LGhRMsWuJDukt12yY7jtXY+GtLGm6bAjLiUIFbHas34kz+T4XnXj94QpJ6VtzXkkjzPNnzTp95Hb6ZfS2EHk6pfyhCU6oua3vid4OtfB40PULAyMblVWZ26lj1rN06xt9NvZrqWUNI7DaB0Fdf8AGy/+26T4biVgYw6FjnpRbQ25veVhNC0xb7WtCsrtPMt2AkZD/FXWfELTrbQJd2m22Le5XEsJ5QH2FOgtUtvF/g3ymAV7MMfc4re+LFzBbeHXkl+8rjH5iqvrYxvc+dPCcv8AYPi3UnS3/dTpgbl4GfSvob4U2cEnhSVTGv72VizY5OQK4TW9Z0FtNjuLmy3SCMHzEGO1eifCbVINU8MmW1g8mBJNqj14FTJcq0Zcm56tHnfxj8L7RNLBDiM9CPwr5p1uDybhlPDYw3FffXiPS49W0uW3cAk8ivln4leA7iCWSa1hZk53ECpkuePMjbDVeR8rPEPKUFiVO0jgVXlP70BQVx3Fb13aSxyOmw8DFUUsGZuQSTx0rnZ6kai3ZLpQ2uu0DBNe3fDVZri1CGMumfkXHfjFed+EfDM93MgMZ8sH0r6V8DeHRo3h66uphtKQsy8dMCt6UXe5wYuqnojnPEd5JDqFvBrhjRlXaYQdx214j8V/AE+j3P8Aa2kxvPpFz8+5Fz5fTrjpWbeeKrmP4jXGoXUjTp5zJhzn5TX0b4B1mGxK2eoRrNo+pDBVuVUn/wDXTbVVNCXPhmpLqfGxBFJX0V8cPgidLMmr+GIy9qxLNAo+71PrXzxNE8MrRyqVdThlPUGuOcHA9ClWjVV4jaKKKzNgooopgFH4UCikMbMP3rduTUY4qWdt0jcDrUdas5VsNoopcVIhKKWrWmWM+o3kdtaoXlc4AFNahtuWvDmiXviDVYLDTYWlnlbaAozj619Gx+HLD4e6XHpsA83UZF3XcvpkZxW/8HPCll4E8N3GrXkavfhcqXA689Pzrh/GuqMdG1DVdSVxLMWCc/lXZCn7ON3uefUrOtLlWxytj8RZ7LX5rJAv2KWTaAw6c4zXrl94VOpeG4r+3QzmRcllGQK+XtNWzmjup7p3Fwp3xgV9n/s6a7Z6x4DitC6NcRcPGx5IpU6l07jxFPks4nzjr/gu5ilZkhcg9iK5qTQLqBxut33dhg19vXPhmGS7aC4tlktm5SUKMr7Gox8N9BMokkid2znsB/KnKEV1IhiZLSx8i+GvB2o6lMgSDaueWYEYr6h+GXgSPwtbC8uSkszD5cfw10p8I6XZfvbaLYF524GKmvdRSODdJhIlHAzxVwgmvdMqtWU9GbIvYSwUOC2Ocdq8/wDjZrENt4UeJHBkLBselZF18QYtK8+O2ijmkYnlj0Fcb431O38U6I81rMFuR9+En+VHJGOqJjdtX2PMNV1iVJrNVXCyMCSa7fWZ31HS4o2+ZoQrDA6V5RcpqGoapbWkUbZjYADHSvUPD+oQSatP4fulVbgW+/zCe9Zxd9zqqRsk0eqNKV1L4fXZ5BiWItVn4mSx3U+q2k7cRwqUX8Aa5iC5a5+F+nXeSZ9L1AIGB5CilOrWuvfFB7e/m2Wd5CBkH7vy1qu5zW/A8evNZZtFmtJN3moSFGOor2b9mnV5fslzpkythh5q57YArk/iF4G0LRdUBs9W88y8mMkEp+XFWPDviax8LajZjSp977QsxcDFZ8r6m8pKUfdR9KySpGpZ3Cj1NYurWljqNrLASokZTjHQ159e+OFVTKHV45ju256frWv4f12DVFjLHZ6EGtYQS6nNK+9jm9Q+EtpeLJOroswPMTdT9KoWHwmWIvP9kfphU29a9yspFnt0cAEjjNWazlNJ7FqUrbnnnh7wVaWMESCPy7pjlkYdBU/xT1K38L+AdQlMirI8ZRA38Rwa7LUb61020kur6ZIYUGWdzivkD42+PJfG3iA2GmKxs4m2pyfmGSMmk6jtcqlSc5WPH7+eGRftAjYXLuWyeh969y+Byz+LtLurNG/0m0TcE9Rk9K4my8FwXcUQvpWBC4AXjFe3/ss+GP7GXW7hmV8lI1bvjJP9KygnF36HdiKkJU7Lc77wDq0uo21zoOtjNxCpC7xgsnTHvivCP2gfhbJaXsusaVCdp5kRR94c819Ka/om66TVdPAS+g+bAGPMA7VM8Vv4m0IGWPaXUqQw+63cVs+WS12Zw06kqcuaJ+cBGOCOaSvSfjZ4Il8JeJH2Rn7LMSykDgdK82NcM4ODsz3Kc1UipIKKKKg0FpKUGkNAEcn32+tNzzTpPvt9aZ3rQ5Apc8U2loAWvdfgl4P8uKHU7qMefc8Q5H3V4rzL4deHn8ReJbe2C5iUh3PoM19xeDvD1ppWiR3VxArNFHiFSOi4/mTXRQh9pnHi6tvcRx/jm4a4l0/wtpkm8j/Wvjv1riv2jfCD6Z4MsTZh3jQjzOO+K9Z8GaS0viCa/vIv9IB3Ekfdz0FdH460tNW0CW2aNXZj8ob1xXRPV8vc4qcuVqS6HwjoXgy5uI1uLx/JjI3KAMk123gnWbzwBqkd1aS+bED8y46iunu9JlOuy2DkQyrkKp6HFYOr2hSSe2vMIU4BrLk5djqlV9ppI+pvA3jrSPF1ikllMqXOPngc4YH29a6uvj/wDptsLtkvZ3t2HMc8Zxg+tet6L4+1bQbgWushNU08HCXMRAdR2z60cl1dGD0dj1nViy2MjKSNuCceleNfEzxZDY2PkISCepr05PFmj3unmSG6Vg6/cbgjPY18j/HDUpLXVyivvR+n5Vak4U3cKcPaTSOa8QeKZftjuGIRugBqt4Z8RudXjMkpjQnkHvXFTTPK25zk0xWKsCpwQcg1yOo73PUVGKjY+k/D1xp8GofaPsxmum6ZXj865C4eOL4rrIVZfOjwBXU/DHxdpsulQxXQRbyKLqR1qW9i0rUtcgvordmuYwTuBwBXVulY4E3CTTR0vw4t21H4Y+J7MnMkF5vA9uKseDNGEF22pS2r3TvFtT/Z4NJ8FLpbbS/EM8422885jyemeK6d1vtDEyQSlLcjcjYyK0gtEzCbs2h+saRoD+E5ry5hD6nCjNtOd27sMV8uapdXcWoPdXEJt08zKqwIBGa92OqTLfStcyJMjjOQOM14d8Y9evdW1JUuViSGM7UWNQMis6zSVzowqblymvdeJbeSwglRyGAwU7V0vg3xn+9hQfKAcda8CF1IIRGD8o7VreHb2SK7iLsRGjAlqwjVdzrnhlyn6D+D5ln0SGVWJ38nP0FHinxNpvhqyafUJgHI/dwry7n0A/rXkfg/xJqd5o9tDp0i28CrlrhwMAAViahqVm+tPdsz6leI2POk+4D9K6HBN8zPNSexn+PPEmr+JraW61qVtO01c+TbKMk+9ecaBYxQ3TXCsGySQzDBxXeeONdfXVG5IyYxglVGK5ASxwxliOApqJWudVNtRsdnZ6ZGdCk1O5uPLZWxFGB96vVvgVbTwafeySj93PtdfzP+NeF/DW5ufGWpTaEXRHiyYt3GcDNfS/w4sLvSvDiR3yoJEYqdpzxnrVXUo3RjVvF8rOvfO07euOKp6bAIVcxt+7kO7Zj7rd6u1StnKahcwEYUgSqfrwf1qI7NGT3PM/jt4OXxFosrBMuEJVvQjFfEF1A9vcSQyLh0YqRX6YX9st5aSwP0dcV8N/HXwlLoHiSS5Ee2CdvyaoqrnhzdUd2CqcsnTfU8u7UUpGBSVynqBRRQeenFICKX77fU0zPPFOkOWP1pvetDkClFJ3q3pls15fwW6/elcKKAvbU+i/2ZfDKYF1cJ887dx/DxX1WYkESx7R5ajAH0rzj4NaLBYaV5ioAY0EY49ua9JY4RiegFdcvdtFHkSlzycmZXh2PEdzOesspx9BxVfxldQ22lk3EjRpySVOCMCtPSAo0+LaMZy361yPxInaSD7LDGruVwxP8ACD3rRa1GyNopHhPji4gsreTXvtZOxisW77zGvNtN8SX2ptcTXse+OU5VsdKn+L1+9zrNto1rP5tvHyVHA3ZqbR4fsunxQJGpzjdxWcpXkdsIqME3uzW0y/kDReUeF4YY6iug+2Jbhn3yxlh8oPIzWXDYgJ5sQCqvLc1PHp0mowsS7KB0561SujN2Z1egeKbJYzbaraRyIeBLHhSK8z+MHhq6nuEv9MLXdoefl5K1rwaDdy28pjYgoeGJ61f8IajPb3k1hqkWImH/AC05B+lD95csgj+7fPE+fHRkYq6lWHUEYNIK+rdY+Del6/bLd2TQv5o3ZQgMDXnGsfBS90y435LW2cHeen5CsJYeS2OuGLpy30OW8Kx+TfWjRFiHXmvTodMuQgkRijONqoOpzXRfCzwh4X0uwkutcb7Vdw/6uJeg61g654rii8aMkYWOGNcxxjoK2jHlV2c06ntJPlN7xxLD4G+EFvYI2NTuplnbaeVHvXZ/CfxlpvjPw/b2GolBe+WI1YkfMeePrXzb8QfFFzrXiGCGSRnjxjaTkVB4F1yfw/rM0aM6GOQMvOMUvaWlZbD+r3p3e+59UX3gK01SG6htJxb6nBkeWfusOx+h9a+c/ivo3/CP2MsWo26i+Mm0Fjk969N8NfFCS48VSTtIzXDRBMHox96yvHfgeTxZdLc6rqJiuJZN/DZwCf8A69XP307EUn7Ka5z5ttLeS8nEUKlnPQAV6b8P/hpfahJ9q1FGhtYvmbcMAj619A/Dv4MaFpunwXDEyqwz5hA3P+OOBVr4z6hZ6HoMFjppSDIIZY8DIxxmsoUUn7xvUxcp+7A82vtZdoV07TkWOxgGwleC2OKo2UvlXMallWJ+Ch7fWmaRas9odyYZju3dqo+IbZhFsifFyOcg1o3pcxSV7G5LpUe2dImU7hnJrjp7YK7JKDtBIz2rsPDl9bXWilLiRobpOjH+KjRNFl1m/eOAeaoJJbt1oa5rWHGTje55DaXmqeF/FUeqW6ywRl8CTBCkHivoz4deJ9Sj8RQqmoi4sb7DGNjkA+3pXnfj3RnuLeewAxHCODjgkVg/DXWbhIhAvmG4sGBwOuM1Efcdma1P30Obqj7hRtwz3qBwBfxN3KMP1FZ+g6nbalpdpe2jkwzKFYH+Fver8rAX8CnqVbH6UJWZxXLNeL/tI+FU1bwy9zFH+9TLZA5yBXtFZPiuxXUNAvIGUNlCQD7UQ3t3KTcWpLofm5OnluUPUcHtio66v4k6P/Y/ia5RBiKRi68epNcpXJOPLJo96ElOKkgoooqSiKXG5sY69jTO9PbBL5yD2AFMHWrOQK7n4RaYL/xbC7jKw/N+NcMOte3/ALO2nebqKSFTumlVFJHXrWlJXkjGvLlptn194UsRp+h28ZGGYb2+prRvSRZzFTztNTYCqABwOMVBf4FjPnoEP8q2TvK55uysMtZI4NMjkY7Y1jBOa8r+IuqXFpYyXKMAtwxJb0Wu+lmS7t7CwQ/61QZAOyivGP2jNXhiiewtHVRBHghT0JHStl7l31FFczSPBrWaPX/GV1NJ8saEqCvfmvbfCugWOo6A9isBjveCkhPWvKfhvpAW3kuZcAyMTlutb+t+PP8AhH5tkDB54jxz1rODSV5HVVTnLlh0Os1HR20axNpcKm5j8xzzVKXUvJRI0RAqDAANcNrvj0eI1jmV/IlX7yk1gQa7Na3BclpA3fOabqLoKNGVtdz1mz1ETKd6bFB554NRas1rejy5HCy4+Rh2rzO58bzBBFGm0jtiqUeuXVzOHkzz+lJ1EUqEtz2XwXrdxptw1s9wUkj5Ug9RXq114u8LyabZx6leFrtsbhzjPvXzLoN81xev5rgFU4JOM11Pgizt9Q15I7wGaJnw3zfd+lVGfRGU6SV2zu/FUtlYXs1xpccZWReVXoa+eNdv2uPEMtxsKc4Kt2r3Tx94RutG1qA6Te/aLKU5Ee3cV46Zrn9Q+DutavcxX1tBIYZfvfJg/XrSqJyLoThDdnh80zNriyxn5k5zUl1rLXmprNsUPnBYd69a+JPwXuvBvhdtagl8+R8I8agkoT/+qvCSGRhkFT+Vc0rwPQpyhUV10Oy0TWRpmp/bQobHTHrXqGk6/NEqapfSB42GSrHoK8R0icyTeWwB7r6A1b1rV7hkNqX4HXB4qo1OVXM6lDndj6I8H/HqOC/n0y4t1mtc7bcZxt9unSue8eawuteKLJJiPKB3FR/KvDfDO8aojRqSQCTgdK63VtTkn1CJwPuDBxVRqNrUzlh4xl7p6hJqybfKjKiNeNoqLyLW5gacH94PXqK8uk1KdYmaNsPnOaonxHfwuS7sFPoar2nclYdvY6DxPr/2S6FtEwjk6bs1pwfFV9F0OGx0tV84/wCulHU8V5Le3Ul3cvNKSWaoKxdZp6HV9Xg0lI9y8OeO7bWLeSwuYx57ncJCeawr95vDPi6LULSUN55w646j0rzGzuZLS5jmhYq6HINeo3zDxD4Yju4UzcRDJI61cZua13MpUlTd1sz3f4a+IbeV7i2eU2plTeik/KzV6xpt6t9b2lyBl0YxP7EjrXyn8OdUiLwJfnMQ+Utnla+ifA6M3hy6a1lEgjk3Rt1zgZxXRF80dTz6sOSR3lJw6kcEHiqqTJeacsitgTJxtPf0rO8IyyvpbRzQSQtFKyfPn5h61ly6NivrY+Tf2hdJaK/lmZeYZmRj+JxXiFfV37StjGovsAEyRCbHvzXyiaxxHxX7nrYKV6duwUUUVgdZC/3j9ab3pz/eP1pverOQBX05+zvp77tGRR84YyH8MmvmMda+uP2dVK6jYYAOLcg89PlNbUd2zkxfwJH0LcXcEEsUc0qI8hwoY4zVfW2EWlXjn+7VXxJ4ft9dW186SSGW3kEiSR9fp9Kp+KpHZLbTUb/WlSSTyQDW1NJtWOGTavc5LxP4iXwdpyTqvmalcw7YgedtfOXjlbqeONryR2ubmQu+4nJzXu/xWSztvEkGoaid1taQ7Yoeu44rxW8mk1zWPtd0ojUNlIwOgq6juaUdNSveSR6H4XaXftuCuEXOO1ePXt1LeTtLO5Zyeua7D4kayt1ciyjORFwTXD1y1Za2R6FCNld9R2cYIPNdJpIItBPkSN6HnFZem6c12CedtdHp9gbaR41J27cnNKCZdSStYX+z3dhK4XLcjC9Kka0YE7QBkVv2KCXSkfrsbb0qpfFYw244NaWMFJt2Mm0ZoJs56jGc113wrN5eazLHA5Egf5STXAJdF7xkKyBAeWA4rrPCviD/AIR3UY3SItC7bi3fNEXqOpF8rXU+pPBaX1v4jW21SKJmKZy/JHHavTOgr568J+NNP1TUm1TVr14tgAVc4ru9R+Jlpa2W7T3iu2x8pOf1racefVM89JxdmjutZs7PUrP7LqGwwyc7XwM/nXhPjf4Y+H42uJ7SyS4hT77KAQv4iptV8XajruHkcx7eycUWutXNlpFxatIXSfllY5NVGKSsxpyi7o8l8U/DRNJ0oalpz7POzshJy1eUNp98bwxSW8hlzyCDX0nqGoKtn5r4dgMbX5ArjNZubWG1a58ryy/BOPWsalOL2O2jXmtHqed+G7G6gNx5Ue5xwzY4H4092C3jZbtz7V1tpHJdWUcVvGsVux3O6Hlqr6h4Jt7qB7y2vzE3QR+pqOTTQ19or+8c7GySMIxhs1HqkAETqV+YjAwK0LLQbnT5SJ8t6N1q7cWIZCGBz9KVh8yT0POJEKNtPWmkV2dz4W8yPzIskk881zuoWBtHKNnI9TWTg0dMZxlsZ1dp8Pdbjtrv7BetttpeAfQ1xZGDSrwcjIIqYy5XdBKCkuVnrs1jPo2os1vzbyjIzyK9p+AfipIrS9t76ULAWyCexFfM+meMroWQs9QYyoowjnkj2rt/hzqYEczox2FuQO9dMJJvQ4a1KXLqfVPhK+83Vbm3juA9qCWiTPSuxrw34X6gtn4keS/MkYlXESde1evW2vafdXwtLecST4yVA+79a1qJyd0jhXu6HiP7SjrE1wzYJa0wM9utfIlfUf7V8hjtkkjkyJSEOD6Zr5crnxG6R6uBX7tsUdaSikrmO0jcfO31pu0gjNPkQgbhypOM03ccjPNa2OUTHNfVv7N8qT3Gny+aqFUIOe/BGK+U88k/pX0N+ze8spWOUFooDkBOvetqHxWOTGL3Ln1xHOkgcqwwhwTXl3xov761Nm+nsscg5R8/eql498fL4Rs2XTQLlpeZoyQSgPes3xDqkPi/wvpd8jrC0YDKrtzXSoKLdmefdtJs818b+KLjVkgkvQTdQjD+n1rl9a8QRadohureRWuJsoo7g+tXviXKBG00W1WC/vMdDXjVxO87fOx29hngVjUm4s7qFJSVxs8rzzPJKxZ2OST61etbWJ0R3J2nrVS3t2lkUAHaTyfauqsktpWEZTaNu3PYVhGPc65S5US6ZJDDdRx2wDRtj8K6pdOeaZDsCow61zZ8Pq0ka2j5fOdymugsJZrCVIJnMsY+8w5xWy8zlm09Ux1tbXVkLuykQNv5RhWVYQlruSO+Rmjx19K7aGexvEZ45lWYDHPeuDv9SnsL+SSdlKE4I9aclYUG5XPQNGktItM8lbWEr/tDk1SuvDyags906rbwxqcOeAKq6Q8N5DFexo4UjAU8Cud8d67e6vdrpsEhiso+HCcbjTbVtSYQblZFu0s7D/hG7u6373XPz8gHmr3w3jOp2rlTsgiOTnv9KyNPt7m50M6RbRboiPmbHQV2HhqyjsrOK0hyFByzD+VKKu0VN2TR12lzQwSEqAxAwFp86mW7YFSrMckelZ8sc32hJLTZHgck1fttUa3kIv2Vt44YDGK2OZrqjkfFkG62kW1dvMHJQda5ifXYLjw9JaXalSvyjcO9d/f+TM8k6ECWLkejVh+J9G0+XQBqV8BHE7YYrxg+tZyT3RvTktEzn/CxtL6A2FvO1re4yrNkq1WJJrnSpmtdRiDKvRxXH3NwNKukk0q4F1brySDkir8fi5ryINcwb0Q/MO+KzUlsdDpt6rY29Q1u3axEcDZckFmPapba4W709ZlK4TAz61gS2kN8XuNIlRoGGZIyeVqlcWs1s0Zt5yUH/LPtSuw5E9DtpbmFrZ44nC5Xg9MGvOtWjku2lO8fuSS2e4ro21YJpDRrBvuCc7x2rmrm5jeNtyETS8HHSiTuXRi4u4zTNPN1avcCDbCnBc9KrLaQ3GDBIM55FT32pT29iNOibEOMsB3rIRyoypKt9e1ZNpaHTG7u7hMqrI4Q5UHANejfCW5eweeaa3M0HUf7Jrzq3j82UL0z3rsPCd02myOIJTiXjZ1zRT0dyK6vCx9B+HrwXMqTRyKbuXhC3RRWRfHV/A/i2XUBO11bzDD7BwM1iORDYQXCu1tNFzuPQ1rNq1zqlglrdN5jN0OK7b3PK5bO/Qy/jg0+ueDrW/gBZEcM691r59SMuDjtX0jq0cq6JNaD512HcG6dK8GIgtr+QQ8OGwU7fhWFaN2mzvwc7RcTExSVcnkikaR3B8xjxjoKqHrXK1Y7SJmJJ9KRgAwwcjFNY8nvSd6s5bkkSl5FVeSxwK+l/hbEvhXwZK9vtOo3C/ff+Hr0r5r0+QR30Lsu5QwOK9uj1rdoaSOSDjhB3reg0nc5MTeSS6HQ2DeH9Utbm38SPffb3OROoOw+2arazpcbQ21jBfPDChzHtbqPrWRpXiO3ldbC9iVBLwpPqav+JNPkVYYhKRGMFXHUCtrpo5rNOxjeO7JIvCl4/wBoWVlAAGeeorxXpXs/jYwtosdrbAsHGGbHWvKH051MiYJdeR9Kwqq7OzDv3dSKxuzbyhz8yj+H1rq7DULWdAHhC7h0XjFcWC0cmSMFT3FWjqEhTgBX/vLxURlbc3lHmO/a806ztvNFwwI/hB5rHbxPFJNtgR0B6se9ckkgaRTOWZc881o6bZRajf7IVKQoNzZPanz32IVKMVdnU2E8M6NKs4UA8kHis7V57GNi9w5uWb7qqaqXps7bMNtMoj6MMnrWZb2lvMWzdAHsMc023sEYLc1ZfFV8LFbe3/cxjgY9KrQXoto0uZn824fny8/qazrmSBSFgQkrxubvUCNunV5DxnJJqHJmqhHoj3L4UIr+GdW1TUZAj4/drj3Ioj1m0gRN0ihm5IXvXLR3V6/hnNlIq2Z4bbxnmuXOoSykiJH3JxurbnskjkVLnk2epN4vGSqpujHAOOapv4jlkl2vEDb/AN49RXna3EqDc8hz3AqxbX7zMbGNiHcZBzS9oyvYJbHf3OqQR28kiS5XHTNS/EXUNMvvAVnFZXYMgAZ0z3xXnEF6DcGxuSwY/Lvq7rnh64ttEkm+V1UhgwPOKfO2mNUlGSuzjIZpIH3Rtj1HY1p2NzC7YRhbynufun61j/WgVzJtHW9Tfu7XUtPD3kQ8uJ+C0RypzTdGvd8rJdOWLDALngVkx3U8cZRJZAh/h3HH5U63Qytk/NjqM0766Ao3VmX7ie40+4xHLvhz65BqGa/MkbYjVWNUnJzgg8UzvScncqyQ4sWPPNPt4xLIFLACo8Z6Vd0+wnuXUpGdnc5xSWrKv1ZraZZwI4IVnY9iK7Hw9pqyTFjCAR0GKwbcQ6eFkuWQBeQM5Jpf+E3njdorVFjToH71vGy3OWalU+E9qsLaPUIbWxdFZieSaszaPNazXhTaqQJ19K8o8L+LpI9QiMty2RySPWvSbTxFHqmhasmSZzGcOeprojJM4alOUGYdreTvFdedcL5WGyzntXi3iOaCTVZTaNujB+8O9W9e1+e4i+xxuyxqSHIP3vaudHNclSpfRHo0KTg7sfnIx3NIevPWgqVOGBB96SsTpuSappt3psqJewPEZFDpu/iU9CKpV9AfFXSINV8H6Zc2qKXtrOMs+ORwK8AYYOK3qQ5GedSqe0jcToa7rwbrdyIWjuYfOgjHytjGDWV4D8JXvi7XYLCzjdgzYYqM17z45+GbeCfDMf2eIOu35mj5596unF7kVakV7rPE/E+rxvqUU0YKOpBx6V6tBq0N74f02aXBLIA3NeB3Zku9SYAEuz7QK7bUb97LTbW0iO0QoM57mnGerCpTTSSNrxDqcD3phRgEX7q1hRJbzSSuJUWT+7muWn1R5GckfM3fPSqEU0kblkYqx75qXNGkaNlYv61bvFcsWVgD0OKzAD2rTGt3flmOXy5VIx865qjJO0meFUHsoxWcmnqbLsyPHFT29w9ujiI8uME0+0itmR5LqQqqj5UXqxqBOWO0fTNJJopWehLDEJFJYnAqFMq4ZeKljuWjBUgMvoakjmeRjgRjvyKejGV2IJziul8EeDNV8Y6ilrpsR2scGQjgVR0ewF3ewtKMQs43HHAGea+7Ph34X0ay8N6Zd6AI4pDEpMoQHJxyDWkKabvJnPiK7p6R3PlzxtoVz4L0tNFch36M2Me9cZp8Q2FSBk8GvsH486JpOoeCbq5uY4/tyY8qRcBmORn9K+W9GsDGQxGVPWrktrGFKpeLvuRWejWjEvdysqY+6M81jajpuzW4pbNCkQP1Nd5IsWwKq8epqNbRTIh2DB/ixScS41Gnc5ibSdxd3TDHkNTLm7n+xfZJWZ4On0rq7sgkxcHA44rntSsv3TZIB6gihqw4yvuchcaWzB3tznB4XvWS6lGIYEH0rfF1PazbJFB7Agdaragn2gh8BXI64xmspR7HWr9TIp6Er0OKdLE8Rw6kVFWZexMGBHHXvTrVIXuAlw5RDxuHaoAcUoPei473LN/AtvOUSZZVxwVqBZHUYV2A9jTevNJRcV2Pdmb7xJPuaaKKKQyxaztBIHXrXoXhG/kt5ElEgdZPldPavNa6DwjqH2bVIVcBkJxzV05WZFWPNEseNNBksL6S7hXdaTMWDD+EntS+BPDcmvakoZW+zofmI7+1e+eAfCqeJL5VuoCbLgnzB8prU8exeHfBu600JIUm6ylcYU+ldHsU3zdDj+tO3IlqVtP+G3hLWYY7DUpo7WUjCPn5s/nXg/xf8IW3gjxtc6NZ3X2qBI0kVz1G4dDWrN46ZNVLiQMAwwc1y/j/AFZta8SS3jtuLIi5znoKirKLjoaYaFSM/eeh7xpmnQax4Xisp7jyUvLNUjlAyA4HQ14z4/8AhlrngwRz6isLW0zYjeN92R2NaXgrx+NLsfsss5hKcLuXcP16Vn/ETx7deI44rQ3DzQxnO5uPyrSThKOpy0o1ITstj379mfTtN0iIKAjalPEWjJx1xyAa6i41m88VanN4d1iEW0zSFAhXArwX4Za3Jd2lu1vObe+sn+Vlr2u61OTxDPbjUEW28QWyeba3UXAlxzg9q1p2a0OWqmpO5x3iz4Jad4VtbjW2uhNMGJSIdB79K+e/Fc7G9bDYDHoO1fXHivxmur+B2nurVDcQs0UwHY4618eeJ7hLnWLh4xhd54/Gsqq5YnXhZOTbZk8ml96T6UoOeK5TsQGk96dtNLjNA7Maeg60oJzxV+10m7udpjhbYf4jW4vh3ICAKoxyx61Sg2JyUd2coAScDrW5pmjSv+8mHydh611Gi6Jp0SZeJnl/vGthrGMQmSLK+XyVNaRp23MpVraIr6bpkUKRKwBc4IQCvp/4NeKNPfw+mmXEsdtdQMcI5wGGB0r5r0N45ZpJXwG6AGuh0yG5utSigsoWmuXyUVevAJP6AmtUlY5aicmeo/GfxDFdRpYQlTJn5th4xxXjcNvFDKygnnt2q3cymOYmfcZG5yTUKSrKQGj596qTuxQjyqwhWLJ+bHoM1JGdwxk4HFRT2sbAEAqw9KREuFwGKslLYsVoQ8mQeBxWFrW1GMYOfc10CKhf5SQR2qlf2jyyFjEjrnqaloqLszO0rwu+owfa5mVIEBIHc1Uk0WBpC0icDgYFdpFe+Ro4t4oxyMEisuZsWLYALngUOKGpyucNcaQ04kDH5FPy+tV/+EWd4vMWXA967QQgosaoQ2MkirMNtnCOMjGc+lRyJmvtpI88Hhx1B3OG+lI3h1yp2PtfsG716DLaRwS5TkkdDUZjVh8yA+3pS5ENV2eX3GmXlu2Hgf6gZFVmjdQNysoPqK9UV5reUIQroemazZ9KvL7Vre4WNTCjZZKl0+xpGt3OG/sy9MPmi1mMf97aaqEYOCCD719K6lq2l6b4WceVG1yo5jxzivn/AMSXUV5qsssEYRCegpVKagtx0arqN6WMqp7E7b2A5x868/jUOMinwf6+MH+8KyRu0fZfhHVhp3gmRooif3QCSDsdtfN3xN16e61JrYStvBzK2eSfSvoHQopI/g15oLMuRg/8Br5R8QStNrN28hyxkPNdleTUEjzsJBObfYoDrSsxZskkn3ptHNcR6dyFzlz9aTHrSv8Afbp1NJWhxl/RdUuNH1CO6tHIZeo7EelfW3grde6D4f1a9AUSMSq9wK+Ofeve/hT49QaB9jv2R5bZCE3sBsHPIzXRQlZ2Zy4qDkro63xHtdPEcdo2I2BO0c8818wX4xfTg9nP86+kPh9qcfiH+2bY7GMisEYnqa+fvF1jJpviS/tZVKskzflmnX1SYYb3W4syOtOA9KREZ2woJ+lOHFcp2xNCytopQI2bMz9AP4a6fR9GhhiZseY+OpFc94btWudURA2zjJJ9K9EgQL+7Q/KvfHWt4oxrTadiuHeJolTjjoBwKtY35bBGOtTKp+Y4GPXFaEYDQBSOvUYrSxzNmRYZmMhVdiqeCe9aUUMs6MsrbFxz71MECKqKvy/SpCxA92OKaQmzNsrbyrplxmIdDXu3wE8OoZ7vXpkyEzb25I7nl2H4YGfc147jHtXR+CtU1SPX9D0+DVdRisWvoUa3juZEQq0g3DAPfJ/Ok1oJ6mb8VIJNA8aX2lmEC2D+ZA3/AEzb5gPwzj8KwobllG2RDnsar+I7jVNa1COTUbq4uSgCCa4kZ2C9cZJ6ZJ/OrVo5todr4mQcBu9CLsrEzMQFOPmbj6VCs0bXhjWdCwHKA9KrX813Die2AePup61zkVgZdSa685oEPL89DQ2VGKZ2KyRmdlAyAOSDUM0+9zHF6c+1GmG3uLON0l4B59TTb2SIW8qWAIZuC7U+hPUSzG6JgHyM4IoQsS2VJjXNV9L8xItiDgcZPc1qYwoBpIb0E4CBgvzY6UiHcxOCAOKkJOfpQOcU7CK95AJNpBPBokeNVVIwDzyfSrDsFBZjgAd6hCBbZQ3WQ5pNDRn3kZS53ZJXGamtZZI2QpwZOme1SOAVY9h8qk9agEzjAI+Ve9IofrU1i/he+nmjI1AEpuz29q8bdizknvXp3ivWDbaU1u0K7ZOjY5rzFjuORWNV7HXh42ixBUltH5txGgOCzAZ/Gox9a3fB2nG/8SabBIreW8y5OO2axirs3k7K59X6sBpPwQ0y13bXmUMR3I218g60QdUuSvTfX198Y7tLTwfp2nRpxHbjBP8Au4r46vm33kzerGurEaJI4cDrdkFFFFch3kD/AHjjpmkpW+8frTfatEcYpoViM4JGfSkopiPRPhNrv9maoFDlcMCP9rmvTvHHgDS/Fzf2ra3qw30ibnjBFfO2n3DW15FKrEbWB4r6L+GUaarCs8ymbcuAFPJropNSXKzmrpwfOmeH6pYNoXmRxzo8wbY4/wAKyZ7mFmTyoQoH3uc5Nex/GXwG1g5vY4fIVhuAPevEXGGIwRjsazqJwdjopTU48yOx8FWnm3VzdocwonOeMH0rsLdlEQznJFct4JSeKwlDLiGQ5B9a6lDtPOOmOauOxjVd5MnjIcAHIUc1aXcXUpyvcVWhY4Ee0Z681chDBRnH4VaM2PycnpjtUsRAkUnpmohnB9Kk6D3qhCOFMhPUZrY8G4/4TXQAM4+3wf8Aoxaxee4A/GtrwWP+Kx0Hgf8AIQt//Ri0mBhyx+arKWIHtTYo0RAoHTmpKDjjPBoGVrqT5Cu05rnrqOSeJolO1nPWt+4IZD8w3dPpVWOIJJHj5jUvUuLsSWlt9mhSKMABV5PrVqBFMBUrk5708nGc459KmH3fT2ppCbGKiqAFAAp2ckEUdSKKYhQeWzQmAwzSfSnY754oArTxtLMNw/dg5p9xjfERnb0IqTueMn0pkoDRnccd6QyC7dQAAM4qpGjsxAbrzipJHGQAc4FJC5Mu1DywxmpKOJ8Yzll2O2SG4rk+h4rf1hXl1Ce0uyUmBzGexNYLgqxUjBHBrmqau56FNWjYbnmve/2afBUuu+IYdWvRutLQbgG6cHivKfAHha88WeILfT7KEys7YIBx2r7T8M6NZfDHwW8Urqbl1JwDxnHStKMLu5zYutyrkW7PNP2idTginkMD/u449mOwPNfKjtuYt3JzXpvxk8QtqOoNErkhiWIz2ya8woxErysi8JDkp69RRS0lFc51XIH+8cU2pJjmRvqaZWiOMQ9aKKKBBXpnwV1uey1+K3E7Kh5AJ47V5pk4xxWl4dvWsNXt7hTjawzzVwfLK4px5otH198SdPk1nRk+0MHiZeGr5W8ReH5dOu7neDtXkN2r6g0PVYtb8LmKTIm2fLzXzz8R7i7F/NbTuBGp44611VkpK5yYRtS5TE8MSTLEyqxKbunpXawc4Jfccdq840W5aG6ClsK3H416BYF2s1I6nPQ1hB3R0VlqaEbfMBjpWlCcpxmsxAFGXJ9qvWrHbwcD0zWqMGTqw6c0/t1NICduSf1pSSW69qYgYB/vc1teCsf8JjoPPH9oW/8A6MWsYZ9ea2fBef8AhMdB5P8AyELf/wBGLQwMWkZlQfMQB70bm5Paq8wW7iaMkpIMlc8UDRWO2WRihHB7UZVZAwJOKiSK4TCxJ+8X7wz1pWmbngh+mCOlSWS2swacoevWtEEMueo9ayUtzAwdpd0zcnB4ps1hJdTIxu3ihU8qp60JhZGwOnegH86iRWQBY3+QDgscmpQcjNUSKfxpRj8aDn/Jo59aAAYFQy5BOBketPkZxyDxVdnbAAbac+tJlIr5Uk/r7VEeMCMHGfSlk3FyARnPY02WTy4i5ONoyako8/8AGMofW2Kk5VQM/nWVM/m7GAPmnhsd6XUZzcXs0hbduY4Neg/BPwPN4x8QxJgeRE25iegAwTXOk5SaO5yVKF30Pcv2X/A7aNpUmv6nEYndcws3HBBBP5cUvxv8XLLCyMyrBDkpg9frXrniu9tfDvhYxIgWNYxFGo44GK+JPij4ibUNRe1icmNTlsH9K6bqELnm04uvVuzjNUvJL+9lnlJJYnGewqpRS1xN31PWS7BRRRSGQy/fbjvTadJw7fU0ytEcYUUd6KBBSg4INJS0DPpv9njxRBtRLqCGZj8hMn8PX1qn+0f4Els0/tSzhJgc7sgcAYryH4a62+lazGgYBXbIz619q29vbeP/AAGbadiZdhX0wccV2RanCzOGadKrzI/P/wD1YDA/PnpjpXb+F9R86zUM3zpwaz/iN4Zn8N+Irq0lQoodsZ+prC0a++xXIZuY24aude7KzO12qRuj05XBG45IqxDOARtBwe9ZtpdJJGmCChGRVxWKofk4NbHK0aKT8YYfpVhT7VlJI+FJ7dqspK4bqAKdxWLwIqe0uZLO6gubZzHPA6yRuOdrKQQfzFU0YEcd6AzbvmIxTESEZGMkZqpceaq5zyOh71Z4HLEVFOgkXdu4HahjRT86VAC5Jb+8OtMhuFdm3Lu+tOkjyCS2VPGPSuWup30rVisrl7eToT2qG7GsY82h1JlRJN8pGO2elN3rKwKcr69qwbS4XUrsR5zGOwroIkMSbUIWMdqE7g42LkEh2E43DpirCMCv9MVWt2UoN6Y96eH52owzVIgnPTvTTgMo547Uzec9eabJKoYZySOwphYJ5Pl4H5VC3Me5gMClDnzCeoPYUzZIwJjUnnpmkMpJtNxsXKu5wM1jeONRjsrVbG3fdM/32B6Vr+IbmDQrVp7lw99KuI4x/DXllxM9xM0srFnY5JNZVJcuh0UYcz5ug+0t5Lq5ighUvJIwVQO5Nfb/AOzx4Mbw14VW7u4hHdXIBA7hcDn8a+fP2dPAs3iTxVBezRn7FbHezewNfW/jXWY9A0Mom1SybEyegxiijDT1McZVu+RdDxf49eNxtljjdljhyqrnqeK+UbiVp5nlc5Zzkk12XxN12TUtWNuG+SI5b3JxXE1NefM7LZHThqfs4ebFpR0pKKwOlBS0lLQAwRSTTMsMbyNydqKScfSoe9e23lvf2XjTxdEtnqDazcyW00K6deLaTeSVbzGDqCNmduR0zj0riPE1lpQ0KBbXUPtmpQNcIEKhVMKzufN3A/M5/u46ZPPFdDpWR50a1+hxIxuGRx3oNet6pJpeq3et2Wkadby38+q2XFzfAxXXyyZAA2lV65w3fGa4vx/atZ6zFEdBh0NfIXEMUjt5vJzIdzvgk9s8YFKULK441OZ2scxRRRWZqS28rQzJInDKcivrH4EeLv31rH5wEMy7WBPFfJVeg/CrXHsr8WxcqQd8ZB756VtRlZ2ZjXhzR9D6W/aN8AQ6/ozavaxM1xEvz7PT1r4wvrWSzuXhlUqynuMV+ingbV4vEfhsLOBIQnlyK3O4YrwH49/BhoC+s6G2Ye8eOV6ccVdSF9OphQq8uktj5+0DVfs0ixzHMZPX0ru4LpWQOpDJjjmvK5Y3hkZJFKOpwQeCK3NA1r7NiC4J8o8BvSsoTtozrqQ5tUd8jK4LjuexqzB8zKoI68k1lW1ypA8pgVIyM1bEuzIAJP8AFmtrnO0aRaON2O4nA6ZpplJXjBJqmsisOuPrTkZsDt707iLyybhyAx9PSkL7W+YoBUIZvUZ9RTcgrjPT2oCwxxgkxc55rG8S263VshZPn6VssWUZ6+lUdQm22EzTJjbyCallxdnoc5ob+Rf7F6gV2QcFQ3avL7DUDDfGV+jHn2r0e2lSeKNs9VB4qYO+xtWjZ3LnmHYARkfWpEK4XGRVVc/KRj0qYZ2DLqR6CrMSwW5B4xSkZwflye9Qbhtz/OovOAxk5x+lAEskgXDDaPSs3UNch0+GRhKvmc4Hv7Vk+IdaFoNiHLfw4ribu6kupWeVs57elZyqcpvTpX1ZJql9LqN488zEk9MnoK2vAnhO98W6zHaWcTNGCPMcDoKwrC1e8u4oI/vOwGfSvtL4B+Bo9F0uK7MTRrgEMyjMp55PtUU4875pbFV6vso2juz0TwP4YsfCHh2Gws0Vdi7pXxyTjn8K8V+N/iwS3E5bCQ2ylVGep5r2nx5rkei6JMSf30qlUH4V8T/FvXZbzUjZhjjO+Tnqc10X5YuTOGjD2k7Hn9zK088kr/eckmoqDQa4T1gooooGLRRRQMinUCWTgDk8AUz8KluBiaTr941FVo4xDj0FKMDoKQ9aKYhaKKKQwqxY3L2d3FcRH5423Cq9ApjPqH4P+N5IJbaaGTEMhCyIemeMivppGt9V07JUPDKvIPOK/PHwB4gOlagLeZsW0x6n+Fuxr6q+Gnjj7En2a7YPEeh3dR7V1xftI6bnn1ockvI85+JfwQ16712+vbeKMwEExSRYO72Ydq+f9Z0q80a/ks9QhMU6HkH+dfpbYX1tfwCW0mWRD6HkfUV5J8Z/hQPFsEtxp8ELXJ+YHo4PPSs5QUr9GaUq7jZPVHxXZ6hcWpGxsoD909K6Sz8UxPhLiIxj1HIqLxb4F1jw3dvDd28h2nBOwg1yrKVYhgQR2NZXlDRnZ7s1danqVpe29zErREMKuFl2gKfwrySG4lhOYpGX6Gr9trV1E4Lv5ig5IbvVKoupm6PZnp4b93lE+UH71IJl6lcVwtx4wvJyoZEWJeiLwKgbxNcMpAUD8elV7RCVGR3c1yirycHrzXHeJdb89WtoGJzw1Yt3qtzc8M5A9qog85PWolU6I1hSUXdmtNpLRacs+csRkj0qXSdbe0VY5OVXgH2rMa8nZcGQ49Kr9ajms9DW11ZncW/iS3IYk4I6DFaMOs20kSlHAJ615tzT03Z4JFUqjJ9jFnos2uwRclg3FYWpeKWkDJbrx0z0rnIoJJTxn8avWekySuNwfHsM03KT2BUox3M9mluZSWJdzW5o/hi81FlEack8Cuw8K+B5b6RQimPPTcvJr6c+Gnw80vSreC5vv9IuyAVTaQq/41UaPWRjVxSjpHc85+GvwYtr9NNub1HiW3YSSHbjf3wK+i9Tv7TRbEPLhI1G1EUdcdhVPW/EVjoyMJiMoPuggYrwP4jeP/tQkc3WyEZ5J/QVuo9XojhvKo+7Ivi745N1HcXTYWGMYjUdz2r5j1G7kvryW5mOXkbJrV8UeIZ9amCklbdD8q+p9TWDXNVqczstj06FL2cfMWg0lKRjGCDxWJsJS0lLSGFGaKKBjbk5nkP+0ahNekWvgK2ufEuu21qdQ1Gx01YDiFooZpfNUEN8/wAoAOeOTyPrXnt3EIbqeILIoR2TEgwwwehHY+tbODitThjUUtEQ8c5HPailOMcHnuKSpKClpKKAFzRSUUDFzXbeEfGkunBLe+LPCowkg+8tcTRTjJxd0JxUlZn1V4O+IMtpHFJbzg553g5DD0Ir2Xw78QrHUEjW9UQSMcb1IKfz4r4A0zVrzTXDWszKM8oT8p/Cu/8ADnxCVZEW+Jh7ZXJWuhVYz0kcs8O1rA+2PEfhrRvFVjsvoY5QR8s0eNw/GvAviF8ApTvl0sCaL+FkHzj6jFL4T+IM9rHm0visTc/Kdw/KvWfCvjaza2aTU9XNxM5+WPywoX8q05LrujBSlB6aHxdr3gHVtHneOeGTKnHMZGa5m5sLi2OJYmHviv0XnXw/4lhxcx285Ix8wG4fjXM6v8H/AAnqSfLE0J9UII/UVjKlH0OmGLf2lc+Btp9KURtjO049cV9rzfALQ0WRrcqz4+UOoxUC/APTSqs8kW/uoXj+VT7FdzT63Hsz4wWJ2JCqSR7VLHaTv92J/wAq+1bX4EaOrHzzHjHAVR/hV62+CehxN8zfKOgCA0exXVh9cXSJ8T2uiX10T5UDn8DWxY+BdZuzhLcgfQ/4V9u2Hwt8PWnPlO5/Af0robfw/olqFEVpbIV4J4z+NNU4d7kSxcuiPijTPhHqtwqmYMC3RApyf0rrtJ+BN/LGzyxS7h/AFP8AhX1VLf6LphwZLaJl6YAz+dYuo+PdLtSwWdDnoRya1jTXSJlLE1H1PG9B+AEm8G6IRMZ+Y4x+leieG/hR4f0F0uL+WKVk/hOAv4561heIfik671iuQiLzxxmvMfEPxUL+Yz3pYn+AE1TUYkpVKh9Gaj4i8PaEh+y2tsWHQRKi5/GuE8RfFyVYXS2ihto+QDuy355r5s1X4i3M2RbKWJ7uTxXH6hrV/fsfPuH2n+EHArKVWC21N4YRv4j1Hxp8SpLi5k/ftPMfRsivLdV1a71OTdcyEgdFHQVn5yaKwnUlPc7adOMNgopKKzNBaKKKAF7UlFFIBaKAaKBnb+KPELQeKNQXWfCcVrFcRQi50uWaZcsi/u5N+d44PQHBrBk0fxD4hiv9fi0q7uLQvJJNcxQkxoR8zc+wIrS1PSJb3xJp2iSavo1rbCJkgup79JIYlyznzZUzhmbPHYsB0pdDa1vvDa22pNpBtbQzMXlneK7hDAHMa7wsmSOBtbHOetdVnJ2Z50bRSaOLzzRXpWlRaPfWvhWORNNDNe28clsBEzS5IDhtn77HUnecdl7VzvjIWn2fTdj6Y+o/vPObTQoiMXy+VkKAA3385+bpu5qHCyuXGpd2OYopaSszWwGkpTSUyRQSM470dqSigYtFFFIZas7+5s33W0zxnrweDXW6X8QL62CrcxrLjuDg1xFLVKbjsJxUt0ewab8To4CpSWWMnrknj9K7bT/ikfJQpfAj0Jr5ppQxHQ1qsRJGTw8GfVcfxhuVk+W+VW6df/rVrWfxZuXCu94CV7buv6V8f72z941LHczIMLK4HoDVfWH1RP1SHRn2Y3xfmMZ+eNCeh/yKzbj4sXiqH+2jHsf/AK1fJf8AaN0Vx574+tRm6nJ5mf8A76o+sLoh/VF3Pqe4+K947Ai/O3uA3Wuf1f4oEsTNckj/AGT/APWr51M0h6yN+dIWLdWJ+ppPEvoUsJA9Y1j4liZmMbFz7k1y2oeOb2fiL5K4+krJ1pM2jRhHoaF7q95dkmWZsHsKoEknmiis229zXbYM0UUUgCiiigYUUUtABRRRQMKWkopDFFFAooGdH8SdLs9H8Uy2mnQ+Tb+VG+3ezckZJySTXLGiitp6SZx09YIVHeKRZImZJEIZWU4KkdCDSCiipK6hSGiikAGkoopiFooopAFKKKKBgO1FFFA0FLRRQMUcHI4I7ikFFFIBetAoooKFFLiiikUgooooGFFFFABiiiigApaKKBhRRRQAtFFFAwooopAL3pKKKBn/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A right-sided acoustic neuroma of the eighth cranial nerve is evident in the cerebellopontine angle (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter C Weber, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22448=[""].join("\n");
var outline_f21_59_22448=null;
var title_f21_59_22449="Shigella and actin EM";
var content_f21_59_22449=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Shigella and actin filaments on electron microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 281px; height: 220px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scanning electron microscopy of HeLa cell infected by Shigella flexneri. The cytoskeleton has been insolubilized, and the host cell membrane has been removed. A dividing bacterium is seen with tight bundles of actin filaments at one extremity (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Prevost MC, Lesourd M, Arpin M, et al. Infect Immun 1992; 60:4088.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22449=[""].join("\n");
var outline_f21_59_22449=null;
var title_f21_59_22450="Patient information: Rhabdomyolysis (The Basics)";
var content_f21_59_22450=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16961\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"         Anatomy of the urinary tract",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/5/93\">",
"          Hemodialysis",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/22/25952\">",
"           Peritoneal dialysis",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/9/32913\">",
"         Patient information: Acute compartment syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/46/5859\">",
"         Patient information: Acute kidney failure (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/59/23474\">",
"         Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/1/25619\">",
"         Patient information: Hemodialysis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/43/16051\">",
"         Patient information: Peritoneal dialysis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/53/10066\">",
"         Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Rhabdomyolysis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/rhabdomyolysis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H8801344\">",
"      <span class=\"h1\">",
"       What is rhabdomyolysis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Rhabdomyolysis is when muscle tissue gets severely damaged and substances from inside the muscle cells leak out into the blood. This can lead to serious problems in the body, including:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Kidney damage &ndash; Normally, the kidneys filter the blood and remove waste and excess salt and water (",
"        <a class=\"graphic graphic_figure graphicRef79864 \" href=\"UTD.htm?26/28/27072\">",
"         figure 1",
"        </a>",
"        ). Severe kidney damage can lead to &ldquo;acute kidney failure,&rdquo; which is when the kidneys stop working.",
"       </li>",
"       <li>",
"        Not having the right amount of certain salts in the blood &ndash; The body needs the correct amount of certain salts (for example, potassium) to work normally. Having levels of these substances that are too high or too low can cause problems.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Rhabdomyolysis can be mild or severe. Severe rhabdomyolysis can be life-threatening.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8801359\">",
"      <span class=\"h1\">",
"       What causes rhabdomyolysis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Different things can cause muscle tissue to get damaged, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Muscle injury, for example, from surgery or getting hurt",
"       </li>",
"       <li>",
"        Very intense exercise",
"       </li>",
"       <li>",
"        Lying in the same position for a very long time, such as being in a coma",
"       </li>",
"       <li>",
"        Some kinds of infections",
"       </li>",
"       <li>",
"        Some kinds of medicines or poisons",
"       </li>",
"       <li>",
"        Muscle problems that some people are born with",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8801374\">",
"      <span class=\"h1\">",
"       What are the symptoms of rhabdomyolysis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people have no symptoms. They might find out they have it when their doctor does blood tests for another reason.",
"     </p>",
"     <p>",
"      Other people have symptoms that include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Muscle pain",
"       </li>",
"       <li>",
"        Urine that is red or brown",
"       </li>",
"       <li>",
"        Muscle weakness",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8801389\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Call your doctor or nurse if you have the above symptoms, especially after getting hurt or exercising very hard.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8801404\">",
"      <span class=\"h1\">",
"       Is there a test for rhabdomyolysis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse can do blood tests and urine tests to check for rhabdomyolysis and any problems it has caused.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8801419\">",
"      <span class=\"h1\">",
"       How is rhabdomyolysis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on what&rsquo;s causing your rhabdomyolysis and how severe your condition is. Most people are treated in the hospital.",
"     </p>",
"     <p>",
"      Your doctor will treat the cause of your rhabdomyolysis, if it can be treated.",
"     </p>",
"     <p>",
"      He or she will also treat any problems that the rhabdomyolysis has caused. Treating these problems usually involves:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Fluids that go into your vein through a tube called an &ldquo;IV&rdquo; &ndash; Fluids can help the body flush out the substances from the muscle cells.",
"       </li>",
"       <li>",
"        Medicines to correct the salt levels in your body",
"       </li>",
"       <li>",
"        Treatment to help until your kidneys work normally again &ndash; This can include medicines, diet changes, or &ldquo;renal replacement therapy.&rdquo; Renal replacement therapy is a term for treatments that take over the job of the kidneys. It involves either:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Hemodialysis &ndash; Hemodialysis is a procedure in which a machine takes over the job of the kidneys. The machine pumps blood out of the body, filters it, and returns it to the body (",
"        <a class=\"graphic graphic_figure graphicRef56992 \" href=\"UTD.htm?0/5/93\">",
"         figure 2",
"        </a>",
"        ). People have hemodialysis at least 3 times a week.",
"       </li>",
"       <li>",
"        Peritoneal dialysis &ndash; Peritoneal dialysis is a procedure that people do at home every day. It involves piping a special fluid into the belly. This fluid collects waste and excess salt and water from the blood. Then the used fluid drains out of the belly (",
"        <a class=\"graphic graphic_figure graphicRef71539 \" href=\"UTD.htm?25/22/25952\">",
"         figure 3",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people with rhabdomyolysis have an abnormal build-up of pressure in a group of muscles. Although this is uncommon, it is an emergency. It usually needs to be treated with surgery to cut open the muscles and relieve the pressure.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H8801433\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/46/5859?source=see_link\">",
"       Patient information: Acute kidney failure (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/59/23474?source=see_link\">",
"       Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/1/25619?source=see_link\">",
"       Patient information: Hemodialysis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/43/16051?source=see_link\">",
"       Patient information: Peritoneal dialysis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/9/32913?source=see_link\">",
"       Patient information: Acute compartment syndrome (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/53/10066?source=see_link\">",
"       Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?21/59/22450?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16961 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-794AB5B1AF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22450=[""].join("\n");
var outline_f21_59_22450=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8801344\">",
"      What is rhabdomyolysis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8801359\">",
"      What causes rhabdomyolysis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8801374\">",
"      What are the symptoms of rhabdomyolysis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8801389\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8801404\">",
"      Is there a test for rhabdomyolysis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8801419\">",
"      How is rhabdomyolysis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8801433\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16961\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"      Anatomy of the urinary tract",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/5/93\">",
"       Hemodialysis",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/22/25952\">",
"        Peritoneal dialysis",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/9/32913?source=related_link\">",
"      Patient information: Acute compartment syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/46/5859?source=related_link\">",
"      Patient information: Acute kidney failure (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/53/10066?source=related_link\">",
"      Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/59/23474?source=related_link\">",
"      Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/1/25619?source=related_link\">",
"      Patient information: Hemodialysis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/43/16051?source=related_link\">",
"      Patient information: Peritoneal dialysis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_59_22451="Classification of jejunoileal atresia";
var content_f21_59_22451=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classification of jejunoileal atresia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 408px; height: 411px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGbAZgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKDQAUVy3iLxxpGi3K2e6W+1JzhbOzQyyfiB0+prHjvfH2vQb7WxsPD0TD5ftjGaX8VXgfnQB6DRmuHt/BOozRKdX8W6xPOR8/wBnKQoT7DaSPzqZ/AcAVzba5r0ErY+cXe7H4EEUAdlRXCv4b8T6UBNofiWS+ZRzbaoisr+wdQCD+Bq9o3i9XvY9M8Q2jaRqzD5Y5WBjl/65v0b6daAOsooFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFY3iDxPovh2IPrWpW1oD90SOAW+g6mudPxN0m5QnRLLVNXP/TpasR+ZAFAHd0V58fiDqRUMngjxGynp+5UH+dPt/iPiULqXhnxDYoQT5kloWX/AMdzQB31FcLZfFjwbdPsOsxwSZIK3CNEQR67gK1h468KmPzB4h0zYO/2hf8AGgDpKK5WT4h+EEBJ8R6YfZZ1JrOPxY8HmbyYdTM8xOFjhhd2Y+gAFAHd0VwM3j2+uHVdE8Ja1fK3/LV4xCgPuXIot9S+IV4+7+wtJsIuoWe8Lt/46DQB31FcNd2XxBuJT5OqaFaRYGMQSSH9cUsFt8QLSFi99oWoPngGN4f8aAO4orgJPEvjDTJwmq+EzeQdTPptwsn/AI62DWlpXj/Qb7UV06W5ax1JulreIYnP0z1/CgDraKQe1LQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUZFNd1RCzsFUckk4AoAdRXI3/ji0N4bHQbW41q/6FbQZjQ/7ch+Vfzql/ZPjDXoM6tqsWhRFs+RpwEkm30MjDGfoKAOr1jWdO0a1a51S8gtYV6tI4FcZPf6147SSHw9NNo2hkFH1F4iJ5j/ANMlPQf7R/Ctay+H+gQyQTXttJqd3CwdLi/kMzBvXngflXWAYwB2oAyfD3h7TdBtfJsLZFdh+9mIzJKe7M3Uk1rjjiiigAooooAKzdf0fT9b06S01W3WeA88/eQ9mU9QR6itKg0AcV4Z1C80bXX8Nazceenledp95IcNNEOCjerr69xzWlr/AIz0PQ28u8vVe5P3beAGSVvoq81jeP8ATtM1TxN4ag1NImCmd9zSFGUbQMggit7w74b0LRS76NZW8cknLzD5nf3LnJP50AYS+JPFerW7SaH4YNshOEk1WYQ7h67BlvzFOGp+N9NQz6no2n39uq5ddOnPmr9FcDd+BzXZW91DcSzRxOGeFtjj+6cZqrfa1p+nsBqF3Da5OB5zhc/TNAHNWnxK0GWNmuxfWDJ95bu1ePH5itzR/FOh6yQNM1S0uGP8KSDd+VaVtcW19AJbeWKeFujIQwNYereB/DmqSGW40q2S5PS4gXypV9wy4OaAOkorghpHiLwkhm0a9n13Tg257K9cGZE/6Zydz7N+ddV4d1uy1/TIr7Tpd8TZBB4ZGHVWHYg9qANOiiigAooooAwbbwnosGoz372MdxezOXaa4HmsPZS33R7CtyNFjUKiqqjsBgU6igAooooAqXOnWVypFzZ28wPUPErfzFZE/gjwvPIJJvD2lO46E2qf4V0VFAGJaeFPD1oxa20TTYiTuylsg59elakdpbxsGjt4kYdCqAGp6KACiiigAooooAKyPEXhzSfEVobfWLKK5jJBBIwykdCGHI/Cteg9KAPPNGv7vwbr8GgazffbNKu22addytmSNuohkPc46N3xXodcv490yy1LQL23keKK8ePzYJOA/mR/MpH0I/ImrXgrXrXxB4csb62uYpjJEu/YwOGxyD+NAG9RRRQAUUUUAFFFFABRRRQAVy1/430u2u3tII729ukYoY7W3Z+R1GcY4+tdTSKoXoAPoKAOIfxD4tv5lTSvC32aFv8AlvqFwqbffYuSabe+GfFepz+Zc+LTYRHrBY2q4x/vNzn3xXdUUAcRdeD7Gys5LvUNe1xo4U3ySPd44HfAFY2ieC7nX2ku9c1TWP7EnA8nSppsEqP4pGADc9dua9OljSaMpKiuh6qwyDSgY4FAFbTNPtNLs47TTraK2toxhI4lCqKtUUUAFFFFABRRRQAUVCkjm5kjcKFABUg8n61NQAVGyKZVds5UHBzxTpZEijZ5XVEAyWY4ArzvVNavPHFy+j+FZHi0gMUv9XX7pXo0UJ7sehboKAM+e20f4kfEWZLmJLnTvD8exSCQs8r/AHuQeVXGPrXRSeAbe2i2aBq2qaQAcrHDN5ka/wDAXzx+NcXommL4K8dQadpzyR6dFOsCRtkgxTKWAyepDqx/Gu98deIE0WCMOHZmG5I43AaRh0X2XuT6UAeceMbPxRY6raaPbeNtQubiYb2EdvGjDd8qLnnvuY+ymu/0f4d+H7UJNqNmNV1DaPMudQPnsT3wG4H4CsH4aaHe3+oT+KdczJPKWa3Ug9TwWGegwAq+3PevRbNC0807pLG7HbsdsjA7ge9AHB+MrP8A4QuO31PwnGlvLcXKwyWI+W3lyDlsD7hAHUVDp3ivUdSvNJubiwvtIguZAfOlZJLeUFfuZBypOMgmo/i5qax6lZ2ryqkEUJkkzxtMjCMMT0HBes/xJrknie2Xwn4as5DZuixtdAAEqONyZHAB/i9uKAPYQcjNed64n/CG+N7LVrSMRaNrEn2fUFBwiTn7kuO2ehP0rR8C6pNY6cui63cmbU9OURTTN/y0UD5ZPoR3rqNSsLLWNOms7+GO5s5hteNuQwoAtqwYBlIIPQilri9J8I33h3Urb/hH9WmOj7j9osb5jNtB6eU/VcehyK7SgAooooAKKjfeHBX5h02/1qpe3N3DcIsFoJINhZ5S4G056Y6mgC/RVPTmvGj3XwhViBhYyTj8TVmeVYYjI2SB6DJoAeelNQ7gTxjtimrKrorpllY8YqSgAorG1LxFp+manHZ6hI1v5i7lmkUiI84xv6Z9q07e6guVzbzRyj1RgaAJqKitp47mISQtuTJGcelSkgUAFFNxhs5P0qrdahBaKGuS0atIIlJHUnpQBcpsih0ZGGVYYI9qhu5GS2kZJI4mA+V5D8o+tcTrvxEshdpo3hh4NX8QzZWOGN/3cZA5aRugA9OtAEPxBm+16jZ+HPD0VufEM0LD7TIu/wCw2x4Z/qegHevFvHnwmg+G+iJd6J4u1lNXvZ1htbaH5RPMx9AenvX0J4L8M/2BBdXmpXP2zWr0+ZeXbcZPZV9EXoBXCaiIvGPxSivoYTd2egxM8C9nlGeV+rHGf9mgDmrNvjB8P7e31DVJofE+kqoe7gTBmiHfHAJx+Ne3eD/E2m+LdDg1XRpxLbyDkdGRu6sOxFO8MWV1b6cZNUkaS+uWMswJyqk/wgeg6V5F4cji+G3xxvtH3yRaH4jT7Raqf9XHPzuX2zQB7tRRRQAUUUUAFFFFABRRRQAUUhOO2aWgAooJx1qMyqJhFzuK7unGPrQBJRWVrGqS6bLB/oM89u5AeaPBEfPUjritNGDqGXkHkUAOpgZvNK7CFAzuzwfaq0UstvHM+ozW6qHJUj5QE7Zz3rlLz4gW11cyWPhK1k16/jIV/s5xDET/AH5DwPwyaAN/UtVuNOa6nmsZJrCJAyyW53ux7jYOeK5ix+JnhMzSRQ6hPJcPId0JidnRvTGOKhuvCfiDV7Zp9ev4ppT9zTbd2htkz/eYfM5/IVp6RaX/AIbhsvNt7FbRysM0VpHgRMeA4J5IPGc880AZOqfFXR7K9eGKy1u5nWPzBHHZOA65AyCQB1I703xJ4v8AFlvo63th4ftrGOQqqvqNyNwJz1RM/wA6l8eXMV0LO+tdziOWXT5kPG1mXK5H+8q4/wB6uf8AEniOx8W6JYJGtw9pHhGih+WSW6K4ESntt5LHtQBQ8VpJqNvYnXdSutV1CYJI9haN5NtED0UqDlix4wT6ntXqnhTS7Xwr4UsbBFEUMChdvYMx6fma5r4YeHLOGA38yebcxOY42yWjUjglSeWPYsevbiun8USyG2trVcCS4uU2n/ZUhyT+C/rQB554xTU5Ne1bV9OEOy0vLaNTcA7V2o25gByxy4AA6mtPSPCE86y634jFzeTMPNSyJy0h7b+3phBwO+aq+Gkl1TW9LgukZo5pbjV5lZwwGX2xZHpjp9K9IfTFk1hL+SeY+XHsjhDYRc9TjufrQBR0K31aSc3mrOkCldsNjDysQ/2m/iP04FbF1MsEalnVNzBRnnJPapq57xTbtdXmhpGxDJeCUgHgqqMDn8xQBy/je6dNcvraMR5uY7S2LMgbaHkbJweM8cV2GnabYeHbBY7O3YBiqMwBZ3PTJPWuG+JavH4hcec0aTWSXCFEywaCUMef91jXZeIL7TIdGtr3VJytujJKgUkF2/hAA5PJ6UAZ3jTRdCj0pLy/uW0yS05hvYnxIh9OfvAk/dOa8/8ADXjjVbLz9PnVTYxSeaupPAwAU9pgudhJ5z6dhWpZW2ofEfXBfXaG10W0YrGM5JPfaem71bt0HrXqdhp9rp9klpZwRxW6jARRx+PrQBV0DXLDXLd5dNuobpIztZ4myucVqVXtLK1s9/2S1gg3nLeVGF3H3x1qxQAUUUUAcjrF54su9WlstCsbSzso8Br+9Ytv/wByNeT9SRXCa3qXjDTjHcp4rtn09pGheU6aQUlU8oRu4yM4Pcivaa5/VdKle+do4Y7mwvB5d3bOcD/fHv60AYtk3i+7sre60vWNDvrd03bpIHjLfiCcVgyeMvGv/CRvottpmg3VyjbCy3jKAdoY8Fc8ZH51X1DRdY+Hd9JqOi3L3GiM26SGQ5Ceit6egYfj60fD6z/tb4h3evfZp7ddsrqkqbT85Uc/98GgDdW/+IxkWI6V4dhYjgG9c8euAlYGrar47TxZYaHca1o1p9tIJa1tnd4gQx43HB+739a9Jm1a0cfbYri2Nnb+YJ5mPKBeDg/UfpXA+BEPif4g6n4lmgYQwr5MJY5UHoMe+3Gf940AS+LPhdHrGgXi6zresarPjzdkk/lxsV5xsUAVW+GvhHwzq3hSyvNFe5tJYy0Lz2Vy6eYyEqSwzg9K9Iv5ZItWsV8zEEodGU9CeMf1rhPhGkWma14m0iIxxpHdtKsCDATkgkfXAP40AayeGfFVpO8ln4xeZBny4byzRl+hZSCfrXOXvjDxtaeMU8OW+n6JqNyUEhkWdotoxnJBBx2r0Hxhra+H9CnvvL82UYSKPON7ngD6d/oK5D4V6FcteXfibVmeS8vV2RtIoDFM53ewPYegFAFt9Q+IzqBHoehxtnlnvmI/RaQ2XxC1FNl1e6DpoHRoInnce43bQD+dd/SZUPjI3GgDz6D4aLdyGTxVr+ra5k5MMknkw/8AfCYz+Jqh4x8PxeH9T0a58L6ZBDITsEcKhFLJ8wB6clS4yfavUa8v+KOpXF/rul6BpEkf2ncTKSeULqVGPopZvyoAyY5/FnxBzsVbPSvMKPGHKRlemC4+aQ+y4X3rtfC+m6Tod1/Y9ij3N2VE1zOBwpHCg+nsvtS3LXUkkPhvw6fssVvEoub1VBEI/uKO7H9K6HRdKtdHsltrNCFByzscu7HqzHuaAL9cJ8afD2n694DvzfyG3mskNza3KcPFKv3cH3OB+Nd3XE/GEMPA88qsirDcW8rtIflCiVck+woAx/Dln8S7fw7p5m1TQru4EKlknhkVmOOAWHf3xW/4e8XSS6kuj+JLL+yta27lQvuinHrG/f6da6bTZWnsIJXUKXQHAOR0qh4p0C18R6TJZXeUY/NFOn34H7Oh7EUAbFFcH4J8RXFpqknhPxNNnWbVcwXD4H26HtIPQ9iK7ygAooooAKKKKAEcgISxwAOSa5fU9S1TQk81bX+0tNVNxmEqrIp5zkHAI+ldBqTTrYXBs4UnuAh8uJ22q7dgT2FcBrPgjWNesxcaxq0j3KjcumwN5dspx93PUkep49qAJbHx5da0sclj4Q1uWFTuWWRVjUkcZBJ5FFh8QNR1F76Gy8LXy3NocSJcSpF3xnJPTjrU3hTxNcWkyaV4h/dyAiKGZl2nOPuyAcA+hHB7VzPxN8L2d54qUQ31/ayaqkcEyWsm1W+bnd7EA0AdDYXXjjWtKg1BbjRtJiky/lurTMq9sngVg+ILzxnpGpR/2vrcf9msyskllaBfNU8bNzEhXz07EV6tZ2UFrp8VlFGot4oxGqHkbQMU66s7e7tHtbmGOW3ddrRsuQR9KAOE0Twp4c8QRNc3V5qGslcxyRX1ySI27q0YwAfqKyfg7cQxTamiRxWluijKoAoBjdo8kD2UU6/07V/C+smPQ9txdTqws/Nbas645jlbuydVJ6jIrR+GmifZLTVrmCSKYSHyEk2gh2TO9j9XLUAeiqQwBByD0NDAMCGAI9DTYQwiQPjdgZx0p56UAc74zs438NaqXRNpQSABcHepBBz65ArltH0yLXNY8QGzeO2ks9tpAVj4hZ0VpXAH8TbjzW94+aS08H6lLa+Y81xJEqo56FpFXA9OM1J4Dt0jj1e4SLYbi+kLN/fK4XP/AI7QBtRW66XpCQWUO8QxhUjHGa5zxNqUZ8PzCxuG+0zN9ghGN375+CQe+Bk5HpXT6pJNFZsbe3NxKWUBAcdSAT+HWvOfGF4BqzWmnxrGdPVbe2ULgfap+Mj/AHVyfzoA2fhxbB59QvomBslKWNrgcFIhtLfi26u4qlothFpel2tlCoCQoF47nuau0AFVI4hNc/aJYmV48omT29cVFql3Nby2kNqkbyzyYO9toCjlj7mqvinXodC0/wA1gJbuX5La3BwZX7D2HqewoA5Xx/rFomsJbywyyx20DpKYgC7vMNqRJ/tHk+1Z2g/D+9v2tp9eubqK0SMILWSbzJsDoGYYC8dQvJ9at/D/AEV7++OsXxeRI3Z1LcrPO33pR6qB8q+w969D+0xm7+zK2ZQu9h6CgBbO1gsraO3tIkhgjG1EQYCipqKKACiiigAooooAKKKKAK1yY5mNpNA0kUyMGyuUx0IP1ry2yvLjwJ4payucSaYUCozMWkMGTtYeoTO1vbBr1usXxV4etvEOnGCZ2guEO6C5jA3wt6j2PQjuKAOH+LK2cemWD20sUFvevtZ1GUcKpZVx06kmu3sIrfRtJ061sY9sUhVAypkcjJJx646+9eOeI9O1zSY4dKvfs8Vp5ySnzwTaSYOD5Un/ACyJBOVbj0Nd94Uu5dT8OXehSzBNY07AXDfeUHdE4PdSAOfrQB2Wr2Ed9boGGZIXEsRHBDDp/hXmfic3Hhnxnaa9HYy7bwBp1Vh1AAdPc4AYeuDXpmjXb3lhFJPGYbgDEsbdUbuKbrelWutadJZXqbo35DDhkYdGU9iKAPOPjBeQalpmgvDL5llOZJRtbAY7QB0/3jXo9o0we2hhjQWywjc2e+BgAV4lq3h6fTzdWN/qkiNYurQwNGBFIssir5qt26cr2Ne5xW+FgZXK7QN23o/GOaALIGO3NQGOKS9WQojSRKVDZ5XPUfyqxUaIiF3UAbjljQBjeL9fi8P6WZsCS6kykEWfvNjqfYdSfSuI8FaRqVpZXXia/iN1q15xbRlMFdx++fT19gMVBtl8eeOtxRf7Hs/uvuwxQHsP9thz/sqPWvTmtZzqUMqz7LWKMqIVH3mPc/QUAN0XTYdLsVggU5JLuzHLMx5JJ71edgiMzdFGTilooAzNEvbjUYZLma2NvAzfuVfhyvqw7VxPxnv4J9JTRAUd5v38yMNwCLwgI/2nKgfjXQeLPGNnopNrb4utTZSRCp4jGPvyN0VR6mvNBouv+IbP+0LBClxNOtzLq1xMIVcqDhUjKk+UvbI96AOksJNX+HegwyanN/aegQxKzyM4We2/vZz99R2xyK7Pwz4r0XxND5uh30d3HtDbo+QK8k0rwKNYvDF4t8T6h4h82TY9taBjAuOfmOMD3xiu71HwtdeHbeSTwTEIrZo9kumxsI16ffiJBAf68GgDV8f+Eo/FWjtBFMLHUo2WS2vo0HmQspyMHrj1FZngfxJfJqs/hbxUVGu2qb47hV2x3sXaRB6joR2NdN4Y1SPWNEtbyNXRmXDxyEF0YcFWx3BrnviV4eudRGlazoyM2taRcCWBVIHmoxAkQ+xXn8KAO2opsRZo0LLtYgEj0NFADqKKKACiikbJUgHB7UAYHizw7DrdsWAVbpVwCeki/wBxvY/p1FeaPHexaoi3squ9iiTLFOxW5Ty2J2+ki7WPzD0r2G5+1rZH7N5T3XGN+Qp55/SsrVLS218z6fqFrLDLAQ8NwBgg9nRvY8UAa9hdw31pFc20iyQyKGVlOQasV5dZyX3grVzHMS9pKTJNEgwjLnmaP+6R1ZPxFehTXAEcd/HOGshGWYKu7cDjDA0AZnjpZF0M3VuN1zZSLdIoxlgh+Yf98lqofDv7LZwX+kW3C287Tpnnckp3g/qR+FdHdSxz6c08EIu1dPlVcZZT1wfpXm9q934X1RI3WeaWwQo2V5urMnIZcdWjzgigD1aisyPUbb7GNQjmae0nK7SoyFB4z/jWhIT5TNGNzbcqPWgDlvH7xyR6Xay5KG6FzKoOP3cQLk/ntqx4DiuIvCNk85LXMymdt428uS2D+dcz4lkn1LUdOvVyiXVjcWYgYjAn67CfU4K12fhbU4dU0C0uo4mgBQI0TjDRsOCp9wRigDUKlguTgjk4ry3whcHWNVsrq7ISQ6nfSbDzkoQg/Q16qeleVeCfIu/ENmVWUFLm+uYtwxlS4XP0JBoA9VozzTZWKRuwUsVBO0dT7Cs3w/bzw2kkt40huLiRpmRzny89FHoAOKAG6v8AZbMy6vfnKWcTMuVzs9SPc8CvO9K0q58ZatNqOpv5cGDHc4f/AFaf8+6+nGC7dSeK1viTrBuJrbQ9PjN1N5iy3KI2MY5jjPuzYP0U1Y0vTpJzFoBkJtbVBLqEinBnlbnZ9O5/KgDoL7VLXS0t9O06JZbtkC29tEOAo4ycfdUetadlapAHk2gTykNI2c5OKj0/TLWwlnktotrztudick8YA+g9Ku0AFFFFABRRRQAUUUUAFFFFABUdwzpBI8UfmSKpKpnG4+lSUUAYdlqVlrljcQ31nJCoPlT297FtGT254YfSvP8AX9AuPCWsWV5ocpSzZ9lqG+7Ex/5YO3/PN/4c/db616nqFjbajaPbX0KzQP1Vv88Vz50FDZXPh65WSbSJ4cRSSSFpEPpnrwcEGgDR8NX9lqlk17ZoscsjYuE/iWQcFW9x0rSm8/zYfJ2eXk+Zu64x2/GvMPAt++l+JZbW82xNdObW5U8Zuoxw4/30wfwNeqigDhfifpiXUenXDD5d7Wsg/vLIPl57YdUOa6DwdqQ1bw3Y3X8Zj2SD0deGH5isT4q39gnhuXTric/brp0FrBESZXcOCMAc445NZlpq8/gl7jTW0LWb63eQ3EMtrF5qgPyVPoQSaAPSK5bx9qD6f4QuwrFbm5xaxZ67pDt7exJ/Cqtr8RtEJCamt5pUpx8t9btEOeB8xGP1rlvGur2es6yf7Mnjvbeyh8+Vo2LJ5pBSFOON2WJx6AUAdH8KNLt7PSLm9tlKpdy/uxnOI0GxcfgM13NZXhewOleHdPsm2hoYVVtowM45qPVvEFpY2D3EB+1y7/KihhILSSdNo9/X0oAl1jWYNOeOAAzX04Pk26fefHc+g9zXAaz43vJ1k0+ynVJXkMb3NtGZGDDrHCv8bDu3QVk+IL50uZ4FuJJryTC6ldQDLsT9yzg9GPcjoOTXd+AvC6aPaJeXkEa6lLGF2qPlt06iJPYdz1J5oAwPC/gJrgi615GhtmfzBp+/c0rdnuH6u3+z90V2N1op1K5zqUmbKPiK1jJVCMYy/r9OlXYLe5a/knu5F2KxEKRkgBTj73qeKvnpQBDaW0FnAsNrDHDEvARFCgVgfEPxRH4R8LXOpsgluOIraHvLKxwq/nWzFqVnLBPPHcxGCEkSSbvlXHXmvJn1CH4l+MYJdNV7nRdDuQ2/b8ryL3U9Cc/oPegC98HLXXtP1TVIPFtyJNSu9uoqkeQiCT7y46cEYr1est9P8/VLLUtohuIo2icE5JU849OtalABRRRQAUUVwui3fjHXoLy8s9W8P2dsmoXtpFDLo80zqkFzLCCzi6UEkRgnCjrQB3VFcr9h8cf9DD4b/wDBDP8A/JlH2Hxx/wBDD4b/APBDP/8AJlAHVUhwASeAK4TX7rxloOnpqFzrHh67gW5t4pIY9HmiZlkmSM4c3TAEB8/dPSu8PIoA57xhYDVNDM9qFluLY/aIMchiByv0YZFZPw/1RAX0g4EHli4sc/xQN/D9VOQfwro0ey0OOG3eUxxzSFYg/IBPO0Ht7VxXirTJtCvRe203k2XmGaCcgkWkp+8rY/5ZP39DQB3cGniC/kuIp5RHIuGgJygPqB2qtrmlWuuQGBpnhuoCHjnhbEkLdiP8O9ZvhzxfbajItnqSDT9VxzA7ArJ/tRt0dfcV06ogZmCqGbqQOTQB5hp2oXPhnUp4blV8qMhtQtlGEVD0uYh6H+Jexr0tbmE2ouVkQwFd4fPy7fXPpXM+PbQtpk2qbVWbTVM0JDf61cfPGw6EMOMfSuQv7CyUWllFNq98byNbiHQFcLHGpx99gMiMHsT+dAFjUbmPWrG50vRY0mt1vPtE+qSt5cFuwfdlG/ibtxxU13dLYXt3P4Z8V6HDHdsJZYbw71EmMFlIPGcZI9a07TwV9vijbxZLFPAgHlabb5S1hA6DHG8+5/KtG78P+ENPhV7nSdKij3LGpNun3j0HSgDj7nxDqQC/2x410G3tW+VhYwF3YEdASePyqPU9Q8JGDT7PTr3WLee0iKRzadC29kbqGO0g5PNegQLoVssQtrS0SNt2GigG0beuSBxV+21Kyn09r22uIpLVQSXQ8cUAeTwPYwM8i6j47jCDcJpELKfwKc/StG61vWo9AuNS07xNZ3GkQDbNNLaH7XG3AChRhd2SOuOteg28mp3FmspS3hkaTIUkt+79/wDaxXN+I9Ot49ZlaZdun63D9muDjCpMPuOfc9M+woAw9B0y70k+YIftGu3WXgic7/K3dZpn7tg9u3Ar0Hw/pY0qxETyGa5kYyTzHrI56ms7wPez3GmNa6kEGqWTeRcY/iI+630Iwa6SgAooooAKKKKACiiigAooooAKKK4HwvdeNvEHh7T9WTWvDlst5CswhOizuUB7bvtYz9cCgDvqK5X7D44/6GHw3/4IZ/8A5Mo+w+OP+hh8N/8Aghn/APkygDqqqarBcXFlIllcfZ7ngxyFdwBB6Eeh6GuS1C88W6Le6Q2o6poN7aXd9FaSRwaTNA4D55VzcuARjupruKAPI/G9jJca5bXiFop7nEaBl2qLyH5kYZ7Mu5a1L/x7JqGnLHoBjgnRA17eXilYrLsVYd39Fq/8Rr+O8ii0KyRZtSkdJmkyMWSK2TMx7YwceuayI1j8Szrqeo2/naNBITYWKICb+Uf8t3HcZ6Z+poAg8LaXqWpFrzSEa2Ew+bXNRTfdTjuY4z9xfToPY1vL4I0q7DzTaxrN1OhIklTUHX5u/wAqkAfTFa+nR+ILu6WTUTZ2dgUx9liy8nI7vwB+GatNdaN4dstjz21nboecsBz7+poAxZfB93DH/wASvxDfgdfKvlW5jb0ByAcfjXN6tYXllpb2euaF5dssy3K6h4fXBEo6O0eM8e4Ir0nSdUstXtBdabcx3MBOA8ZyM1doA8hn1fUL6BIZ7241jTYj5jSaY4husY+7LF94/wDAcVjPqrNaST6eLqJIBsnvWs2gjs1bqsCEZeZiQM816trvhPSdYn+0y25t9QX7l5bny5VPb5h1+hzXMaqusXOm3GgX8yPq9s6XVhdEBVvAjBsezcbT9c0AJ4S0eDQtOGua9CLVIgfsdmfnMKn+I/3pX7n8K6Br/VJEXVLi3uYrNMeVYwpumlyeC/8Ad+n51lXnjPRp7aGW5tJpdbtWIXTGH72OXHJI6AAfxHjFcpf674m1vyrgaxDo9jKQEaNRtJz90E5aQ+4AHvQB6rZ3eoT2NzJcWKWs4LeTHJKDuHYsR0rifEF3PFG58VeIIY4Mhl0/SwRJJ/sl+uPoB9aybTwdd300xfxFfzxlSWE0UyofXHzis/SNJ8K6ddGHVdXmu2I3tbxWrRhlPIDnlmHsTQBZgXVvFqLb6VYLHpcBKLAXMdqnoWYDMrew4z1zUmg/DXxnplsIF8Zxx26ksIILUKuT3LYBJr1PS547mytpLCLybXoEeMxkL2wMVoUAYHgvSNT0XSTb61rEmr3Jct5zxhNoPRQB6Vv0UUAFFFFABXK/DT/kXLz/ALDWrf8ApxuK6quV+Gn/ACLl5/2GtW/9ONxQBoeNdRvtH8J6rqelxW013Z27XCx3LMqMEG5gSoznaGx74qn8Ntcv/E3grS9b1SC1t5r+FbhYrZmZVRhlQSw6+tafibRovEGg3uk3FxdW0F3H5Uklq4STaTyASCORkHjoTUHg3w5beFPD1ro1jc3dxaWq7IjdSB3VOy5AHA7cUAZ/xP8A+RQk/wCv2x/9K4a6quV+J/8AyKEn/X7Y/wDpXDXVUAMkjSVdsiK65zhhkVQeynWYKkqy2j/LJDMM8Y7H+hrSooA861vwWtuksejol1aDMh0ycn5M94JOsZ9ulJ4R8VCxdbPVrlzp8h2Wtzc/LJG4+9DNno47HuK9Grz7xFNaaXrWqXOq2MUmn3USRpZlBLJfTDuqfiBmgCr4o8Q22tSSC3kkk0KxdXmljIxezA/JBGe/PX8q6XwZpM9jbXGo6od2p3zebNkf6pf4Yx7KOKz/AA54akllttV8QRQQvAubXToQBBZj1x0L46nt2ratLtNcvRJZzv8AY7OUqxXIErjjg91GfzoAff6U+q3kb3Vw409FBFquV3sDnLHr+FaxiQhQUUheRkdKidZJt65aJRwGHU+9LJbLJPDKzyBos4AbAOfUd6AJQoAwAAPTFZslnYW8kkDxxJHfEhoscSNjn9K1KayKxBZQSpyMjpQAKoVQoGABgCs/xDpqavot3YyKD5qHZk4ww5U57YOK0qKAOf0LRJbbUP7Tu5ALya1jguI05Usmfmz+OPwroKKKACiiigAooooAKKKKACiiigArlfhV/wAk48Of9eUf8q6quV+FX/JOPDn/AF5R/wAqAMfxR4u1/Tfid4e8M2Fnpclnq0ckqzzSSCRFiAMmQBjOD8v64p/wp8W634sfxJ/bNnp1smkapNpP+iSOxklixvb5gPlO4Y79citDXfAVlrHjLTfEs2p6vBf6eCtukE6rEqnG8bSpOGAwefyp/gTwNY+DH1RtO1DVLr+0rlry4F5MsgMzffkGFHzNxn6CgB3j/wD5lz/sNW3/ALNXVVyvj/8A5lz/ALDVt/7NXVUAc3q3hKz1C5Lbmggnl868jj4N0QMAO3Xb7CtaCzt/tYl+yKj26+VE+OAuB930q9RQBDdxNPayxRytCzqVEi9V9xWbp3hzS7G38tLSOYk7mknHmMzepLZ5rYooAit7eG3UrbxRxKTkhFCjP4VLRRQAhUHGR05rDvLfS/FNk6LIWa3lKrLGdskEi8Eg9j/Otxs7Tjr2rL03TDZ39zdFk33KqZguQC44yB24xQB5zrkbazp2nC8+zWt81xJaajcrFl5IogSVBHOCQDj8Kn0zQ9Sv5ZpLe1uVstytDLNMIHfAxkAAlV9BxV7w1a395cW101lLAiavdyOsg5CfMAfoa9GoAxdI8N6dp1wLuC2Md2Vwz+c75z16nH6VtY5zRRQAUUUUAFFFFABRRRQAVxWneHfFWkLd2+leINEWylvbq8jS50aWWRPPneYqWW6UNgyEZ2jgDiu1ooA5X7D44/6GHw3/AOCGf/5Mo+w+OP8AoYfDf/ghn/8AkyuqooA4nVfDvivWLVLPU/EOhmz8+GaRbfRZY5GEcqyYDG6YDJQDO09a7aiigAooooAKryWVtJeR3ckEbXMalUlZQWUHqAe1WKKAI54IriB4ZkDxOCrKehFFtBFbQJDbxrHEgwqKMACpKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK4bQvDni/Q9Hs9MsfEegNa2kYiiM2hzM+0dNxF2AT9AK7migDlfsPjj/oYfDf/AIIZ/wD5Mo+w+OP+hh8N/wDghn/+TK6qigDjbjw94m1K90xtZ17RpbSzu47sx2ukSwu5TOBva5cAc/3TXZUUUAGKKKKACiiigAooooAKMDOe9FR3TtHbSvGMuqEqPU4oAbNdQQsiyzRoXOF3MBk+gqbNeSeGbKw8Xa7cQ+JbeK6eGygngVyVKtJku6gcg7uM+1dI6al4MPnG6uNU8PD/AFgm+ee1H94MPvoO+eR70AdvRUcE0c8McsLh43UMrA5BB71JQAUUUUAFFFFABRRRQAUUUUAFFFNaRE+8yr9TigB1FVzfWgODcwA/9dBS/bLbGftEOP8AfFAE9FRfaYCu7zo9vruFZGteLNB0SHzNU1azt17b5Rkn0A70AblIzBRliAPU1wcvjPVtZfyfB2gz3EbDK6hfZgtseoz8zfgKVfA13rMIbxnrd3fyHrb2bm2gA9MKdzfUn8KAO0N9ajrcwD/toKmR1kXcjKy+oOa5Jfhr4QWARf2HblQMZZnJ/MnNVZ/CVz4cjN14ImeLY2+TTZ5WkhnHdVLElG9D09qAO5orL8N61b6/pUd7bB0ySkkTjDRODhlYeoNalABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABTJZEiXdIyquQMk4p9cP451qzScRSu7x6eyzyRRjcZZj/qouOpJ5x9KAO2jkSRd0bBlzjIOadXmHw98Xiz8PJa6zYX0F3BlpysRkIYnJLADKn6iu00vxNp+pzyRWpnBRdzPJCyIPQbiMZ9qAMPxJ4G/tjVV1KPUrjT723XFtNatsyNwYLIo++oOePc1oeEdZm1WG803W44E1eybyrqKPJR1I+VxnqrD/Cl17TNT1q5RI9RSz0gId5hOZJG7c9gPY1zVmmkaV8TdMt9Guzc309nJDeRfaDIY0Uhlcgkkcsw696AN7wmzaRrF/4cfd5ECi5smb/ni5PyD/dII+mK62uU1hnX4heHvJBy1rciU442gx45+tdHe3ttY27z3s8UEKDLPIwUAfjQBYoriB8TNBlYm0j1K7gH/Lxb2MskR9wwGDXUaLq9jrVil5plzHcW7fxIeh9COxoAv0UUUAFFFFABXN674sgsL46bp9tPqerldwtbYZ2DsXY8IPqa6QjIIrP0fR7HR4pEsIQhlcvI5JZ5GPdmPJoA5WfSfGmtg/bNattCt26RWEXnSgehduM49Aac3wy0Kdg+oz6tfScZafUJRux7KQP0ruKKAON/4Vj4NOc6BasT1LM5P55pJPhh4OkChtFiAVt2BLIAfqN3T2rs6KAOHl+FfhGSVWOnTKq/8s1vJgn/AHzvxW1png7w7phDWOi2ETg53+SGbPrk5Nb1FAAAAMDpRRRQAUUUhOASelAHHaEtxafEfxFbAbbCeCC7Rcf8tDuVyPrtH412VcR4Kcaz4o1/xFDMXspSljbD+FlizucfVi35V29ABRmiuF1iG88X+IrrSYr26sNF04qt01udklzIyhtgf+FQCMkckmgDszd24cKZ4gx7bxmpgQQCDkHuK5WL4e+F47L7L/ZaMnPzvK5k56/Pnd+tZMvhbX/DRabwXqX2q1A/5BWpyM6f8Al5ZfocigD0HvRXJ+GfG1nq18+l38M2l63EP3lldDax90PR19xXWZoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqpquoW+l2Et5eSBIYxknuT2AHcn0oAqeI9XXSrHKAPeTfu7eLu7/wCA6k+leOade674o1KTTtIm0OfSTKfPnnG+W4mGd0mFYGMZBCn0FdNFb33jPXpFuMx2gGLl0P8AqY+1ujf3z/GR0HFdlf8Ag3Qby2jh/s6C3aIDypbVfJkjx02suCKAPPo5W0rXRB4jtJpJYIyyXKFjLAAPvb1wZYvqMr3Her0nxA8MzeH7q11Oa31TyGA8i3ZpjJzlc8DBzjrV3WQbWSLSfFNw4Xdv0vWkG10cdEbHRvbowrktJ1V/Dd9qEOo6VpRvZN0tnqrRZEhJ+85ALYyeo5HQ0AT+JJvEfiLS1E2i6/b6NvVTaaS0cTtHj1J3Hn+6APetL4L6PpKaxrepaVot3pUcBTT0jvCTMdo3MzZJIyW/SpLr4o6VaSh21j+0b2OMI2maZbNIZJcchW+vqBUXw78T6nH4kvbbxHpM2ipq87Xln9pJIcbQGTJ+62ecHseKAN3xP4it9K8eQxiK5vb9NP8A9Hs7aIuzs7nOT0UfKOTgVDeaPZfZ0174lTwSTJ80Vozn7Pb85Chf426cnPsK6O+k0vw9/aniC8kTfKFV3H3mCjCxr6nPQeprK8LaFPq10niPxVGXvpPntLKUApYoegA/v+rde1AF/wAEa9da3as0uhXWmWq58lplCB1z8u1eo4welVry0j0r4gadcWCug1OKSO6hjHyEpgrKR2PJGe/FX9e8ZaJojyQ3d4r3aD/j2hBklJPQBRzzXNeBdWs9Z8Q3Wr6nci31eVfs8GnylkaCEHIBVsfOepI+nagD0eijNFABRRRQAUUUUAFFFZeu67p+iwq+oT7S33I0BZ3/AN1RyaAL11cw2sBmuJFjjBALMcDJOB+pFSqQRkdK4y18e6PqV/c2Vva6rNdWmDPB9hkymeQSCPamf8LN8Kwzraz3slrdkEi2mgdJcDqdpGaAO3qC/kuIrKZ7OFZ7hVJjiZtoc9hntXHT/FHwxFZC7+0XT25OBIlpIwJ9jj2pT4p1/VLYSeHvDExR1JjuL6dIoyMcHAJbn6UAXdO8YafdXSW2oySaRqCDL2d4BGW91J4YcHkVs3ut6bZ2pnuNQtIouzvKAM9q838L6ZB4w05dW8YJFrWpw3DxpaoP9HtnB6L+HdqXx/4Ni0q+svFHh3QbW9a0Ux32mCJSLiH1RTxvXHHrQB0dx8SfC+nW0X9o69p7XDD7tu+/cfRQOTXJ+IfEniDxbq9toNjY3egaNekB765QrPcJ1ZY16rkA/MazvF/jHw3feAYdQ8MQ2tvNHcRl7X7OscsRyRymM8HrXcask8XjHwtqCzB47kNblCuQo8vdkH6igDsNMsLbTLC3srGJYbaBAiIowABVqiigArzW51bUvDPjK/u10+bUfDmosXlmtULvZyRqFYuMcqcdR6GvR55BFDJIeiKWP4V454l1HUdJ0Gw0LQriafxF4mysKyYAtIiMu+PYE/jQB6Lo/jXw3rEaPputWM4cEgLMM8deK3oZY5l3ROjr6qciuT0b4f8Ahyy8N2elT6TZ3KQQiJpJYF8x+OSWxnJNcHcwNpfj9NM+GNsIZrSEzahHLM5tZV6CJQScScdRx60AeoeKvDOm+JrFbfUocyRnfBcRnbLA/ZkYcg1geD/EF1Y6rJ4V8UT51aAbrW6cBRfQ9nHbcOhFdF4X1+18Q6Yl1akq4JSaFuHhccFWHYg1H4q8LaT4ptoIdYt2k8iTzYZI5Gjkjb1VlIIoA3KKxPDvh6LQ2m8m/wBRukkwAl3P5gjA7Lxn881t0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFZmv61baLaCa43SSOdkMEYy8rnoqigCfVtStNJsZby/mWKCMZLHv6ADuT6V5zPc6p401cQ2bG2hgb5yVBFqCOp9ZiOg6Lnnmktk1XxrqJMrJDDBIQ8yfMlsf7kR6NIO79B25r0jS9PttMso7WyiEcSDoByT3J9SfWgBuj6Za6Rp0NlYx7IIhgDqSe5J7knmrtFFAFTVNPtdUsJrO/hWa2lXayN/ng+9eT65pUvhUS2uqQz6hodxIDHdq2JIX7Et/C4x97o3fnr7HTZI0ljaORVdGGGVhkEehoA8PFh4htVW58OX82pafct+9mto1W5QnvJH3P+0uPpXU2nibQfFGgCw8SxW0U4X7l23y7xwDu4Kt+RFaGo+Hbvw9cDU/CxdrdDun0snKyL38r+63+z0+lVbrT9I8f2N3LBElvfITGXZQRIMfdkXuOxB5HagDmvDeh6LN4w0Wxtb+2uRbCW/kt7a8kmjV1wqHDk/3m/EV3PjK88Ste22l+HrKKOK7JWTUZHz9nXHLBB1PYZxzXnuj6hcaLqsbTaBBp99oTPDdRWiKFubRgv71cDJ24Bx6E167aa9p13GsltcCSNoftAdfu7PXNAGNZp4f8DWsFq0gF3dNy7DzLi6cnljjljk/hWxr2hadr9kINStw+PmjkHyyRN2ZW6qRXO/DiI6vby+KtQiH27UiTDu58m3B+RV9Mjk46k129AHOeELq6j+16PqcxmvNPYIJmxumiIyjn3xwfcGujrmtQAtfHWlzAqPtdrLC/HLFCrL/AOhNXS0AFFFFABRRRQAjZCnaMnsK8ym+Ht7qFnJrF7fzW3jDzXmguoZCVhXPEIUnaUwAD+denUUAeT2dsPH1lMRevofjbSX8ie4teCGHIDqfvofQ/hUVnaXXjjT73QvFSDTfGejnMGo2wwcH7s0Z/unuvSun8YeBhq2qDW9Fv5dJ15YvK+0R/dlUHIDjviuY0yzv/CnjOxn8QTR39/ft5Ju42bJQjGGBwOCFxgfxUAWvAmuNc39/4O8bWccGvRrksMiK+j6CWPsD6gd6zJbbV/At5c3WiXtxcaNA+JbC8B/doD95T/d9CPxHeuy+JfhyfV7C3v8ASDs1vTn862YHaXx1TPv/AJ61F4Y8SWfirQGupYoxqtipivrXq0Zx86EehFAGP8IL7T59e8ULpVzJc293OuobyNqq0gwygdsFTXplxEZYiqu0bZyGX1rzzwKkNh451ext1ZbdYFWHd2UMWCj1ADjFekZ5oA8r8Y+Ere/stT1WK0gtfEllE7ErGGhuRjqVI7jPIwc55qbTddhTwX4XutSZYbyG9jtApGC0nMZ2g8+/0r0HU7aOazuyUBd4HjJxyRg8frXkMdgdV8B3glUPdadqMV7GTycgLJge5BIx70Ae10VV0y7iv9Pt7qBt0U0YdT7EVaoAxPGEr/2K9rDKIri9ZbaNu+W6499ua4TwlanUfjN4hvJ9slvolpDp9qzEkqzDfIefcjmutFwNV8bKkZdrbTI2BI+6ZmxnP0H8zXDw6fL4u1u//sS7udOjaaT7XOHI3rvYKAvc4B5yBg96AOg8V+NGnuW0bwqUvNQYlJpUbK24789Mj36fpV/wN4Vi0a3BeW4muA5eSVzxKxHUeqjJx9Sa1fC3hXR/DOntaaTZxxrIP3zkZeY+rnvW4qhVCqAFHQDtQB5348spNLnvfEmhp9h1C0RWdy22G+JIGx17np83Ue9WNL+IBj0+KbxRpk2jFkV/tEh32rZ9JRx+eKX4xKLrwr/ZqGTzbqTpEMttQFycd+g/OuNkutV+INmnhzTrG5tPClsqR39667XutoH7qJe2T1NAHsWk6nZavYx3mmXUV1ayfclibcrfQ1crM8OWTWGkQW7RRQbBgRRABYx2UY9K06ACiiigAooooAKKKDwKACqM2pQw6rBYShllnRnjYj5W24yM+vIqp/bsLX2mxW8Zmtr4PtnUjCsuOCOvPP5VF4zso7rRmm+0paXNownt7l/uxSDgE/7Jzg+xoA3qKw/BevR+JNAg1BF2sS0cg7b1JVseoyDg1uUAFFFUNb1W20bTZr28ZhFGOFUZZyeAqjuSe1ABrWqQaTZG4nyxJ2xxLy0jnoqj1Neb6dZan4u1ieWeVVj5juLqFuIE728J/vf33HfgUtlb6r4w8QNLcyG3WDKTNGcraqf+WUZ7ykfefsOBXpml6fa6XYxWdhAkFtEMKiDA/wD1+9ADrCyt9Ps4rWziSGCJdqoowAKsUUUAFFFFABRRRQAVy/ibw48841TQ/Lt9XjHzZyqXSd0kx+jdRXUUUAeUeJTJ4hRJdK36d430om4SynwDOg6occMhHAbtmqsur6LrfhVZfD9qtlr+pzHT3tgWRreZhiXdGDjKruPT0ruvF5/s25stbWKMi2DwzTMceVG4+8fUBgufrWDo3hzT5/ilc65AkZkhsk3+Xny2ncktIO2doUZoA7nSLGLTNLtLG3ULDbxrGoHTAGKuUUUAcx4rZIdd8MzyNsH2t4gScZLRtx/47XT1jeLdKk1fRZYbVkS+iYTWsjDISVeVP9Poad4Y1lNb0tJwpjuI2MVxEww0ci8MpH1oA16KKKACiiigAooooArRWxhubicTTSebg+WxBVcD+HjiuZ+I2myav4ckk06Rvtlm/mIYlDMCOo/kf+A119QiBUZmi2xlyS2F6n1oA5zwb4lt9es4YblRFqcSBpIW79t6nuD6isDxj4VuNM8Qr4v8Mh1vgmy+to/u3Sf3ivcj25qr4q8P3sWqx3WhwT2uoBmmCwgtE+O6t0ViOSh4b681c0X4mWkb/ZPE8TaddR4V5WBEefRs8ofY0Ac/qWqweIrjT/EOhT/2fr9nGRLZzHll/wB0cN3zjnH0r0Pwd4qtfEdodv7m+iwJ7ZvvIfUeqnsaqaz4O0PX3/tGIrFPIu5bmAgqxI+8R0J9xg+9cHqvgO88GWjazpeo/aZI5VleQxlHiHTOdx3If4lPrntQB7UeR7V5Z8LoEOo+IbNS8co27lk+ba6llDYP+6PyrvPCuspr2hWt+q7HkXEkec7HHBH51xuiSR2Pxb1WAhFNxEfmLck8Pj/x8kfjQBv+ElXR7680Byx8s/aYGPRkckkD6HIx6YrX8R6kNJ0a6uwA0qIREmfvueFX8653x3pTx3dnr1g7JqdqfLjIUlXDfwPjop6ZPQkVz2u6zLrG3UdZ0y90/SNPUttuI9hkn6HGevXav1JoAWTUZfBPg0wXd1JJr+pyPKwldSyFjywA7DIwO5xXV/DzQ30bRBJeIiX10RJMF6LwAq/gMfjXIfDuzPiDXm1zWQks5Hm28SZdI16KST04+6Pqe9eh65rthpKBbp987AlLeMbpHx6KKANImTzwAq+Vt5bPOfpXN+KPGNno2+3t1+2ajt3CCNgAg/vSN0VfrXHa54u1rWLWUaVbXSW/zDbYwtPI3bDSKNsf4bjXKaNc32jjOoeCNU1F4wZkjt1LQl88bt3zO/u3T0FAHYaNpOoa7JLrXiO9lFnKNiLEChkQkfIndUJxz1b2HFej6VE0NuEWCO3gAAihUYKDHQ9s1zXw61bW9YhvJ9a0CbRYi4MMU8haQ568Y4H0rsqACiiigAooooAKKKKAKiahavqUtgsyG8jQSNFn5gpzg/Tg1bzmuK+IGnX1oR4p8PiNtV06Bw8ErbUuYMFihPYg8g/X1rV8Bbn8KafcyPI8t1H9pkLsWwz/ADEAnsCaAKF7YPY31zbWyym0mja7gCn/AFUynLKp64bPT610trJHf6dG7oGjmjBKsOCCOhFZ2uM66rpJSKV13Sbyi5AG3v6Vd0mQNpFvJHE6qYgwjI+YcdKAOM0W9bwhq134Yg06ee0SE3mniAD5oy2Gj5PVSfyxXT6Te6pqQaS5099LiVwUWZld5BjnIU4Xt3rzzxR40tU8b+Fzqun6ppCQTThp7qEpEwKABQw4bJHT2rv9H8UadrN8LfTWkmUoXMu0heDjHNAG6zBVLMQFAySe1eUaxfXXi7xHb21hIVhZj9kZR/qY1yHuTnjJPyp+JrqfiLqkVtYQ6e9x5H2zeZmAyRboN0n0yML/AMCri/CXi/TPD1u2paxF5I1HZgwRszQjnyoSgGQNmMHuc0Aeq6JpVro2mw2VhHsgiHGTkse5J7k+tXq8x1T4larFPbx6d4N1Sc3DbYUnZIZJPUhCd20dyRitmyTxvqcDTXM+k6PuOUhRGuWA/wBpsqM/TNAHa0V5pq3jDXfC2rx2mrxWetLPgRw6WrC7HuYjnI9wa1E8ReLb1lksPCJitj0N9drFJj/cGSPxoA7eiuR03xljUI9P8Q6ZdaPeyNsiMwDQzH0SQcE+3WuuoAKKM1HJPFEMySIg/wBpgKAJKKhjuoJf9XNE/wDuuDUwOaAKOu6emq6LfWEqqyXMLxEN05BHNcB8HfNjvvFUE0jube8SMqybTGREuV9wDnBr03tXLWhNl8Qb+A5EV/aR3C8ADehKMPfgL+dAHUg5ooooAK4/Voh4d8UW+rwER2OpOttfJ/CJDxHJ9T90/hXYVznxDRX8G6oxUEwxidcrnDIwYfqKAOjoqCxkMtlbyHq8at+lFAE9FFFABRRRQAU2VmSJ2VS7BSQo6k+lOooA871Txn4sjVBpfgLUJ5Cfm865ijUfiCaxYtB8e+LLiO78RxaRpCxSb4IB+/ZBjHzY+8eT3A9jXr2Kr3kU7pm1mEcig4DLlSccZ9qAPKrOfUfBWuPpWrNFdaDcDJ2J5aojHG9RnjB4ZR0yD0r1OWO2ksPIbabWVPLwTkFSMYrmviBa217pFvBd+UdRB32+VJVm6Mp9FYHafrWd8NddV7X+xtQnR5oSfszNwWjB4U/7a9D9M0AUPhzOPDniHU/DV2jxK0m+3kc8SnHP5jDfifSrXjzTZJfF+ivpE6Qarc7sOU3iPYpxIy55XBKn6j0p3jrwfNql2by0uUS9GGhLsQXxklM9sZyp7HrxWPpsmofYbW+fUGuNY19lsrSdoQhtYVUliRk/NwxyOCSKAGeIJ4rF3g1zx3qkl8RseLTbVWSM+6BXI/E1W8Q6V/wkOg289r4huPEFlZSqZ7aFFWRE/ibavLOBxjsCcDNepeHNCsfD+nLZ6dFsXJeR2OXlc9WYnkk1jeJPDdtLcJf6VLFpniDJ8maPCi4I52SD+MH8x2oA5K18W2On+HhZeEHjuLkANdXjwlUgY8YKdWk7CMc/hWh4Y8JtqUlxLr88hMrLJJZmT97IOxnYfThBgD3qa61Vbux0nWxabZrC9MGoWqAHypG+RnOOpU459Ca6zwvbSRWDS3Nt5FzK7M5ZtzsM8Fm+nbtQBeQPb3EFvb2qLZhD86kAIR0ULVpVxnknPrS0UAFFFFABRRRQAUUUUAFFFFAGT4sUnwtq4WMyn7JL8gGS3yHj8aqeFtb0680/SreyIVprJbhIlXhY+nOOBzx+FdCQCCDyDXmfhufRvB2q67ZweZJdTaiscFoh3SBXUMFUdkGWPoOaAPRrpQYwxlMQRgxYHsOx9qztJvS2pahYz3ELyxuJI0U/MImGRkfXI/CpdY01tSsp4kvLi0eWLyw8WCU5zkAgjNYnhSLbq1893IW1OFEtJ2YBQ4UZR1HowP6UAWPH76O3h6a11y9t7NLgbYJZnC7ZRyrKfUHBrgfC+vNqulJcnUdJ08Khlv7mwBllcKcEFsYUsceprvvFOn6tdzQy6fFpF1DGM/Z76EklvVX5xx7Vwt8kKayg0+zPhnxMxJW2lUfYtRx/CSPlJ44IwwoAo+Mb+3mk1NtdlvLWS5gjhinjU+Vp8e8MgmcZwzsBn0BFL4PudH0a1u9f1+5/tPxWmIktmIaSMMf3ccQwM5z94Dnk1oeHprjxLqi28nhaeCxt7x21T7RPG265x3UnLIM8fhVW+0XQbb4w+H9LsbuQyW6yXjWJVXS3woChXI3KDuJ25xQB22iWkmk2d94l8VTwrqEkJeVsfJawjkRqe4Hc9zXFP8RvEdyl3JonhyCw0i3heQXOoylCcY2kRqCecjGcV1fxqwfh/do08UAeaBN0rYQ5lXhvY968xS28UT6ZYT3tzN/YSahbFmlnjZLiLzABgKvK9Op9KAPXfC2kweG9Bm1HUpRc6jLGbm+vSg3yHGSB/sjoBXJap8XpY44jpng/xBcfaJVggllg8mN3b7vLHOO+cVrfGePWJ/CgttIXZYSsov5ouZUhyP8AVr3OevoM1wvw8stWk+K1rB4lmkkWyspGtomuGkVTuAUkEAbtpyOpw1AHoEPhHVdegWXxjrE5ZiH+w2B8qGI9QN3LMQe+RViTwaYGaex8Ua5a7VOQ06SoMdyGX+tZ3xs1rVNI8O2sWl2u9b64S2luPtIgMIJzw3YnBANeTaLd2Hii/sNC0uy1ey+3uUkuRq0kmFQ5lDKWzyBjOO9AHp+iT+LPFqTQw6rBa6JE5jXVbeHE14BwSitwo/2uc9q2U+Gfhx1c6lHeam74LteXcj7iO+AQB+ArrbaG20zT44YRHBa28YVRwqooFeK618T9a1rXbjT/AA22laZpzKVt9R1NyVuDu2/Kq88noaAO/wD+FZeEkR0tNNa0LdWtbmWJvzDVFPoOreFoDdeGby61C3iXMmm3spkLqB0ic8hvY5B9q5/wX/wkPiLSbq7j8VsNcs5zBNAtsotQ6fw4xuKnsc133g3Xo/Enh+21GNQrPuSRQc7XU7WH5g0AWfD2r2+uaTBf2u5UkHzI4w0bDqrDsQeCKx/HsMlvbWeu2yM8+lS+a6qMloSMSDHfjDf8BpmgxPp3jjXrKNUWzuY4r9FHUO2Vf8yufxrrGAKkMAQeCD3oAo2+qWk2nRaglzE1lMFaOQHghsY5/GrwORXn7i68B3M+yzmvfCsr+YqwLvksGPLfL1MeeRjpW1ouveH9UtLddL1iCZAc7TcfP9Dk5z7GgDpi2GAOcmua+I0oTwleQ4k33ZS1TyxlsyMFyPpkn8Kde+JtH0cXEl/rloQX3BGkXKj+6AOTWdYS3vizXrS/a2ns9BsSZIBMu17uQjAYqeQoGcZ6k0AdhaReTawxZJ2IFyfYUVLRQAUUV574W0a41+yvr+88Qa9HKdV1GEJBd7ERIryaNFUY4AVFFAHoVFcr/wAIb/1MfiX/AMDv/saP+EN/6mPxL/4Hf/Y0AdVRXnfi7RLjQdHXUbPxDr7zRXdqu2a73oyvcRowIxyCrGvRKACiiigBskaSIySKGVgQQR1B615v488GG4mW50yB4FyrSPbks2VGAxXgk443Kd31r0qigDxaW48aWNhctNqBbRpB5K3UkHmNCG+TPJV8gnup+tdjClpZ63bIG8y10HTd+NmSGbuPfav610XiLRzrUFrA1zJDBHcJNKqD/WheQh9s4P4VVXTZbC8leAq5vrjfcTNgFEAwqKMHPAA/OgDatZxc20UyqyrIoYBhgjPrXNa7bXOsa9YfZbdkTTp95uZBgBiOdoPXjjI9fauqHFH6UAYmnaF9h8R6nqEMw+zX6xmS328CVeC+fcbfyrcoooAKKKKACiiigAooooAKK5r4kXVxZ+CtTmsriW2uAqKssRwyZkUEg+uCai/4Q3/qY/Ev/gd/9jQB1VFcr/whv/Ux+Jf/AAO/+xo/4Q3/AKmPxL/4Hf8A2NAHVdq4HQ9NtLv4s+I9VntlN5aQQWkMjLyqldxI+pOPwqfSrS40f4g2+njVtTvbSfS552jvJ/MAdZYVBHAxw7Ut9NHoXxJt7m4crba3bi2BJO1Z48kD0yyn/wAdoA7asPVbPTY9QjuLkGO5uGRVdSQWZMlR+RPFbmaoaw9hHarJqrRJCjhlaQ4AYdMe/WgC8DkA1neINJt9a0qayulGHGUfvG/8LqexB5qr4burmSW/guSZIopd1tNjiSJgCOehIzj8Kv381mXS1u5lR3HmqpfaSEIJP0HFAHm2g+JfFdzp7WmneEz/AGkGaCbUJpY0gd1+UyEg7j06YzV4eCLnSdAW+jnl1PxPDci/luOEa6cAqY/ZdpwB7Ctb4XwKNHv9QikLwalfz3kQIIwjOcdfbmuyoA4WwttH8ewm4vnmu7NH+fTblQEjkHBBXqccjmua8bfC/Q7DwzqM+nz6ghgjMtnZPfstvHIp3AKpPqOhJrttb8C6NquptqOLqy1Bxte4srhoWkH+1jg/UjNZsfwt8PNMj6k+paqiHcsOoXjzRg+u0nB/GgDW065tvGPgVWsbspHfWmwTRnLRkrjP1BrlNR8NeL7SGz1FtYtdQuNJzKkcNr5Ul2Nu0q7Fj25x3IFauo+B7qxvpb3wRqi6JLMQZ7VofMtpCO4TI2H1I61n2Xg3xleXUp8ReMiLKQjNtp1v5e4em9skZ9qANcLZ/EXwEsV8Et2ukV2VHV2gdTkHg4yCK42Lw8nhHxb4Wu57mLUtUu57mGW6VRFlDHuRFXOAPlx9a6l/hP4WUf6DBeadlCj/AGO7kj8wHru55J9etV/+FS+H7aznOnLcLqWwC2vLmZpmtyOm3ccAfhQBveLtCsPF/h6e2uZ5UQxOu63nYAEjkNtPzDjpXkXgT4N6brfhyLVNQupLeW4JaFIoEXyEBwoBZd3bNddpXirTfDC29lrslvoVwJ2E9q0JVJDjG6NwMEE8596tav4ok8aL/Y/gqCS4hkO241Vg0cFuvQ7TxvbrgDj1oA4/wV4s0b4f+JNR0zV7yWS2vpTJHqMiFlKqAqln6AEDA9MGui+F11pek6HcxrqkDX9kZ18v7RthlDOzo/vkEfNUtzoGneEfGWjD7NJNpGpWa6TIsih4lZMlNwI75b867uLwtoMVtbW6aRYiG2OYUMKkR/TI4oAw/Ak19rmoXXiK/gW2SaCO2hiXkEKSWcN3Uljg46Cu2pFUKoVQAo4AHaloAMVzeseBfC+sXJuNR0OxmuD1l8va5/4EuDXSUUAc5ovgfwxok3naXodjBN/z0EQZ/wDvo5NdHiiigAooooAK8e1vVdV0L4LeI9Y0G++xX1hqurTqxhWUOBqNwCpDAjBz168V7DXAeGPD+leJfBd5Ya7ZRXtmdc1VzFLnaWGoXODx9TQBzKa14sh8e/D3SpPEhltNZspLy7U2MILGNVkKggcBg23jpjI5qp4c8deINMsPHF7rusW+pnR9XGkWcNxALdZWLIAxMMbuWIY/KqtnHHrXocHw48IwX+n3sWhWq3Wn7fsso3Zh2tuG3n1plt8MvBltaXtrD4dsRb3m37QhUkSFTkE5PUEZz1oA5GLxnP41+G+qXN7pp0280/XLbTp4dzMC6XNu24blVgMOOGUEYNevV5/4r8O6R4Z8CXNroOnwWFtNqVnPJHCuA0huYAWPvhR+VegUAFFFFABRRRQAUUUUABHFAFFFABRRRQAUUUUAFFFFABRRRQByvxS/5ETU/wDtl/6NSub8Wax4gtfjN4S0Sx1kwaRqkU889v8AZY2P7gBiocjd8+cE547V0nxS/wCRE1P/ALZf+jUq1qPgzw7qXiG212+0qCfV7ZkaG6bO9CpyuOexFAHkcHijxmPCfxMv5PExe58NXc1vat9ggAcRKGyw2/xZx7U0+PvF2i6lBcyTQa3bw+DYtevIbiRbQFmmdmZNkbZcIFQLwDjPXr6XF8L/AAXDaXdrH4es1t7sgzoN2JCDkZ55p0vwx8FzLaLN4csZEtIhDCrqWCxh2k2YJ5Xc7HB45oAisL9NU8e6DqEKOkV34emnVXGGUPLbsAffmrPxT8OSeJ/Bd9Z2jmPUIgLizlU4McycqQf0/GnTqF+KWmqoAUaLcgAcADz4K6ugDyPwb8TJ9P0u2t/HsBt5FQKNVt1L2sxHByw+43qDWn4k+IPgrVNLa1fUftkMn/LW1iaUQns5IGFx61qa74V1GC5ubzwjeWtrJcsXubK7i3287Hq2ByrHuRkH0rItdJ8fXtsNOuP+Ee0SxKlJJbJGldh0wqEBR+OaAL51/QvDD24uvEYjt57GP7LFLgptHHmDA5J471gz6/d+PdTsdG023nh0eeJnudTdRG08QOCIl+8FY8bvQHFQ3/nal4H0Sa2M8NtbyfY9QEUf71EjJ3Ef3eVOT712vgHTRHZnVZUCTXiKI4x0hgH+rQfgcn3JoGdLZWsNlaQ21rGscEKBERRgKAMAVPRRQIKKKKACiiigAooooAjmt4ZwBPFHIB0DqDj86dHGkahY1VFHQKMCnUUAIyhvvAHvyKWiigAIBGD0ooooAKKKKACiiigAooooAK5GLwSbZ7n7B4k1+zgnuZrowQyQbEeWRpX27oicbnY8k9a66igDlf8AhErz/ob/ABL/AN/Lf/4zR/wiV5/0N/iX/v5b/wDxmuqooA4+58Dm8WOO/wDE3iC7t1ljmMMskG1yjh1B2xA43KOhFdhRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVV1DULPTbdp9QuoLWFerzOEA/E1xV38UtILOmiWOra3IvQ2Nqxjb1w7YWgDv6K4H/hLfFd0kcmn+CJ1jZd3+l3iRt9MAGo/+En8dBNx8ERHGPlXUlyf/AB2gDsfEWkQa9o11pl3JNHDcKAzwkB1wQQQSCM5A7Vjf8Ilef9Df4l/7+W//AMZrEl+Iuo2ExTWfBeuW0a8vNb7LhAPX5Tn9K6jw54t0TxHuXSb+OWZBl4Gykqf7yHBFAFL/AIRK8/6G/wAS/wDfy3/+M0f8Ilef9Df4l/7+W/8A8ZrquaKAOd0Xwsuna1/ak+r6rqV2LdrZDePGQiMyscBEXnKL1roqKKACiiigDgdcSfwxq2p3skE9z4c1NC12sCb3tZNuC+0clWHXGcGn/C/WX1C3uLS3mkvtLs1RLe+khaJn45RlI5I45HrXd0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRWB4m8QzaEY3Gjahf25GXks1VynOPukgn8KwJ/it4etn2XcOsW8v8Ack06XP6A0Ad9RXn7fEg3rCPw74a1zUpWGVLwfZoz/wACf/CoBpvjzxIW/tbUbXw7p75H2fTx5lxj0MjcA/QUAdX4k8V6N4cjVtWvo4pHOI4V+eWQ+ioOTXLnW/F/iptnh7Tv7B04nDX2pJmZh6pEOn1b8q3fDPgfQ/D2JLS1868I+e7uSZZnPqWPNdPQBx2mfD7SYpBcaw0+t33B+0ag/mkY/ug8AZ9BXWwwxQIEhjSNRwAoAAqSigAooooAQqpIJAJFc34p8GaT4hVJJ43tb6I7ob21by5oz6hh/I10tFAHnmieJdV8O6rBoPjVd6zP5djq6fcuOflWTA+V8fga9DrmviHbR3vhLUreRGLmB5InVc+XIillbPbBFaXhm4kuvD2m3ExLSSQIzE9zigDToork/iVrM+k+HkjsZ47e/v7iOygldgNjOcFhnqQMke9AHSTX1pBII5rqCORuAryAE/ganDBgCpBB7iuDtPhT4TW3QXunC+ucAvc3Dl5HbuxJPepT8O7SykD+HdU1TRjzlLectG2f9hsigDuKa0iKfmdQfc1wM3gfWbqN4tQ8ca09u3G2IRwt/wB9KuaZD8IvChw91DeXk5+/NPeSOzn1PNAHoQYMMqQR6ilrhV+GejWiE6Ncalpc45WS3u3+U/7pJB+hFXPAmtXNy+o6Jq91Dc6xpcgjlkjwPNjYZRyOxI6++aAOuooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAprRIxyyKT6kU6igBAoAwBgUtFFABRRUccQjeRgzEuckE5x9KAJKKx9T1S6spA8di9zaqHaWSE7mAUcAL3Ynt7VZsfP895GMrQTKJFEhAMZx90D9aAL9I7BFJY4A71XmmgQsXkjBIxy4FMkvLNo2ja7gG5cf6wf40AWy3GV59Kp/2lbC4a3eTZOq7/LYYJGcZHtmsnU/FPh7QLWJL/WbG2GMKDKGY49AMk1xM/xXh1fVrTR/BumzXuoXYdYb29iMFvhfvMCRlsegxQBv/FjXzo/gO9SKOW41O+ha3tLaMfvJHZT0A9Bkmt7wNdLeeD9HnQEB7WM4IwQdo4rlrXwk2lyy+Jtfu21fXYo3LTOSkdvHg7hEnQcfia3/AIat5ngbR5PmxJArjcMHB5FAHTV53qiWPinxXdtqUIl0fRVaAF2wjTMMyP8A8AXjPrmtvx7rs+lWEFnpaiTWNQk8i1Xsn96Q/wCyo5/KvNPHZgtvDNj4W0o3Lz6gxtYruI7zJu/1jk/7RyM+gNAEHg9dduNM1DV9D8VXWi+E1lKWUd9Et0zgHGVLZbaT0HWug062+JmvRtK+v2elWIbEEgsB50y/3mViQv0rb8L6bp+oagLJQr2Ph4R20EAXCrMF+Z89+oArqtauJkmsILWFpXkmBcggBEGck/yoA8lsvh9Hr3xAvItf8VahrC2EEf2m288xjzWzglVwAAOgFdBr/hrRvAWhTajp2o6zZEOFjhhunlM8jHCoFfIyTWb8Sb2LwR48tPFemw3F1NcRC21GytgCZV58tz/tZwBjtWz4a0PW/E2t2nibxkq2scA3WGjqdywEj/WSHu/8qAKuleC/F+s2NtJ4s8YX0ayKfNs7FFiG0/wlwMk46muJ8DfDZbu91/xF4O1K+0e8jvXt7F3lMqSrH8pEitnILA19E14Bax+NtF16/wDBegXVnbWt1qEk0WoyjMsUTgSMFToeWIBoA67wp478V6loc09x4QeeezlNvM0N0qid1bazRqw6cdzXY+GfFuma+zwQPJb6hF/rrK5Xy5o/qp6j3GRXnh1u3+C4sdP8Q6q19pOoSsy3MzA3EUpOWLL3Qk9R0rtNT0bQPHWmwanp9xG04XNpqdm48yI+oYe/UGgDr6K47wv4iuotS/4R3xPtj1mNSYZwu2O9jH8aejeq9vpXY0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRWN4j16PQUhmurS8mtXOHlt4/M8r3ZRzj3GapWHjjwzqB8u012yEzZASWQRuD/utg0AdNUczMqgrnqM4GapS6rYQRBbjU7RH2/eeZFz78msS/8AiD4U0yH/AEvxDYSOPl2xSiR3PoFXJJoA3xdNLKY7dW+RirMykDjqOf50atqdlo9lJe6pdRWtrGMtJK2AP/r+1cPceNtb1qFl8G+H51Q8m/1UeRCg7nb95v0rlNAsdQn+MjWXja5TXT9iW8sJQmyCBs4YKmSD1HPtQAy5u5fFHieH/hHp9U8KabduXXUmyn29/wC6iHhfXJGT2pmjWMzeKbzwt438SeI/trndaSm5McN3H/slcYPXivcJraKWJUeNSqkFePun1HpXE/GLRYNS8LC7YOt5p0qXFvMnWNsgZP8AsjOT9KAOD+NPw/8ADuj+B/M0yymOovdQxQkXDl3JYAgknpjNdlZfCrwRGYvO0e3+0yxqfLdyegGcDP51z3hOx1zx54wi1TxdBHb6foJ8u2ton3JNcY+aUnvjsO1euvDC2oRStGhmRCEYj5gCecH8BQB5B4s0HR/hz4u03xRb6Lajw8YTa37JFua2JOVlx6djVnxHqdnqnxU+H0mhXlq9tLDcSq0eGDIQOgFet3VtDd20lvcxpLDIpV0cZDA9iK8B0TSNP8KfG6zsw7R+YzpDGFxHGu0lOexIPQdcUAep+J7uVP8AhIrNmYq+lvPFxkL8jKf5Vp+B54rnwfo01swaF7WMqR0xtFT61PaWZSa8RQs2LbzCM5LHAX8Sa5bwlq1vpvwk+3xv5cVnaygHH3SmQBj6igDDOpHV/Hd/fI0Sxws1hDJIMhLePm4fHux259q5nwjFcavq+seOLOEHR7OT7HpMTAhEgTIeVF7seg+tY0EN3rR07whpgkhF7Ht1K8dQrxxf6yUD3Zm5PbNev6VoIvnt9PFs1l4a0llS1gU4+0svRzj+EHoO/WgDS8EaQ+j+F9scNvDf3Re5dVGFMj88/pXMePPGmpQOvh/w0I7nxC6bJJVQlY3PYeh75PA+tdr4l8uztZNVbDSWULmFS2BvIwM/U4Fed/CuJdJ0GLW9WKy65rNy0caE5xliSqn06kmgDV8KeDbDwVp82ta/Jd6rrU7CSe4cNOwc8BUHoOlb9v4nku7mGCHTL5bxjzC64VEPRnboDjsMmuqAyBkc1m69rNjoOnve6jJ5cQIUBRl5GPRVHUk+lAFu9u4bGymurt1jhhQu7HsBXiGh6dqXxbvdR1xri60LSftAjtJYcC4kWPIBBI+UZz9asXtz4g+KOsxWtksum+H7eUPLKCOQOCpPRnPp0X3Nex6VZWunafDZ2KqlvAuxVXtj+tAHIeHvhno2m3cl7qct1r2oOuwXOqP5zIv91c8AVX1zTZfA10+veHLV30piP7Q02EYUDvNGvZh3HcV6HXEfFjxTBoHhme2idZNX1FTa2VsvLyO/y5x6DOT9KANLXtMsvGHh6GaznUS4FxY3kRBMUnVWB/Qj0zT/AAPrcutaNm+jEOp2rm2vIs/dlXg/geo9jXE/BjSJfBmoar4Tur15xGkd5beY3zFHHz4HswIrb08RWvxi1WK0kc/atNinuYwflWQMyqcdiVA/KgDvaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAKmpw3E9m0dpOIJiR85XcMZ5H5V53qX2LSHNj400aPUYBk22pmBWV+pCyH+Bvc8GvT6ZPDHcRPFPGskbghlYZBFAHz3HoEeiz3N74X8NWfiLR5ZPMn0+6GLq1JHO0tkFfTHHpVLV/EXhfWpdBstE8JGw1OLVIWuIpLQxvbLuwHyPUjj1r6Bh0TT4Lq1ntoFgkt4/KTy/lGz+6R3FcH4kdJfi7pOnRW8UUbwrdXE44aRlLBF9+poA9DubeSV4lXabcqyTI3RlIrzDXbKz0b4o+DHtJGSOCGWybDAqFOSEI65BAr1a4jeRU2SNGVYMcdx6V5T47iGqfFLw1p+nAJPZsby528ZUkZLHv0H50AetjkVjeMkZ/CurKoJJtpOn+6aZc6/HDo9tfhQ6XEyQp5bbgdzYBzWg1mj3Fw0illnjEbgscEc8Y/GgDjvgqwPgeKPA3xzyqzA53nefm/Gur1G0dr60vY5xEtvu80N0ZCOf1A5rzn4f3H/CJ+MtU8LanOFW5f7RY5GFK9NoPrgZx9a7aPXGs9ZfTNbjjgSd9tlPuyk4/unPR/bvQBvxSJLGskbBkYZDDoRXnHxY8PzSKNb00MJ4wom2jJXYdySgd9pzkdwTXpCqFUBQABwAO1V764trSMSXbBUdhFkjIJPAFAHFabdx+PvC0V9ZztBqVsGQx7sqsy4PzAdRkAg+hrhLu/8Att9H4Rkcx6Zqd0t+JIlIVYUy06E9sSL+tdR4B0ltF+IviO3sV8rTnQFI1+4Gye3rg4rRh8HaTqfiLU5ZbG9tJ4lkh8xW2xSrKQ7MnPXIwfxoA4r4dMdR0/xJdaZcb7t7hLVZAAzRKzAufxya9viEdrbxRllRVAQZ4ryT4TWKaH8SvGdhAkhtruUXSMy7QpBKlR+Q5rvfFOqNbWd88MSmS1RfKd/u+c5wv5ZFAHLfGfxBCtjb+GbOR5NW1JwqxRDcygHI3DsM4/AGpLB4bDWNH01lNxb6FaqkkiDJ+0vhQgHrtyT6ZrA8AaLbWWlyeK2D3/iPVXNvbzyYZ1ySN382PsMV1vgXQ/8ASGvZpJJI7d3jiLk5mkz887D+8TkD0FAzrdZ1S30jSp7+8bbFEucd2J4Cj3JIAryCK0u/GuvS3Wv3otrSKUQMsLnETH/l3j9Xx99+vYYrf+Jd9c32uWej2jxgRlWUEnLXL52Aj0VQz/XFTQtNpWpjRPDelfbm02BWLO4SHz35Znbklsc8DPNAHc6LYDTrP7JHHBFbRnbCkK7QqdgfU+9XkREyEUDJycdzXM6bYeJri/iuda1O2gt0wfsdlHgE/wC07ZJHtxWlrniHSNBgMurahb2qgZCu43N9F6n8BQItaxfx6XpV3fTkCK3iaVsn0Ga+brDXfD+n6/q2peMNZmbxjdSmOH7NbvK1nCQNoiX+E4PWuv1XxFq/xRvDo/hmGSy0WKfFzdyr82VIPI6dei85746V6No3hjQfDFs07pB5+N099dkGSQ+rO1AHk+r+IJvFVpZQ+HtL1jTdRsXVYPEGq/6OEB4Oc8ybv7verHw78ZWfhS/1qy8ZrqEvilrkvd3aWbOskX/LN/lztTb2q3q/j3Q7rWX0/wAD6JL4s1fzPOL7ibeFhxne3Ax7VtfC3U73UfFXiNPFVnptp4gdYX8m2ffm324Xnvg5oA9LsLy31Czhu7KZJ7aZQ6SIchgasVxnw/eK01DxHo1sFSCwvSYowOEWRQ+PpljXZ0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXA/E3RruaS01mwDO9ipLIvVcHcrjHJxyCPRjXfVl6yuq+bZtpDWpj80fakuAfmj77SOhoAxfCPjew1/SpZmZYby2j8y4g3bsDGdynup9a4vwmsz2Wu+JWjniv8AW737JbJdHzDDHu24GOg6nH0qbx74QtbOWXXNGluLe2lbF0bJv9Q2QDKq9x2ZfTntWl4cuBP4Dtl0uU3GoaTKrXEcf35SD82P94EkHvQM6zVdGEunabaW0Mfl21xFJtztAC9x/hWrfi4a0kFk6Jc4yhcZXPoaktZluLeOZAQHUHB6j2NSE4HQmgRw3xG8Bx+MLeyuVkW21ezyYZsEjnqpxg/QjkVzHhjVNUGrt4N8cILhz/x6XgXLKwGVJbvwMhuvBBr1m8lNvH57OFhjBaT5SxIx2rgPivZXDLpWsafN5RimRJDjggnKE+g3cf8AAjQB1HhTU7i6S6sdSULqNjJ5UpAOJF6q4z6j9c1pNZlr2aaaXfbuijyWHyqQSd38vyrlIrh9YlsvEXh8qb2EfZr60kO1mXup/usp5B7imeLPGWkq8On2cl5qOomQA2mmfvCTjlJGHyqp75NAGXos1jpnxY1tLy9MeoXyKIIy3ybMZB9M8n8q6Lxf4ssdB0tVk1bTotQlYRx+dMFXP8RP0GTXJP4e01N+sfER7Gwtxbi1tbAy8QxA7hluryZ9Onas/TtQ8CWtxMvh/wAFalqMg5Mqacdre4aTGaAE+HWt6XoviDXNS8SatZ20mqbbm2aeTYDExJAXPatXxL4n8PXWh30Gn6xYalf3N7DIlvaygvJ+9XAwPbv7VYk1651dQs3w2v5Y4flT7SYVwPYEmrWnXV7azCW0+HYtiBwwmhVh+QoAi+EUuj3mh2UEN3DLf6ZJNCYN43RHec5Xr+Nd1rOpWmiaVc3984itbdC7H+g9SelcFs8Oa9qa22raRN4f8QZLwysBG7N6xyrwx46fpWV8Q7O9fxBp9vreswW+m4LQTTnZFGFA3MxPDzHnGeB1xmgC18Ps6rrep+KtXkSKKEsMNgKjHrk+qKFXP1rOl+JjfbpNO+HXh241d5JGaW6YERrIT/FnB/EnpWbqF5P4klg0vRN9h4VsEEjXMgxuUf8ALVh3J/hB69T2ru/C+kvGZtM066tNP0qKMbYLUg3TZ/jkbqpNAzlj4f8Aib4lQHWdUt9GDY3R2srED6AY7epNaeifCL7D50114j1C4vZSSZiqEj2+YE11+r+D7XU7lbh9Q1WCdYfJV4Lt0wPXAOM+9UYPCWtQQLCnjHVWRejSJEzY9yV5oEcQ3wQkW5Esfiy/tow+9lt40h3H3KgVdtPgfoAk+069qusa0BlmW7umKEe4HUV3LeHbGTSv7J1y9m1L7RL5v+lS4dyOcADHA9BUuua0NCNnZWmk319JMpWJLaMFE2j+JicKKAMRLXRZfCo07wvYfZorwmONIYzBlQeWJxkLwee9czqWteHPDfxW8L2NtNaQ3jWsthdEHasajDICemc5/OtnUdei8I6feX2sTwS+Jbxcx2cb58ofwqPRB1LHrzXni+G7X/hG9L1PWbf7TqGravAsMkyHhdxYn1UMcn8aAPVtLT7F8UdWRIVEOo2UNyJFP3mQlDkfQCu1riNcVYPiB4UaAkXDwXEUqK3/ACyAUgkem7+ddvQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRXB6FL4r163vb2DXdOs4F1G9tYoTphlKpDdSwrlvNGSRGCeB1rS/srxh/0NGm/wDgnP8A8foA6qiuV/srxh/0NGm/+Cc//H6y/Ez+LtA0WfU28QabcrAyFof7KKbwXVSN3nHHX0NAHfUUUUAZ+ox3UUUQ02G3dTIPOjk4BQ9cY715h4q8P3nhTWG1/wAKNiFSq3EKfMIlzkh1HVOc8cr244r07V9Ys9I+ztfu0cU8nliXblEPbcf4R7msvWtCZ7z+2dFl8nUVX51B/d3S/wB1x0Pse1AEPhDxhZ65D5JiFrqQXe1qWB3rn78Z6Mp9R+NdWORXjHibQUms4PFGiNLZW6N5lxCn37KTOGlTHoeGToR711WnfEbTE0wLqkpXWI2MLWUS75ZnHQoo6hhgg9OaAOtMskeqtB5czxyxmTzDjy0I42/j1rk9c8UaemnSaJcqmvaxKhjewsV3ZJ/vHog9yaytau9Q1C2S68ZagPD2jTHbFpls5Nzcf7LsOcn+6v51Lo1nrF7afZ/DGlQ+FtJbj7TNGGupB3IXop92yaAM+40Hw9o+iae/jrUjHq5TDrb3Do84/hQqhzJgcZI7Vc0u51m4txZeBfDMOhaf0+36ggUkf3liHJP+8a6fRPCOiaBMty0bXWoStta8uyZZnJ/2j0+nSjV/FRto7iOy02+e5iICmS3byzzzyPagCpoXw+02zvl1PWZZta1nqbu9O/b/ALi/dUfQV019DdyWtxDYSRWspUCKbbu2n121biffEjkYLKDin4oA5WPwxqH2SRbjxNqr3LjmVCqhT7KBgVmXjeKPClnJfXGpR63psOGmWaIRzxp/EwZeGx1wRXe4rP1+3S70W9gkiSZJImBjdtqsPQnsKAMu5t9G8Z6PNaTSx3YiYBnjOHhlABBB/hYZBrGspWhmg8OeOore93P/AKDeyxgpc46Bh0WQD8+1aHhTwwNLthdNN5l7NI91KIiUjd2AAGPQAACrt7plxr+g3NnrcEME0gPlmFyxjb+FgexB5oA4G+tL3Q/E40W41A21pq169zbXCwbzMSOIG7DZjI9QB6V6Vo2h2GkmR7S3jW4mwZp8fPKfVj3rl9NdvFHw/BupzFqVkzK1wihmjnhJBYA/Q/nXEp4T8X+LbWLWLnxdqOkWjDzE8l8u6euwfKv0waBnuJIUEkgAdSaxdc8U6LoluZdR1CFOMhEO92+ijJNeFL4bs49TmttX+K15Og4a1vgVB+u7ANdX4Z8CeAf7W8yDWRqN88e6SKO6+V1A/uLxj2oER6p8TtT1nUkj8FeEpNRu4WKLPdHaIwR97j7v0Jz7VHq2j/FjUtNkuJr21SaSNttlbXBhCMenzBckD616xoI0uO0ji0eGOK32BlVIigx+VLqeuWel3Ecd+ZIY3wBOyHywScAFuxoA+dfCNnpXhO6toPivp+qJfuQxv7lzNas4PGWH4cNXsXi680vWvCGqSG8sDpcVr9otLmC4G5ZEBKsMdMEDFdpe2drqFq8F5BFcW8gwySKGVh9DXIp8LfBkd5HcxaDapIknmgKMLu/3emPagDH+CNodT8P2vinVdSk1TW72ARySucCFQf8AVhe3v6mvTqytK0Ky0rUNQu7FGia9ZXlQH5NwGMgdBwK1aACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5X4af8AIuXn/Ya1b/043FYXiLxV4mtPitpnhfTY9HNlf2cl2ktwkpkQR4DA4YDk9OOlbvw0/wCRcvP+w1q3/pxuKTUPAumX3ja08UzXWprqdqoSIJdMsSpxlNnTa2OR3oA4vwn8VNR8RN4U02LT7SLX7y+urfV7c7itkltnzSOchjuj25yMt3rtfil/yImp/wDbL/0alGh+AvD+ieMtX8UadaNHq+qLtuHLkr1BbaO24qCfU0fFL/kRNT/7Zf8Ao1KAOqooooAiubeG6geG5iSWFxhkcZBH0rlLaxuvCuq28Wnie50O7fyzBncbNzk7lJ/gPTHauwrgPiOdAlvLaPX9evYIwu06ZaTMDPk8FkT5j/KgCtf+JpnutS0Hw0sOsahPI4DIg+zWSng+aw4Jzn5RyaYl8bDyNB8M2kOq+I7eJYbjUHjHk23HJdu59EHP0p2kafqOr2a2OjWDeF/DYBUkKFu5x7Y+4D68n6VvXcb+F9Lt9N8KaP588p2rk7Y0PeSVup/maAIrLQbDw/HLrOuXEmpapt3SXUw3t/uxp/CPQCtLT7vU9Yt4bhYTptrIrZSUZmwfun0U98c0ui6G0Ei3urT/AG3VSuHlxhF9kXoBW7igDB0nw4tjdi6uNR1C+uQpXfPMSMH/AGRgfpW9iiigAooprLuYHJGPQ0AZ6Xt3JrBtlsGWyVNxumcYZv7qr1/GtIgEYIyKKKAAAAYHArL00akNU1MXpRrLeptCPvY2jcD+Oa1KKAPPtC03UfD3gfxB9qhb7XcXN1NFHCPMbEjnZx+IrrfDtgbDw7YWLMxaGBYyx4OcVqUUAVLnTLG6x9ptIJiO7xgmkttLsLWXzLazt4pMY3JGAcelXKKAECgdAB9KbLFHNGUlRXQ9VYZFPooAAABgcAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcXYeGfEWli6h0rxJZRWct5c3aRzaWZGQzTvMylvNGcGQjOBxVr+yvGH/Q0ab/AOCc/wDx+uqooA5X+yvGH/Q0ab/4Jz/8fqlq/hfxLrFg9jqPiaxa0lZTIsWklGIVg2AfOOOnoa7eigAooooAKrf2fafbHu/s0P2pwFaUoNxA6DNWaKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Classification of jejunoileal atresia describes the pathology as type I (mucosal web), type II (fibrous cord), type IIIa (mesenteric gap defect), type IIIb (\"apple peel\"), or type IV (multiple atresias).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Welch KW, Randolph JG, Ravitch MM, et al (Eds). Pediatric Surgery, 4th ed, St. Louis, Mosby-Year Book Inc 1986. Copyright &copy;1986 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22451=[""].join("\n");
var outline_f21_59_22451=null;
var title_f21_59_22452="Sodium phenylbutyrate: Patient drug information";
var content_f21_59_22452=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Sodium phenylbutyrate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/39/9845?source=see_link\">",
"     see \"Sodium phenylbutyrate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=see_link\">",
"     see \"Sodium phenylbutyrate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F221871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Buphenyl&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692120",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat urea cycle problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702944",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to sodium phenylbutyrate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are on a low-salt diet (this drug has salt), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697938",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in body odor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Period (menstrual) changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695910",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695427",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mix powder with soft food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694866",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12058 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22452=[""].join("\n");
var outline_f21_59_22452=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221871\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030183\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030182\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030187\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030188\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030190\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030185\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030186\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030191\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030192\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/39/9845?source=related_link\">",
"      Sodium phenylbutyrate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/20/11588?source=related_link\">",
"      Sodium phenylbutyrate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_59_22453="Bisoprolol: Patient drug information";
var content_f21_59_22453=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Bisoprolol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/29/2520?source=see_link\">",
"     see \"Bisoprolol: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F141637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zebeta&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F141638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Bisoprolol&reg;;",
"     </li>",
"     <li>",
"      Ava-Bisoprolol;",
"     </li>",
"     <li>",
"      Mylan-Bisoprolol;",
"     </li>",
"     <li>",
"      Novo-Bisoprolol;",
"     </li>",
"     <li>",
"      PHL-Bisoprolol;",
"     </li>",
"     <li>",
"      PMS-Bisoprolol;",
"     </li>",
"     <li>",
"      PRO-Bisoprolol;",
"     </li>",
"     <li>",
"      Sandoz-Bisoprolol",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018275\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not stop taking this drug all of a sudden. If you do, chest pain that is worse and in some cases heart attack may occur. The risk may be greater if you have certain types of heart disease. To avoid side effects, you will want to slowly stop this drug  as ordered by your doctor. Call your doctor right away if you have new or worse chest pain or if other heart problems occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help a weak heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to bisoprolol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Very weak heart or slow heartbeat without a working pacemaker.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 12 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697043",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may hide the signs of low blood sugar. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018279\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11355 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-47BF19C4B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22453=[""].join("\n");
var outline_f21_59_22453=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141637\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141638\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018275\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018277\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018276\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018281\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018282\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018284\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018279\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018280\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018285\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018286\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/29/2520?source=related_link\">",
"      Bisoprolol: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_59_22454="Anatomy of the male ureter - lateral view";
var content_f21_59_22454=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F65876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F65876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Anatomy of the male ureter - lateral view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 444px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the pathway of the ureter in the male pelvis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22454=[""].join("\n");
var outline_f21_59_22454=null;
var title_f21_59_22455="Clinical manifestations and diagnosis of irritable bowel syndrome";
var content_f21_59_22455=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of irritable bowel syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22455/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22455/contributors\">",
"     Arnold Wald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22455/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22455/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22455/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22455/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/59/22455/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irritable bowel syndrome (IBS) is a gastrointestinal syndrome characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause. It is the most commonly diagnosed gastrointestinal condition. The prevalence of IBS in North America estimated from population-based studies is approximately 10 to 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. A population-based study in Europe found an overall prevalence of 11.5 percent (a value similar to that noted in reports in the United States); however, the prevalence varied widely among countries [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IBS affects men and women, young patients, and the elderly. However, younger patients and women are more likely to be diagnosed with IBS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/8\">",
"     8",
"    </a>",
"    ]. A systematic review estimated that there is an overall 2:1 female predominance in North America [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only about 15 percent of those affected actually seek medical attention [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/1,2,9-11\">",
"     1,2,9-11",
"    </a>",
"    ]. Nevertheless, the absolute number of patients is still so large that IBS in its various forms comprises 25 to 50 percent of all referrals to gastroenterologists [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/12\">",
"     12",
"    </a>",
"    ]. IBS also accounts for a significant number of visits to primary care physicians, and is the second highest cause of work absenteeism after the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/13\">",
"     13",
"    </a>",
"    ]. IBS has been associated with increased health care costs, with some studies suggesting annual direct and indirect costs of up to $30 billion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the clinical manifestations and diagnosis of IBS. The pathophysiology and therapy of this disorder are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12697?source=see_link\">",
"     \"Pathophysiology of irritable bowel syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40169?source=see_link\">",
"     \"Treatment of irritable bowel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with irritable bowel syndrome (IBS) can present with a wide array of symptoms which include both gastrointestinal and extraintestinal complaints. However, the symptom complex of chronic abdominal pain and altered bowel habits remains the nonspecific yet primary characteristic of IBS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Chronic abdominal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain in IBS is usually described as a crampy sensation with variable intensity and periodic exacerbations. The location and character of the pain can vary widely [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. The severity of the pain may range from mildly annoying to debilitating. Several factors, such as emotional stress and eating, may exacerbate the pain, while defecation often provides some relief.",
"   </p>",
"   <p>",
"    Despite the variability of abdominal pain in IBS, some clinical features are",
"    <strong>",
"     not",
"    </strong>",
"    compatible with the syndrome and should prompt an investigation for organic diseases. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain associated with anorexia, malnutrition, or weight loss. This constellation is extremely rare in IBS unless there is concurrent major psychologic illness.",
"     </li>",
"     <li>",
"      Pain that is progressive, awakens the patient from sleep, or prevents sleep. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/36/19018?source=see_link\">",
"       \"Diagnostic approach to abdominal pain in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Altered bowel habits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with IBS complain of altered bowel habits, ranging from diarrhea, constipation, alternating diarrhea and constipation, or normal bowel habits alternating with either diarrhea",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    constipation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diarrhea is usually characterized as frequent loose stools of small to moderate volume. Stools generally occur during waking hours, most often in the morning or after meals. Most bowel movements are preceded by lower abdominal cramps and urgency even to the point of fecal incontinence and may be followed by a feeling of incomplete evacuation.",
"   </p>",
"   <p>",
"    Approximately one-half of all patients with IBS complain of mucus discharge with stools [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/17\">",
"     17",
"    </a>",
"    ]. Large volume diarrhea, bloody stools, nocturnal diarrhea, and greasy stools are NOT associated with IBS and suggest an organic disease. A subgroup of patients describe an acute viral or bacterial gastroenteritis which then leads to a subsequent disorder characteristic of diarrhea-predominant IBS, called post-infectious IBS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12697?source=see_link\">",
"     \"Pathophysiology of irritable bowel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Constipation may last from days to months, with interludes of diarrhea or normal bowel function. Stools are often hard and may be described as pellet-shaped. Patients may also experience a sense of incomplete evacuation even when the rectum is empty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other gastrointestinal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper gastrointestinal symptoms, including gastroesophageal reflux, dysphagia, early satiety, intermittent dyspepsia, nausea, and non-cardiac chest pain, are common in patients with IBS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/15,18\">",
"     15,18",
"    </a>",
"    ]. Patients with IBS also frequently complain of abdominal bloating and increased gas production in the form of flatulence or belching. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12697?source=see_link\">",
"     \"Pathophysiology of irritable bowel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Extraintestinal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with IBS often complain of a broad range of non-gastrointestinal symptoms. These include impaired sexual function, dysmenorrhea, dyspareunia, increased urinary frequency and urgency, and fibromyalgia symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of a biologic disease marker, efforts have been made to standardize the diagnosis of irritable bowel syndrome (IBS) using symptom based criteria.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Manning criteria &mdash; This concept originated in 1978 when Manning, et al formulated a symptom complex suggestive of IBS (",
"      <a class=\"graphic graphic_table graphicRef63034 \" href=\"UTD.htm?1/18/1323\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/17\">",
"       17",
"      </a>",
"      ]. These symptoms included relief of pain with bowel movements, looser and more frequent stools with onset of pain, passage of mucus, and a sense of incomplete emptying. There have been conflicting data regarding the predictive ability of the Manning criteria [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/21-23\">",
"       21-23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Rome criteria &mdash; In an effort to standardize clinical research protocols, an international working team published a consensus definition in 1992 called the Rome criteria, which was revised most recently in 2005 [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/15\">",
"       15",
"      </a>",
"      ]. IBS was defined as recurrent abdominal pain or discomfort associated with altered defecation (",
"      <a class=\"graphic graphic_table graphicRef54997 \" href=\"UTD.htm?11/9/11419\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Supportive symptoms that are not part of the Rome III criteria include: abnormal stool frequency (&le;3 bowel movements per week or &gt;3 bowel movements per day), abnormal stool form",
"    <span class=\"nowrap\">",
"     (lumpy/hard",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     loose/watery),",
"    </span>",
"    defecation straining, urgency, or a feeling of incomplete bowel movement, passing mucus and bloating.",
"   </p>",
"   <p>",
"    Four subtypes of IBS were recognized:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      IBS with constipation (hard or lumpy stools &ge;25 percent",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      loose or watery stools &lt;25 percent of bowel movements)",
"     </li>",
"     <li>",
"      IBS with diarrhea (loose or water stools &ge;25 percent",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      hard or lumpy stools &lt;5 percent of bowel movements)",
"     </li>",
"     <li>",
"      Mixed IBS (hard or lumpy stools &ge;25 percent",
"      <span class=\"nowrap\">",
"       /",
"      </span>",
"      loose or watery stools &ge;25 percent of bowel movements)",
"     </li>",
"     <li>",
"      Unsubtyped IBS (insufficient abnormality of stool consistency to meet the above subtypes)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of studies have assessed the accuracy of the Rome and Manning criteria in a variety of practice settings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. It must also be emphasized that the Rome criteria were developed to improve homogeneity of patients for clinical investigations into functional GI disorders and therefore may not have sufficient application for clinical practice. The Rome criteria have been criticized for overemphasis on abdominal pain and failure to emphasize postprandial urgency, abdominal pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/27\">",
"     27",
"    </a>",
"    ]. As a result, some investigators continue to use the Manning criteria or a combination of both. Other criteria have also been proposed (such as the Kruis criteria) but are uncommonly used [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. A 2009 position statement issued by the American College of Gastroenterology states that no symptom-based criteria have ideal accuracy for diagnosing IBS; however, the Manning and Kruis criteria perform at least as well as the Rome I criteria (",
"    <a class=\"graphic graphic_table graphicRef50843 \" href=\"UTD.htm?43/34/44588\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/3\">",
"     3",
"    </a>",
"    ] .",
"   </p>",
"   <p>",
"    Considering the available data and the above limitations, a consensus statement issued by the American Gastroenterological Association (AGA) recommends that the diagnosis of IBS should be based upon the identification of positive symptoms consistent with the condition as summarized by the Rome criteria and excluding in a cost-effective manner other conditions with similar clinical presentations.",
"   </p>",
"   <p>",
"    The AGA guideline for irritable bowel syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/30\">",
"     30",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since many disorders present with symptoms similar to irritable bowel syndrome (IBS), it is important to exclude other causes. Patients are identified as having a symptom complex compatible with IBS based upon the Rome III criteria (",
"    <a class=\"graphic graphic_table graphicRef54997 \" href=\"UTD.htm?11/9/11419\">",
"     table 2",
"    </a>",
"    ). A limited number of diagnostic studies guided by the clinical setting are used to rule out other likely conditions. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Diagnostic criteria'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Routine laboratory studies (complete blood count, chemistries) are normal in IBS.",
"   </p>",
"   <p>",
"    \"Alarm\" or atypical symptoms which are not compatible with IBS include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rectal bleeding",
"     </li>",
"     <li>",
"      Nocturnal or progressive abdominal pain",
"     </li>",
"     <li>",
"      Weight loss",
"     </li>",
"     <li>",
"      Laboratory abnormalities such as anemia, elevated inflammatory markers, or electrolyte disturbances [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with one of these alarm symptoms require further imaging studies",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    colonoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients who have symptoms suggestive of IBS,",
"    <strong>",
"     no",
"    </strong>",
"    alarm symptoms and no family history of inflammatory bowel disease or colorectal cancer, a limited number of diagnostic studies can rule out organic illness in the majority of patients and a sizable number require no testing at all. This limited diagnostic approach rules out organic disease in over 95 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnostic evaluation depends upon whether the predominant symptom is diarrhea or constipation:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455554967\">",
"    <span class=\"h2\">",
"     Diarrhea predominant IBS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with diarrhea as the predominant symptom, we suggest performing screening tests based upon the patient's clinical history. These include, but are not limited to, the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stool cultures &ndash; There is little role for stool cultures in patients with chronic diarrhea. The one exception may be Giardia in patients with possible exposure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33224?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of giardiasis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Celiac disease screening &ndash; Screening for celiac disease with serum IgA antibody to tissue transglutaminase is recommended in patients with diarrhea-predominant IBS [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/3\">",
"       3",
"      </a>",
"      ]. However, the data to support this recommendation are conflicting. In a meta-analysis of 14 studies focusing on unselected adults who met diagnostic criteria for IBS, celiac disease was four times as likely as in controls without IBS; the absolute proportion of patients who fulfilled criteria for IBS and had celiac disease was approximately 4 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/34\">",
"       34",
"      </a>",
"      ]. However, almost all the studies included in this analysis were conducted outside the United States. A prospective multicenter US study compared the prevalence of abnormal celiac antibodies and biopsy proven celiac disease in patients with nonconstipated (NC) IBS to that of healthy controls. Although more than 7 percent of NC-IBS patients had celiac disease associated antibodies suggesting gluten sensitivity, the prevalence of biopsy proven celiac disease was similar in NC-IBS and controls [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=see_link\">",
"       \"Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link\">",
"       \"Diagnosis of celiac disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Twenty-four hour stool collection &ndash; A twenty-four hour stool collection should be considered if osmotic or secretory diarrhea or malabsorption is suspected [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=see_link\">",
"       \"Clinical features and diagnosis of malabsorption\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Colonoscopy or flexible sigmoidoscopy and biopsy &ndash; Many causes of chronic diarrhea such as microscopic colitis require endoscopic evaluation. The role of endoscopy in patients with chronic diarrhea is discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/55/43897?source=see_link&amp;anchor=H25#H25\">",
"       \"Approach to the adult with chronic diarrhea in developed countries\", section on 'Colonoscopy versus sigmoidoscopy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H455554974\">",
"    <span class=\"h2\">",
"     Constipation predominant IBS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with constipation as the predominant symptom, we suggest performing screening tests based upon the patient's clinical history. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link&amp;anchor=H11#H11\">",
"     \"Etiology and evaluation of chronic constipation in adults\", section on 'Evaluation'",
"    </a>",
"    .) These include, but are not limited to, the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiography &ndash; A plain film of the abdomen can detect retained stool and suggest the diagnosis of constipation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link&amp;anchor=H15#H15\">",
"       \"Etiology and evaluation of chronic constipation in adults\", section on 'Radiography'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Flexible sigmoidoscopy and colonoscopy &ndash; Sigmoidoscopy or colonoscopy should be performed if a structural lesion is suspected. Colonoscopy is preferred in patients who are older than 50 because of the increased risk of colon cancer in this age group. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link&amp;anchor=H14#H14\">",
"       \"Etiology and evaluation of chronic constipation in adults\", section on 'Endoscopy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=see_link&amp;anchor=H3#H3\">",
"       \"Colorectal cancer: Epidemiology, risk factors, and protective factors\", section on 'Incidence'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H470979901\">",
"    <span class=\"h2\">",
"     Mixed IBS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with both diarrhea and constipation, we suggest performing screening tests based upon the patient's clinical history. (See",
"    <a class=\"local\" href=\"#H455554967\">",
"     'Diarrhea predominant IBS'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H455554974\">",
"     'Constipation predominant IBS'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7760124\">",
"    <span class=\"h2\">",
"     Refractory symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;A more extensive evaluation should be considered in patients who have had a change or progression of symptoms or do not respond to general treatment measures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40169?source=see_link\">",
"     \"Treatment of irritable bowel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Further diagnostic evaluation depends upon the predominant symptoms: patients with predominantly constipation should have a work-up similar to other patients with chronic constipation (",
"    <a class=\"graphic graphic_algorithm graphicRef88130 \" href=\"UTD.htm?19/57/20382\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link\">",
"     \"Etiology and evaluation of chronic constipation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with predominantly diarrhea should have a work-up similar to other patients with chronic diarrhea (",
"    <a class=\"graphic graphic_algorithm graphicRef75832 graphicRef54849 \" href=\"UTD.htm?28/3/28727\">",
"     algorithm 2A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32025?source=see_link&amp;anchor=H3#H3\">",
"     \"Approach to the adult with acute diarrhea in developed countries\", section on 'Diagnostic approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Consideration should also be given to psychologic factors that may influence the patient to seek medical attention [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Because of the positive correlation between abuse and certain gastrointestinal illness patterns, patients with refractory or severe IBS may be questioned about physical and sexual abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22455/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12697?source=see_link&amp;anchor=H19618533#H19618533\">",
"     \"Pathophysiology of irritable bowel syndrome\", section on 'Psychosocial dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/34/31265?source=see_link\">",
"       \"Patient information: Irritable bowel syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/53/3926?source=see_link\">",
"       \"Patient information: Irritable bowel syndrome (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/14/7395?source=see_link\">",
"       \"Patient information: Chronic diarrhea in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with irritable bowel syndrome (IBS) can present with a wide array of symptoms which include both gastrointestinal and extraintestinal complaints. However, the symptom complex of chronic abdominal pain and altered bowel habits remains the nonspecific yet primary characteristic of IBS. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abdominal pain in IBS can vary but should NOT be associated with weight loss, rectal bleeding, anemia, and should NOT be nocturnal or progressive. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Chronic abdominal pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients may note diarrhea, constipation, or both. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Altered bowel habits'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of IBS should be based upon the identification of positive symptoms consistent with the condition, as summarized by the Rome criteria (",
"      <a class=\"graphic graphic_table graphicRef54997 \" href=\"UTD.htm?11/9/11419\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who have symptoms suggestive of IBS based upon the Rome III criteria and no alarm symptoms or signs on the history and physical examination, a limited number of diagnostic studies can rule out organic illness in many patients and a sizable number require no testing at all. The clinical presentation and history will dictate the choice of diagnostic testing. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/1\">",
"      Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/2\">",
"      Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/3\">",
"      American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 Suppl 1:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/4\">",
"      Hahn BA, Saunders WB, Maier WC. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997; 42:2585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/5\">",
"      Saito YA, Locke GR, Talley NJ, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000; 95:2816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/6\">",
"      Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/7\">",
"      Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/8\">",
"      Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/9\">",
"      Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/10\">",
"      Heaton KW, O'Donnell LJ, Braddon FE, et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 1992; 102:1962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/11\">",
"      Ford AC, Forman D, Bailey AG, et al. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol 2008; 103:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/12\">",
"      Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991; 100:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/13\">",
"      Schuster MM. Diagnostic evaluation of the irritable bowel syndrome. Gastroenterol Clin North Am 1991; 20:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/14\">",
"      Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/15\">",
"      Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/16\">",
"      Swarbrick ET, Hegarty JE, Bat L, et al. Site of pain from the irritable bowel. Lancet 1980; 2:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/17\">",
"      Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/18\">",
"      Lovell RM, Ford AC. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis. Am J Gastroenterol 2012; 107:1793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/19\">",
"      Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut 1986; 27:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/20\">",
"      Hershfield NB. Nongastrointestinal symptoms of irritable bowel syndrome: an office-based clinical survey. Can J Gastroenterol 2005; 19:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/21\">",
"      Talley NJ, Phillips SF, Melton LJ, et al. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990; 31:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/22\">",
"      Smith RC, Greenbaum DS, Vancouver JB, et al. Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology 1991; 100:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/23\">",
"      Taub E, Cuevas JL, Cook EW 3rd, et al. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci 1995; 40:2647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/24\">",
"      Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med 1999; 107:5S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/25\">",
"      Fass R, Longstreth GF, Pimentel M, et al. Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med 2001; 161:2081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/26\">",
"      Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 1999; 94:2912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/27\">",
"      Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/28\">",
"      Kruis W, Thieme C, Weinzierl M, et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984; 87:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/29\">",
"      Frigerio G, Beretta A, Orsenigo G, et al. Irritable bowel syndrome. Still far from a positive diagnosis. Dig Dis Sci 1992; 37:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/30\">",
"      American Gastroenterology Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 2002; 123:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/31\">",
"      O'Connor OJ, McSweeney SE, McWilliams S, et al. Role of radiologic imaging in irritable bowel syndrome: evidence-based review. Radiology 2012; 262:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/32\">",
"      Schmulson MW, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999; 107:20S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/33\">",
"      Svendsen JH, Munck LK, Andersen JR. Irritable bowel syndrome--prognosis and diagnostic safety. A 5-year follow-up study. Scand J Gastroenterol 1985; 20:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/34\">",
"      Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009; 169:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/35\">",
"      Cash BD, Rubenstein JH, Young PE, et al. The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology 2011; 141:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/36\">",
"      Katon WJ, Von Korff M, Lin E. Panic disorder: relationship to high medical utilization. Am J Med 1992; 92:7S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/37\">",
"      Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med 1992; 116:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22455/abstract/38\">",
"      Drossman DA, Talley NJ, Leserman J, et al. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med 1995; 123:782.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2630 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-652B83C886-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22455=[""].join("\n");
var outline_f21_59_22455=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Chronic abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Altered bowel habits",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Diarrhea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Constipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other gastrointestinal symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Extraintestinal symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSTIC CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H455554967\">",
"      Diarrhea predominant IBS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H455554974\">",
"      Constipation predominant IBS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H470979901\">",
"      Mixed IBS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7760124\">",
"      Refractory symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2630\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2630|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?19/57/20382\" title=\"algorithm 1\">",
"      Evaluation algorithm for chronic constipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?21/41/22162\" title=\"algorithm 2A\">",
"      Dx chronic diarrhea I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?12/35/12850\" title=\"algorithm 2B\">",
"      Dx chronic diarrhea II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2630|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/18/1323\" title=\"table 1\">",
"      Manning criteria for IBS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/9/11419\" title=\"table 2\">",
"      Rome criteria for IBS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/34/44588\" title=\"table 3\">",
"      ACG Dx IBS 2009",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/17/32025?source=related_link\">",
"      Approach to the adult with acute diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/55/43897?source=related_link\">",
"      Approach to the adult with chronic diarrhea in developed countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=related_link\">",
"      Clinical features and diagnosis of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=related_link\">",
"      Colorectal cancer: Epidemiology, risk factors, and protective factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=related_link\">",
"      Diagnosis of celiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/36/19018?source=related_link\">",
"      Diagnostic approach to abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33224?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of giardiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=related_link\">",
"      Etiology and evaluation of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=related_link\">",
"      Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12697?source=related_link\">",
"      Pathophysiology of irritable bowel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/14/7395?source=related_link\">",
"      Patient information: Chronic diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/53/3926?source=related_link\">",
"      Patient information: Irritable bowel syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/34/31265?source=related_link\">",
"      Patient information: Irritable bowel syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40169?source=related_link\">",
"      Treatment of irritable bowel syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_59_22456="Non-coronary cardiac manifestations of systemic lupus erythematosus in adults";
var content_f21_59_22456=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Non-coronary cardiac manifestations of systemic lupus erythematosus in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22456/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22456/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22456/contributors\">",
"     Karen H Costenbader, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22456/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22456/contributors\">",
"     David S Pisetsky, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22456/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22456/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/59/22456/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac disease is common among patients with systemic lupus erythematosus (SLE). Cardiac involvement in SLE can be summarized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Valvular disease, most often mitral regurgitation and usually hemodynamically insignificant [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pericardial disease, usually an asymptomatic effusion [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Myocardial dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Coronary artery disease [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/3-9\">",
"       3-9",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Heart disease is only one of many potential manifestations of SLE. Overviews of the clinical manifestations of SLE in adults and children and a discussion of cardiac disease associated with SLE in children are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=see_link\">",
"     \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=see_link\">",
"     \"Systemic lupus erythematosus in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/12/31943?source=see_link\">",
"     \"Cardiac abnormalities in children and adolescents with systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The remainder of this discussion focuses on non-coronary artery disease-related cardiac disorders associated with SLE in adults; coronary heart disease in SLE is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/13/28889?source=see_link\">",
"     \"Coronary heart disease in systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VALVULAR DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valvular vegetations in patients with SLE occur along a spectrum from small nodules to large verrucous lesions called Libman-Sacks endocarditis. Vegetations can be associated with valvular dysfunction, most commonly regurgitation. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Verrucous endocarditis (Libman-Sacks endocarditis)'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Systolic murmurs have been noted in 16 to 44 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/3\">",
"     3",
"    </a>",
"    ]. Structural valvular disease is the most common cause, but anemia, fever, tachycardia, and cardiomegaly can induce functional murmurs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/2,10-13\">",
"     2,10-13",
"    </a>",
"    ]. Diastolic murmurs have been noted in 1 to 3 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/3\">",
"     3",
"    </a>",
"    ]. They often reflect aortic regurgitation, which occasionally requires valve replacement.",
"   </p>",
"   <p>",
"    Mitral valve involvement is most common. A mild to moderate regurgitant murmur may be heard, but most patients remain asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/10,14,15\">",
"     10,14,15",
"    </a>",
"    ]. Mitral valve prolapse appears to occur with increased frequency in lupus, occurring in 25 percent of cases versus 9 percent of controls in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13705?source=see_link\">",
"     \"Definition and diagnosis of mitral valve prolapse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Transesophageal echocardiography, which is more sensitive than transthoracic echocardiography for the assessment of left-sided valve disease, was used to determine the frequency, clinical course, and complications of valvular disease in 69 patients with SLE, most of whom underwent a second study at a mean of 29 months later [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/11\">",
"     11",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thickening of the valve leaflets was the most common abnormality, occurring in 51 and 52 percent of patients at the two study times, and it was noted to affect primarily the left-sided valves. This lesion is thought to be due to initial valvulitis followed by healing with fibrosis and thickening.",
"     </li>",
"     <li>",
"      Valvular vegetations were present in 43 percent of patients at baseline and 34 percent in follow-up.",
"     </li>",
"     <li>",
"      Valvular regurgitation was noted in 28 percent at both time points.",
"     </li>",
"     <li>",
"      Valvular stenosis, which was not progressive, was found in 4 and 3 percent, respectively.",
"     </li>",
"     <li>",
"      The manifestations of valvular disease may change over time. In the studies cited above [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/11,15\">",
"       11,15",
"      </a>",
"      ], some valvular abnormalities resolved with time, others appeared for the first time, and some changed their appearance.",
"     </li>",
"     <li>",
"      Neither the presence of nor changes in valvular disease were temporally related to disease activity, therapy, or the duration of SLE.",
"     </li>",
"     <li>",
"      Perhaps most importantly, in this cohort there was an appreciable incidence of serious complications in the patients with valvular disease. After a mean follow-up of almost five years, the combined incidence of stroke, peripheral embolism, heart failure, infective endocarditis, and death was 22 percent versus 15 percent in the 13 patients without valvular disease. The incidence of stroke in patients with valvular disease was 13 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Verrucous endocarditis (Libman-Sacks endocarditis)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, Libman-Sacks endocarditis designates the extreme phenotype with large verrucous valvular lesions. In one report of 342 patients, 38 (11 percent) had verrucous lesions detected by transthoracic echocardiography (TTE) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/16\">",
"     16",
"    </a>",
"    ]. Similar point prevalence rates (6 to 10 percent) have been noted in other studies using TTE [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/10,14,17,18\">",
"     10,14,17,18",
"    </a>",
"    ]. As noted above, however, a higher prevalence (43 percent) has been noted when more sensitive transesophageal echocardiography is performed [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/11,17\">",
"     11,17",
"    </a>",
"    ]. Valve thickening is also detected more frequently by TEE (70 percent) than by TTE (52 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The verrucae (",
"    <a class=\"graphic graphic_picture graphicRef79709 \" href=\"UTD.htm?37/6/37984\">",
"     picture 1",
"    </a>",
"    ) are usually near the edge of the valve and consist of accumulations of immune complexes, mononuclear cells, hematoxylin bodies, and fibrin and platelet thrombi. The mitral, aortic, and tricuspid valves are more often involved [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Healing usually leads to fibrosis, scarring, and, in some cases, calcification. If the verrucal lesions are extensive, the healing process can produce deformity of the valve, leading to mitral or aortic regurgitation.",
"   </p>",
"   <p>",
"    Verrucous endocarditis is typically asymptomatic. However, the verrucae can fragment and produce systemic emboli, and infective endocarditis can develop on already damaged valves [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/11,19\">",
"     11,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike many other manifestations of SLE that are more frequent and severe during flares of disease activity, valvular lesions in SLE may occur at any time, and their presence does not correlate with disease activity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Antiphospholipid antibodies and valvular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valvular nodules, regurgitation and verrucous endocarditis are more prevalent among patients with significantly elevated levels of antiphospholipid antibodies (aPL). Many reports support an association [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/14,18,21-24\">",
"     14,18,21-24",
"    </a>",
"    ]. A meta-analysis of 23 primary studies, including 1656 SLE patients (668 with and 988 without aPL) and 508 cases of heart valvular disease, found a greater than threefold significantly elevated risk of valvular disease and 3.5-fold elevated risk of Libman-Sacks endocarditis among those with aPL, compared with those without aPL. The risk of valvular disease was the highest for lupus anticoagulant (OR 5.9, 95% CI 2.9 -11.8) and IgG anticardiolipin antibodies at (OR 5.6, 95% CI 3.5-9.0) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following studies are illustrative of those suggesting an association between aPL and valvular heart disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, 78 percent with high levels of antiphospholipid antibodies had at least one cardiac abnormality, including valvular lesions, pericardial effusions, and myocardial dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another report, 61 patients with SLE were followed with serial transthoracic echocardiograms [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/23\">",
"       23",
"      </a>",
"      ]. Initially, 24 patients (39 percent) had valvular abnormalities, primarily mitral, including 19 (31 percent) with regurgitant lesions. After a mean of eight years of observation, 73 percent had valvular abnormalities, including 56 percent with regurgitation. Seven patients developed severe regurgitation, a finding that was strongly associated with high titers of antibodies to cardiolipin.",
"     </li>",
"     <li>",
"      Patients with mild pulmonary hypertension, a less common complication of lupus, are also more likely to have antiphospholipid antibodies [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/18,25\">",
"       18,25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link\">",
"       \"Pulmonary manifestations of systemic lupus erythematosus in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=see_link&amp;anchor=H25#H25\">",
"       \"Clinical manifestations of the antiphospholipid syndrome\", section on 'Pulmonary disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In an echocardiographic study involving 200 SLE patients, antiphospholipid antibody titer correlated with the presence of mitral valve nodules and mitral regurgitation, but not with systolic function, myocardial hypertrophy, or pulmonary hypertension [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is uncertain whether serial echocardiographic examination in asymptomatic SLE patients is warranted to detect the presence of potentially serious valvular disease. A high index of suspicion should be present in SLE, particularly in patients with aPL, and cardiac auscultation should be performed at regular visits, followed by echocardiography in patients with significant or changing murmurs or changing cardiac function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38280?source=see_link\">",
"     \"Transesophageal echocardiography: Indications, complications, and normal views\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Blood cultures and echocardiography should be performed whenever fever and a new murmur are noted in a patient with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/2\">",
"     2",
"    </a>",
"    ]. Transesophageal echocardiography may be necessary for picking up small valvular lesions. We do not suggest performing screening echocardiography in the absence of symptoms or physical findings suggestive of valvular heart disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Preventing bacterial endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications and regimens used for prophylaxis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .) Although the valvular lesions that are most frequently seen in patients with SLE are not among the structural heart problems that are at highest risk of poor outcomes, it may be appropriate to prescribe prophylaxis for bacterial endocarditis for immunosuppressed SLE patients with valvular lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cytotoxic therapy does not appear to have an effect upon valvular lesions, although there have been no trials [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/26\">",
"     26",
"    </a>",
"    ]. In patients without infective endocarditis, antiplatelet or anticoagulation therapy should be considered for those patients with vegetations or significant valvular thickening, and certainly for all patients with thromboembolic events. The suggested approach is similar to that in patients with valvular disease in the antiphospholipid syndrome. Whether anticoagulation should be recommended for patients with aPL-associated vegetations who have never had any thromboembolic event has not been studied. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=see_link&amp;anchor=H22#H22\">",
"     \"Treatment of the antiphospholipid syndrome\", section on 'Cardiac manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Valve replacement surgery or valve repair may be necessary for some patients who develop severe mitral or aortic valve regurgitation, or rarely for those with symptomatic stenotic lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PERICARDIAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pericardial involvement is the most common echocardiographic lesion in SLE and is the most frequent cause of symptomatic cardiac disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/27\">",
"     27",
"    </a>",
"    ]. Pericardial effusion occurs at some point in over one-half of patients, and pericarditis may precede the clinical signs of lupus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pericardial disease is usually asymptomatic and is generally diagnosed by echocardiography performed for some other reason, such as suggestive electrocardiographic abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Pericarditis, as with other types of serositis, most often occurs when SLE is active in other organs as well [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Symptomatic pericarditis typically presents with positional substernal chest pain with an audible rub on auscultation. There may also be signs of serositis at other sites (such as pleural effusion and ascites). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Purulent pericarditis may occur, typically in an immunosuppressed, debilitated patient [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/30\">",
"     30",
"    </a>",
"    ]. Large effusions, suggestive of tamponade, and constrictive pericarditis are rare in SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pericardial fluid may contain antinuclear antibodies (ANA), phagocytic cells containing nuclei (LE cells), low complement levels, and immune complexes similar to those seen in lupus pleural effusions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/32\">",
"     32",
"    </a>",
"    ]. However, in clinical practice, measuring ANA, measuring complement components, or assaying for immune complexes in pericardial fluid adds little to similar tests on serum samples. The glucose concentration is normal, and the protein concentration is variable, being low with a transudate and elevated with an exudate. The pericardium may reveal foci of inflammatory lesions with immune complexes. There is usually a predominance of mononuclear cells, but scarring may be the primary finding in healed disease.",
"   </p>",
"   <p>",
"    Pericardiocentesis may be indicated to exclude potentially life-threatening causes of pericarditis (eg, purulent, tuberculous, or neoplastic pericarditis) or to drain the fluid if there are signs of tamponade. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=see_link&amp;anchor=H2299917#H2299917\">",
"     \"Clinical presentation and diagnostic evaluation of acute pericarditis\", section on 'Indications for pericardiocentesis and pericardial biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of fever or a documented infection that could predispose to purulent pericarditis, we do not routinely perform diagnostic pericardiocentesis in patients with SLE and pericarditis unless they do not respond to treatment and continue to have symptoms and a persistent pericardial effusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Course and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course is benign in the large majority of patients with pericardial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/29\">",
"     29",
"    </a>",
"    ]. Symptomatic pericarditis often responds to a nonsteroidal antiinflammatory drug (NSAID), especially",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients who do not tolerate or respond to an NSAID can be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (0.5 to 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in divided doses).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"     Colchicine",
"    </a>",
"    may reduce the risk of recurrence of idiopathic pericarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/33\">",
"     33",
"    </a>",
"    ], but the effectiveness of this agent in patients with SLE is uncertain. Use of colchicine may be warranted in patients with SLE who do not respond rapidly to NSAIDs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    glucocorticoids. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/44/713?source=see_link&amp;anchor=H12602686#H12602686\">",
"     \"Treatment of acute pericarditis\", section on 'Colchicine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Percutaneous drainage with echocardiographic guidance is effective in treating cardiac tamponade; surgical drainage and pericardiectomy are rarely needed but may be necessary if there is a loculated effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link\">",
"     \"Cardiac tamponade\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MYOCARDITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocarditis is an uncommon, often asymptomatic manifestation of SLE with a prevalence of 8 to 25 percent in different studies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/3,35\">",
"     3,35",
"    </a>",
"    ]. Global hypokinesis may be an echocardiographic indication of myocarditis and is present in approximately 6 percent of patients with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocarditis should be suspected if there are resting tachycardia disproportionate to body temperature, electrocardiographic abnormalities (such as ST and T wave abnormalities), and unexplained cardiomegaly. The cardiomegaly may be associated with symptoms and signs of heart failure, conduction abnormalities,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/1\">",
"     1",
"    </a>",
"    ]. Echocardiography may reveal abnormalities in both systolic and diastolic function of the left ventricle [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/2\">",
"     2",
"    </a>",
"    ]. Myocarditis has been associated in some cases with antibodies to ribonucleoprotein (RNP) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/36\">",
"     36",
"    </a>",
"    ]. African American ethnicity is associated with a higher risk of myocarditis compared with Hispanic and Caucasian ethnicity [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute myocarditis may accompany other manifestations of acute SLE, particularly pericarditis. Among the many causes of cardiomyopathy, drug-induced (eg, due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    , antimalarials, phenothiazines) or comorbid disorders (eg, uremia or post-partum cardiomyopathy) should be excluded. Myocardial biopsy may be needed to distinguish active myocarditis from fibrosis and other causes of cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Histologic examination reveals infiltration of the myocardium with mononuclear cells. Inflammation may lead to fibrosis that may be manifested clinically as dilated cardiomyopathy.",
"   </p>",
"   <p>",
"    Additionally,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    is associated with a rare, idiosyncratic cardiotoxicity, and myocardial biopsy may be necessary to rule this out. The characteristic findings of hydroxychloroquine toxicity on light microscopy are diffuse myocyte vacuolization without myocarditis, and transmission electron microscopy demonstrates sarcoplasmic-myelinoid and curvilinear bodies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Treatment of myocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of lupus myocarditis has not been assessed in controlled trials. Improvement in systolic function has been noted in some patients treated with glucocorticoids, other immunosuppressants (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ), or intravenous immunoglobulin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/1,5-9\">",
"     1,5-9",
"    </a>",
"    ]. We suggest that acute lupus myocarditis be treated initially with high dose glucocorticoids (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    1000 mg intravenously daily for three days followed by 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in divided doses) plus usual therapy for heart failure, if present [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiomyopathy with fibrosis is usually resistant to steroids",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunosuppressive drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CONDUCTION ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conduction defects, which may represent a sequel of active or past myocarditis, have been noted in 34 to 70 percent of patients with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/3\">",
"     3",
"    </a>",
"    ]. First-degree heart block may be seen and is often transient; in comparison, higher degrees of heart block and arrhythmias (such as atrial fibrillation) are unusual in adults. Autopsy studies have revealed focal inflammatory cell infiltrates or, more often, fibrous scarring of the conduction system.",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Anti-Ro/SSA",
"    </span>",
"    antibodies in adults with SLE may be associated with an increased likelihood of a prolonged corrected QT interval (QTc), which has been shown in patients without SLE to be a risk factor for ventricular arrhythmia and sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/39\">",
"     39",
"    </a>",
"    ]. The clinical significance of this observation is unclear given the low threshold (QTc &ge;440 msec) used to define prolongation in this study. However, patients with",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA",
"    </span>",
"    antibodies may benefit from having electrocardiograms and receiving appropriate counseling if a prolonged QTc is detected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Congenital heart block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital heart block may be part of the neonatal lupus syndrome, which is associated with the presence of",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     anti-La/SSB",
"    </span>",
"    antibodies. Some of the mothers of these infants have SLE, while others have Sj&ouml;gren's syndrome, an undifferentiated autoimmune disorder, or are asymptomatic. The risk of complete heart block (in utero or neonatal) complicating pregnancy in women with anti-Ro or anti-La antibodies is 3 percent. As a result, it is recommended that",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     anti-La/SSB",
"    </span>",
"    antibody titers be measured early in pregnancy in women with SLE. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24474?source=see_link\">",
"     \"Neonatal lupus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10376?source=see_link\">",
"     \"Congenital third degree (complete) atrioventricular block\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Resting heart rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The resting heart rate may correlate with disease activity. In one report, for example, 14 of 15 patients with a resting heart rate above 90 beats per minute had active disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22456/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The lifetime prevalence of some cardiac manifestation of SLE is estimated to be 50 percent and should be high on the differential of any presentation with chest pain or shortness of breath. Valvular, pericardial, myocardial, and coronary heart disease occur at high rates in patients with SLE.",
"     </li>",
"     <li>",
"      Valvular disease, most often valve thickening, nodules, and regurgitation and less frequently vegetations or stenotic lesions, is noted echocardiographically, and the presence of valvular lesions may increase the risk of serious complications. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Valvular disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonbacterial thrombotic endocarditis (Libman-Sacks, verrucous endocarditis) may occur in patients with SLE and is associated with antiphospholipid antibodies. Bacterial endocarditis is the most important differential diagnosis to exclude in a patient with SLE and suspected verrucous endocarditis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Verrucous endocarditis (Libman-Sacks endocarditis)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We reserve echocardiographic testing for patients with symptoms suggestive of heart failure or embolic disease and for those with a new or changing heart murmur. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibiotic prophylaxis is not recommended for most patients with SLE and valvular heart disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"       \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"      </a>",
"      .) However, patients with SLE and valve lesions who are immunosuppressed may represent a high risk group not considered in the American College of",
"      <span class=\"nowrap\">",
"       Cardiology/American",
"      </span>",
"      Heart Association guidelines. We suggest antibiotic prophylaxis before procedures associated with bacteremia for immunosuppressed SLE patients with valve disease (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For those with systemic emboli from verrucous (nonbacterial thrombotic) endocarditis, with or without antiphospholipid antibodies, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      followed by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Valvular disease'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=see_link&amp;anchor=H22#H22\">",
"       \"Treatment of the antiphospholipid syndrome\", section on 'Cardiac manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pericardial disease is noted in approximately one-half of patients with SLE at some time in the course of their disease. Diagnostic pericardiocentesis is suggested for those in whom purulent pericarditis is suspected and for those who do not respond to treatment with NSAIDs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      glucocorticoids. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Pericardial disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic acute pericarditis often responds to an NSAID; those who do not tolerate or cannot take NSAIDs may use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (0.5 to 1",
"      <span class=\"nowrap\">",
"       mg/kg/day",
"      </span>",
"      in divided doses).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"       Colchicine",
"      </a>",
"      may reduce the risk of recurrent pericarditis, and we suggest using colchicine (initial dose 1 to 2 mg orally, then 0.5 mg twice daily, orally, for six months) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). A reduction in the dose of colchicine is necessary if there is significant impairment in renal function. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/44/713?source=see_link&amp;anchor=H12602686#H12602686\">",
"       \"Treatment of acute pericarditis\", section on 'Colchicine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myocarditis is an uncommon manifestation of SLE that can cause heart failure, conduction abnormalities,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      arrhythmias. Systolic and diastolic function may be affected. Drug-induced cardiomyopathy should be excluded, as should comorbid conditions that cause heart failure. Myocardial biopsy may be necessary to confirm or exclude myocarditis.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"       Hydroxychloroquine",
"      </a>",
"      -induced myocardiotoxicity occurs rarely, and the histopathology differs from inflammatory lupus myocarditis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Myocarditis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with lupus myocarditis, we suggest initial treatment with high dose glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). A typical regimen is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      1000 mg intravenously daily for three days. For those with heart failure, this is accompanied by usual treatment for ventricular dysfunction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"       \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A pregnant woman with SLE may be at increased risk having a child with congenital heart block as a manifestation of neonatal lupus. We recommend preconception or early prenatal testing for",
"      <span class=\"nowrap\">",
"       anti-Ro/SSA",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       anti-La/SSB",
"      </span>",
"      antibodies and periodic monitoring for the development of heart block in the fetus. Detailed discussions of neonatal lupus and prenatal screening are presented elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24474?source=see_link\">",
"       \"Neonatal lupus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10376?source=see_link\">",
"       \"Congenital third degree (complete) atrioventricular block\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/1\">",
"      Moder KG, Miller TD, Tazelaar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999; 74:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/2\">",
"      Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/3\">",
"      Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987; 17:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/4\">",
"      Schattner A, Liang MH. The cardiovascular burden of lupus: a complex challenge. Arch Intern Med 2003; 163:1507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/5\">",
"      Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982; 25:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/6\">",
"      Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore) 1992; 71:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/7\">",
"      Reveille JD, Bartolucci A, Alarc&oacute;n GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/8\">",
"      Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/9\">",
"      Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/10\">",
"      Galve E, Candell-Riera J, Pigrau C, et al. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988; 319:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/11\">",
"      Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/12\">",
"      Cervera R, Font J, Par&eacute; C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992; 51:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/13\">",
"      Sturfelt G, Eskilsson J, Nived O, et al. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population. Medicine (Baltimore) 1992; 71:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/14\">",
"      Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/15\">",
"      Evangelopoulos ME, Alevizaki M, Toumanidis S, et al. Mitral valve prolapse in systemic lupus erythematosus patients: clinical and immunological aspects. Lupus 2003; 12:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/16\">",
"      Moyssakis I, Tektonidou MG, Vasilliou VA, et al. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 2007; 120:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/17\">",
"      Roldan CA, Qualls CR, Sopko KS, Sibbitt WL Jr. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol 2008; 35:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/18\">",
"      Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990; 82:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/19\">",
"      Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol 2009; 36:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/20\">",
"      Ong ML, Veerapen K, Chambers JB, et al. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 1992; 34:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/21\">",
"      Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93:1579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/22\">",
"      Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006; 54:3918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/23\">",
"      Perez-Villa F, Font J, Azqueta M, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Arthritis Rheum 2005; 53:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/24\">",
"      Zuily S, Regnault V, Selton-Suty C, et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation 2011; 124:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/25\">",
"      Asherson RA, Higenbottam TW, Dinh Xuan AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990; 17:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/26\">",
"      Roldan CA. Valvular disease associated with systemic illness. Cardiol Clin 1998; 16:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/27\">",
"      Doria A, Iaccarino L, Sarzi-Puttini P, et al. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/28\">",
"      Leung WH, Wong KL, Lau CP, et al. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990; 89:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/29\">",
"      Man BL, Mok CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 2005; 14:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/30\">",
"      Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med 1977; 63:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/31\">",
"      Rosenbaum E, Krebs E, Cohen M, et al. The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review. Lupus 2009; 18:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/32\">",
"      Hunder GG, Mullen BJ, McDuffie FC. Complement in pericardial fluid of lupus erythematosus. Studies in two patients. Ann Intern Med 1974; 80:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/33\">",
"      Guindo J, Rodriguez de la Serna A, Rami&oacute; J, et al. Recurrent pericarditis. Relief with colchicine. Circulation 1990; 82:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/34\">",
"      Cauduro SA, Moder KG, Tsang TS, Seward JB. Clinical and echocardiographic characteristics of hemodynamically significant pericardial effusions in patients with systemic lupus erythematosus. Am J Cardiol 2003; 92:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/35\">",
"      Apte M, McGwin G Jr, Vil&aacute; LM, et al. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]. Rheumatology (Oxford) 2008; 47:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/36\">",
"      Borenstein DG, Fye WB, Arnett FC, Stevens MB. The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 1978; 89:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/37\">",
"      Keating RJ, Bhatia S, Amin S, et al. Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction. J Am Soc Echocardiogr 2005; 18:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/38\">",
"      Nord JE, Shah PK, Rinaldi RZ, Weisman MH. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Semin Arthritis Rheum 2004; 33:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22456/abstract/39\">",
"      Bourr&eacute;-Tessier J, Clarke AE, Huynh T, et al. Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63:1031.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4680 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-B3AA2FA6DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22456=[""].join("\n");
var outline_f21_59_22456=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VALVULAR DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Verrucous endocarditis (Libman-Sacks endocarditis)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Antiphospholipid antibodies and valvular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Preventing bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PERICARDIAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Course and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MYOCARDITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Treatment of myocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CONDUCTION ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Congenital heart block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Resting heart rate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/4680\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/4680|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/6/37984\" title=\"picture 1\">",
"      Verrucous endocarditis in SLE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/12/31943?source=related_link\">",
"      Cardiac abnormalities in children and adolescents with systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=related_link\">",
"      Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/47/37625?source=related_link\">",
"      Clinical presentation and diagnostic evaluation of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/8/10376?source=related_link\">",
"      Congenital third degree (complete) atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/13/28889?source=related_link\">",
"      Coronary heart disease in systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13705?source=related_link\">",
"      Definition and diagnosis of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24474?source=related_link\">",
"      Neonatal lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=related_link\">",
"      Overview of the clinical manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=related_link\">",
"      Systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38280?source=related_link\">",
"      Transesophageal echocardiography: Indications, complications, and normal views",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/44/713?source=related_link\">",
"      Treatment of acute pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=related_link\">",
"      Treatment of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_59_22457="Erythema migrans";
var content_f21_59_22457=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81270%7EPEDS%2F62480%7EID%2F67424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81270%7EPEDS%2F62480%7EID%2F67424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema migrans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 241px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema migrans with central clearing and a necrotic center.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dori F Zaleznik, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic \"bull's eye\" erythema migrans lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 298px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eugene D Shapiro, MD, FAAP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vesicular erythema migrans (EM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 544px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) EM lesion in a patient with Lyme disease. The lesion has the complex \"bull's eye\" appearance with central clearing and vesicular lesions.",
"    <br>",
"     (B) Vesicles may appear near the center of an erythema migrans lesion. This patient subsequently developed facial nerve palsy and had positive serology for Lyme disease.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Panel A courtesy of Robert Basow, MD; Panel B courtesy of Eugene D Shapiro, MD, FAAP.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22457=[""].join("\n");
var outline_f21_59_22457=null;
var title_f21_59_22458="Fecal incontinence in adults";
var content_f21_59_22458=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Fecal incontinence in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22458/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22458/contributors\">",
"     Kristen Robson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22458/contributors\">",
"     Anthony J Lembo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22458/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22458/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/59/22458/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/59/22458/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/59/22458/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fecal incontinence is one of the most devastating of all physical disabilities since it affects self-confidence and personal image, and can lead to social isolation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Although its economic impact is difficult to calculate, in 1988 the cost of adult diapers alone was estimated to exceed $400 million annually in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/5\">",
"     5",
"    </a>",
"    ]. Furthermore, fecal incontinence was the second leading cause of nursing home placement.",
"   </p>",
"   <p>",
"    The definition of fecal incontinence has varied among reports. One consensus statement defined it as continuous or recurrent uncontrolled passage of fecal material (&gt;10 mL) for at least one month in an individual older than three years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. A similar definition was proposed by the American Psychiatric Association except that the age was set to older than four [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Considering definitions used among various studies, it is reasonable to divide fecal incontinence into major and minor:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Minor incontinence is the inadvertent escape of flatus or partial soiling of undergarments with liquid stool.",
"     </li>",
"     <li>",
"      Major incontinence is the involuntary excretion of feces.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review issues related to fecal incontinence in adults. The evaluation and recommendations are largely consistent with guidelines issued by the American College of Gastroenterology (",
"    <a class=\"graphic graphic_table graphicRef79705 graphicRef62138 \" href=\"UTD.htm?15/32/15885\">",
"     table 1A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef69758 \" href=\"UTD.htm?38/50/39712\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the prevalence of fecal incontinence vary considerably depending upon the definition used and the population studied [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/1,10-18\">",
"     1,10-18",
"    </a>",
"    ]. A systematic review estimated the prevalence to be 11 to 15 percent among community-dwelling adults, a rate that the authors acknowledge may reflect various biases in the available studies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In different large community-based studies, the rate of reported incontinence varied widely, ranging from 1 to 24 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/1,11,12,17,18\">",
"     1,11,12,17,18",
"    </a>",
"    ]. Part of this variability may be due to the definition of fecal incontinence. In one of the studies, fecal soiling occurred in 7 percent and gross fecal incontinence in 0.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Increasing age is an important risk factor for incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. In a community-based study, the estimated prevalence of fecal incontinence was 8 percent overall, but increased from 2.6 percent in those aged 20 to 29 to 15 percent in those 70 or older [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/17\">",
"     17",
"    </a>",
"    ]. The prevalence of fecal incontinence is even higher among residents of nursing homes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In a large database study, for example, fecal incontinence was observed in 47 percent of nursing home residents [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to increasing age, a number of other risk factors for fecal incontinence were identified on multivariable analysis in different studies. Independent risk factors include poor general health and physical limitations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/1\">",
"     1",
"    </a>",
"    ], chronic obstructive pulmonary disease, irritable bowel syndrome, urinary incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/18\">",
"     18",
"    </a>",
"    ], colectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/12\">",
"     12",
"    </a>",
"    ], and chronic diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Depression and white race have also been identified as risk factors in women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/18\">",
"     18",
"    </a>",
"    ]. Data are conflicting as to whether the rate is higher in women than men [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/11,17,18\">",
"     11,17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The above studies may underestimate the prevalence of fecal incontinence since many patients are reluctant to discuss it. In one report, only one-third of individuals with incontinence had discussed it with their primary care doctor or a gastroenterologist [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continence depends upon a number of factors including mental function, stool volume and consistency, colonic transit, rectal distensibility, anal sphincter function, anorectal sensation, and anorectal reflexes. Within the anorectum, anatomic barriers that help preserve continence include the rectum, the internal anal sphincter, external anal sphincter, and puborectalis muscle.",
"   </p>",
"   <p>",
"    The processes involved in normal defecation are complex, involving a sequence of events that are initiated by the entry of stool into the rectum (",
"    <a class=\"graphic graphic_figure graphicRef54830 \" href=\"UTD.htm?22/54/23394\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/20\">",
"     20",
"    </a>",
"    ]. Progressive rectal distension leads to reflex relaxation of the internal anal sphincter. The urge to defecate increases as stool continues to enter the rectum from the sigmoid colon. When defecation is desired, the anorectal angle is voluntarily straightened (which is facilitated by squatting or sitting), and abdominal pressure is increased by straining. This results in descent of the pelvic floor, contraction of the rectum, and inhibition of the external anal sphincter, thereby evacuating the rectal contents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Rectosigmoid junction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reflex contraction of the rectosigmoid junction occurs when large volumes enter the sigmoid colon thereby preventing contents from passing directly to the rectum [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/21\">",
"     21",
"    </a>",
"    ]. This reflex has been referred to as the \"rectosigmoid junction guarding reflex\".",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Rectum",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rectum contains three distinctive semilunar mucosal folds, which help to maintain its capacitance. The rectum can accommodate up to 300 mL without any significant increase in intraluminal pressure. Beyond 300 mL of volume, the intraluminal pressure increases, followed by a feeling of urgency [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Internal anal sphincter",
"    </span>",
"    &nbsp;&mdash;&nbsp;The internal anal sphincter (IAS) is a thickened, circular smooth-muscle layer innervated by the enteric nervous system. It is tonically contracted and accounts for 80 to 85 percent of the anal canal resting pressure. The IAS relaxes transiently in response to rectal distension, a reflex known as the anorectal inhibitory reflex (ARIR). The role of the ARIR is not entirely clear, although it may permit the sampling of rectal contents by sensory receptors in the anal canal, thereby helping to distinguish solid from liquid stool or gas. It does not appear to be essential for continence since continence is preserved even with an absent ARIR, as typically occurs following ileoanal anastomosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     External anal sphincter and puborectalis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The external anal sphincter (EAS) and the puborectalis muscle represent the voluntary components of fecal continence since they are composed of striated muscle with somatic innervation (the EAS by the pudendal nerve and the puborectalis muscles by pelvic branches of S3 to S4). Despite their independent innervation, the EAS and puborectalis muscle function as a unit.",
"   </p>",
"   <p>",
"    Contraction of the external anal sphincter normally doubles the pressure in the anal canal, although this pressure cannot be sustained for more than a few minutes. A spinal reflex causes the external anal sphincter to contract during sudden increases in intraabdominal pressure, such as coughing or lifting, thereby helping to maintain continence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The puborectalis muscle (PRM) is part of the pelvic diaphragm, which consists of the levator ani, pubococcygeus, iliococcygeus, and the puborectalis muscle. The PRM originates from the pubic arch, loops posteriorly behind the rectum and then travels back to the pubic arch, thereby forming a sling around the anorectum. This angle (which is typically between 80 and 110 degrees at rest, and less than 80 degrees during voluntary squeeze) helps maintain continence by forming an anatomic barrier against the discharge of stool. Dysfunction of the levator ani muscle appears to have a strong association with the severity of incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complex processes involved in the maintenance of continence described above underscore the many potential perturbations that can lead to fecal incontinence (",
"    <a class=\"graphic graphic_table graphicRef74995 \" href=\"UTD.htm?25/38/26220\">",
"     table 2",
"    </a>",
"    ). A loss of continence can result from dysfunction of the anal sphincters, abnormal rectal compliance, decreased rectal sensation, or a combination of any of these abnormalities. Incontinence is usually multifactorial since these derangements often coexist. Mild impairment of any one mechanism will usually not cause incontinence since the other mechanisms for maintaining continence can usually compensate. Some of the more common causes of incontinence will be discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Dysfunction of the anal sphincters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decreased anal sphincter pressures can result from anal trauma, such as after childbirth or anal surgery, neurologic disorders such as diabetes or spinal cord injury, or infiltrative disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Vaginal delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginal delivery can result in fecal incontinence immediately or after many years. The most common injuries are anal sphincter tears or trauma to the pudendal nerve. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9097?source=see_link\">",
"     \"Fecal incontinence related to pregnancy and vaginal delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There have been no large studies on women who were asymptomatic following vaginal delivery to provide a detailed estimate of how often anal sphincter injuries occur. Most studies focused on women in whom there was an increased clinical suspicion for sphincter disruption thus, probably overestimating the rate of their occurrence. A systematic review that included five such studies with more than 100 patients who underwent endoanal ultrasonography after vaginal delivery estimated that anal sphincter defects were detectable in up to 27 percent of primiparous women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/25\">",
"     25",
"    </a>",
"    ]. However, only one-third were symptomatic. In a population-based study, rectal urgency, rather than obstetrical injury, appeared to be the main risk factor for fecal incontinence in women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/26\">",
"     26",
"    </a>",
"    ]. The following are illustrative examples of studies on this topic:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anal sphincter tears were detected by anal endosonography in 35 percent of primiparous and 40 percent of multiparous women of whom symptoms of anal incontinence or fecal urgency were present in 13 and 23 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/27\">",
"       27",
"      </a>",
"      ]. Symptoms of urgency or incontinence usually developed within six weeks of delivery and were more likely in women who had forceps delivery.",
"     </li>",
"     <li>",
"      In another series, 13 of 59 (22 percent) previously nulliparous women reported altered fecal continence after their first delivery [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/28\">",
"       28",
"      </a>",
"      ]. Eight had persistent symptoms during their second pregnancy, of whom seven worsened following delivery. Fecal incontinence developed for the first time in five additional women after their second delivery, three of whom had occult sphincter injury following their first delivery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These and other data suggest that women who develop altered fecal continence, a fourth-degree perineal laceration, or occult sphincter injury following vaginal delivery are at increased risk for the development or worsening of symptoms after additional vaginal deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. Thus, it is reasonable to consider cesarean birth during subsequent deliveries in women who have sustained a tear requiring operative repair or who have developed persistent troubling symptoms after an initial vaginal delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. A decision analysis concluded two to three elective cesarean deliveries would need to be performed to prevent one case of incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/33\">",
"     33",
"    </a>",
"    ]. An instrumental delivery or prolonged second stage of labor also increases the risk of incontinence and should be avoided whenever possible.",
"   </p>",
"   <p>",
"    A study of identical twin sisters shed light on additional risk factors for fecal incontinence in women [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/34\">",
"     34",
"    </a>",
"    ]. The study was undertaken because it eliminated variability due to genetic risk factors (since the pairs were genetically identical) permitting a more detailed understanding of the effect of obstetrical factors. Significant associations with incontinence included age greater than 40, menopause, increasing parity, the presence of urinary incontinence, and obesity. No fecal incontinence was observed in women who had only elective cesarean deliveries (but there were only nine such patients). The prevalence was lower following cesarean delivery compared with vaginal births but results did not achieve statistical significance (OR 0.39, 95% CI 0.13-1.04).",
"   </p>",
"   <p>",
"    Nerve injury during delivery can cause incontinence many years after childbirth. Common risk factors for nerve damage during childbirth include the use of forceps, a high-birth-weight infant, a long second stage of labor, and occipitoposterior presentation of the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/35\">",
"     35",
"    </a>",
"    ]. Multiple gestation is not a risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Surgical trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sphincter trauma leading to incontinence can also result from surgery on the anal sphincter or surrounding structures. Examples include surgery for anal fistulas, hemorrhoids, or uncommonly after injection of botulinum toxin for anal fissures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with diabetes mellitus can have reduced IAS resting pressure, which may result in incontinence. Diarrhea secondary to autonomic neuropathy may also contribute to fecal incontinence in these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=see_link\">",
"     \"Diabetic autonomic neuropathy of the gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Decreased rectal compliance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rectal filling normally produces a sensation of rectal fullness and the urge to defecate. Decreased rectal compliance leads to increased frequency and urgency of bowel movements because the ability of the rectum to store fecal matter is reduced. This can lead to fecal incontinence even if sphincter function is normal. Common disorders associated with decreased rectal compliance are ulcerative proctitis and radiation proctitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/20,39\">",
"     20,39",
"    </a>",
"    ]. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Impaired rectal sensation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of conditions are associated with impaired rectal sensation including diabetes mellitus, multiple sclerosis, dementia, meningomyelocele, and spinal cord injuries. As mentioned above, patients who have undergone ileoanal anastomosis usually maintain rectal sensation, suggesting that the receptors must lie outside of the rectal wall, probably in the pelvic floor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Fecal impaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fecal impaction is a common cause of fecal incontinence in the elderly. It produces constant inhibition of IAS tone permitting leakage of liquid stool around the impaction. A number of factors may contribute to the development of fecal impaction in the elderly including impaired mental function, immobility, rectal hyposensitivity, and inadequate intake of fluids and dietary fiber.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Idiopathic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic fecal incontinence occurs most commonly in middle aged or elderly women. Although by definition, the cause cannot be identified, it is probably due to denervation of pelvic floor muscles resulting from stretch injury to pudendal and sacral nerves as might occur following a prolonged vaginal delivery, defecatory straining, or anismus [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/40\">",
"     40",
"    </a>",
"    ]. The cause of idiopathic fecal incontinence in many women appears to be multifactorial, including disorders of the anal",
"    <span class=\"nowrap\">",
"     sphincters/puborectalis,",
"    </span>",
"    rectal capacity or sensation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of patients with fecal incontinence begins with a careful medical history followed by a thorough physical examination, and specific testing (",
"    <a class=\"graphic graphic_table graphicRef70231 \" href=\"UTD.htm?22/60/23500\">",
"     table 3",
"    </a>",
"    ). The evaluation and recommendations are largely consistent with guidelines issued by the American College of Gastroenterology (",
"    <a class=\"graphic graphic_table graphicRef79705 graphicRef62138 \" href=\"UTD.htm?15/32/15885\">",
"     table 1A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef69758 \" href=\"UTD.htm?38/50/39712\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should initially focus on determining whether fecal incontinence is truly present, and its severity. True incontinence must be differentiated from frequency and urgency without loss of bowel contents, which can occur in the setting of inflammatory disease, irritable bowel syndrome, and pelvic irradiation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/42\">",
"     42",
"    </a>",
"    ]. Questioning should then focus on determining the onset, duration, frequency, and severity of symptoms, precipitating events, and obtaining history of prior vaginal delivery, anorectal surgery, pelvic irradiation, diabetes, neurologic disease, and whether symptoms occur in a background of diarrhea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination should include inspection of the perianal area and an internal digital examination. External examination may reveal chemical dermatitis, suggesting chronic incontinence, a fistula, prolapsing hemorrhoids, or rectal prolapse. Perianal sensation should be tested by evoking the anocutaneous reflex (anal wink sign). This is done by gently stroking the skin immediately surrounding the anus and observing a reflexive contraction of the external anal sphincter. An anal wink should be elicited bilaterally. The absence of this reflex suggests nerve damage and interruption of the spinal arc.",
"   </p>",
"   <p>",
"    Digital examination should be performed to detect obvious anal pathology (such as a mass or fecal impaction) and provide a crude assessment of the anal resting tone (which is mostly due to tonic contraction of the IAS). Patients should be instructed to bear down and then to squeeze against the finger, which permits appreciation of the movement and angle of the puborectalis muscle, pelvic floor descent, and squeeze pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/43\">",
"     43",
"    </a>",
"    ]. However, the accuracy of these components of the physical examination are highly dependent upon experience and, as a general rule, correlate poorly with objective measures of anorectal function [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/43\">",
"     43",
"    </a>",
"    ], though one study did find a correlation of squeeze pressure on a scale of 1 to 5 (with 0 = no discernible pressure and 5= extremely tight) with findings on manometry [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Diagnostic procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history and physical examination often provide insight into the etiology of fecal incontinence, thereby permitting focused diagnostic testing. However, we recommend that most patients have inspection of distal colon and the anus with flexible sigmoidoscopy and anoscopy (if the anal canal is not well-visualized during sigmoidoscopy) to exclude mucosal inflammation, masses, or other such pathology. In addition, appropriate testing should be obtained for patients with diarrhea, which often includes stool studies, and a full colonoscopy. Substitution of medications that are known to cause diarrhea should also be considered.",
"   </p>",
"   <p>",
"    A variety of other tests are available that measure specific components of anorectal function. Some of the more common will be reviewed below. The American Gastroenterological Association (AGA) guideline for anorectal testing techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/45\">",
"     45",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Anorectal manometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal manometry can measure parameters such as maximal resting anal pressure, amplitude and duration of squeeze pressure, the rectoanal inhibitory reflex, threshold of conscious rectal sensation, rectal compliance, and rectal and anal pressures during straining [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/46\">",
"     46",
"    </a>",
"    ]. High resolution anorectal manometry provides greater anatomic detail compared to standard water perfused manometry [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/47\">",
"     47",
"    </a>",
"    ]. The AGA technical review for anorectal testing techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/48\">",
"     48",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    It is most useful when it reveals an abnormally low sphincter pressure demonstrating that a sphincter defect is present. Decreased resting pressure suggests isolated IAS sphincter dysfunction, while decreased squeeze pressure suggests isolated EAS dysfunction. Patients with severe weakness of the external anal sphincter may have prolapsed rectum [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rectal sensation can be assessed by inflating a rectal balloon to detect the threshold (smallest volume of rectal distension) for three common sensations: the first detectable sensation (rectal sensory threshold), the sensation of urgency to defecate, and the sensation of pain (maximum tolerable volume). However, the clinical significance of the last two thresholds is less well-established than the first since the rectal sensory threshold is valuable for determining whether biofeedback will be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/45\">",
"     45",
"    </a>",
"    ]. Biofeedback is unlikely to be helpful in patients in whom the rectal sensory threshold is poor.",
"   </p>",
"   <p>",
"    The anorectal inhibitory reflex can be demonstrated by measuring the amount of distension required to induce relaxation of the IAS (typically 20 mL). However, as mentioned above, the anorectal inhibitory reflex is not essential for continence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Pudendal nerve terminal latency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pudendal nerve terminal latency (PNTL) is determined by measuring the time required after stimulating the pudendal nerves with an electrode as it crosses the ischial spine to induce a contraction of the EAS. Normal delay is approximately 2.0 msec; prolongation of the PNTL suggests damage to the nerve. However, this technique is operator dependent and has poor correlation with clinical symptoms and histologic findings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/45\">",
"     45",
"    </a>",
"    ]. The AGA technical review for anorectal testing techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/48\">",
"     48",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Endorectal ultrasound and magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Structural abnormalities of the anal sphincters, the rectal wall, and the puborectalis muscle can be understood in detail with endorectal ultrasound (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54502 graphicRef71011 \" href=\"UTD.htm?27/19/27961\">",
"     image 1A-B",
"    </a>",
"    ) or magnetic resonance imaging (MRI). Both techniques are comparable in the diagnosis of EAS, although endorectal ultrasound is more economical [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/50\">",
"     50",
"    </a>",
"    ]. Disruptions of the sphincters detected by ultrasound correlate well with manometric findings. A defect in the IAS is accompanied by lower resting pressures while EAS defects are associated with lower anal squeeze pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/51\">",
"     51",
"    </a>",
"    ]. Furthermore, the size of the EAS defect inversely correlates with the maximum squeeze pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, endorectal ultrasound is most useful for establishing the diagnosis in patients in whom the medical history or manometric findings suggest occult sphincter injury, and is currently the simplest, most reliable, and least invasive test for defining anatomic defects in the external and internal anal sphincters. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21735?source=see_link\">",
"     \"Endorectal endoscopic ultrasound in the evaluation of fecal incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Defecography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defecography is performed by instilling a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    paste into the rectum while, with the patient seated on a radiolucent commode, films are taken of the anorectal anatomy at rest and during straining and defecation. Defecography can measure the anorectal angle, evaluate pelvic descent, and detect occult or overt rectal prolapse. However, its benefit in the evaluation of patients with fecal incontinence is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/45\">",
"     45",
"    </a>",
"    ]. The AGA technical review for anorectal testing techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/48\">",
"     48",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    An alternative to traditional defecography is MRI defecography (also known as dynamic MRI imaging), which contributes added information regarding the pelvic floor anatomy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Electromyography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electromyography (EMG) activity of the anal sphincter can be performed using a surface electrode or a concentric needle. EMG is sometimes helpful in evaluating neurogenic or myopathic damage in patients with fecal incontinence. However, endorectal ultrasound may have rendered the EMG obsolete in sphincter mapping because of the discomfort associated with EMG.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Benefit of anorectal functional testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of obtaining anorectal testing in patients with fecal incontinence was illustrated in a study in which anorectal testing led to an alteration in diagnosis in 19 percent and of treatment in 16 percent of 50 patients who had been assessed by history and physical examination alone [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/55\">",
"     55",
"    </a>",
"    ]. Another study that included 56 patients with fecal incontinence demonstrated that manometry, sensitivity testing, PNTL, and saline continence tests provided a better understanding of the underlying pathophysiology that directed specific interventions (",
"    <a class=\"graphic graphic_table graphicRef66687 \" href=\"UTD.htm?21/3/21563\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three main approaches are most commonly used for treatment of fecal incontinence: medical therapy, biofeedback, and surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical therapy should be aimed at reducing stool frequency and improving stool consistency. No specific medication has been proven to be of benefit for fecal incontinence except for antidiarrheal drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific treatment should be sought for the underlying cause in all patients who have diarrhea.",
"     </li>",
"     <li>",
"      Formed stool is easier to control than liquid stool. Stool consistency can be improved by supplementing the diet with a bulking agent (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/28/29123?source=see_link\">",
"       methylcellulose",
"      </a>",
"      1 to 2 tablespoons per day). This is particularly helpful in patients who have low-volume, loose stools, but may exacerbate incontinence in patients with decreased rectal compliance (such as those with radiation proctitis or a rectal stricture).",
"     </li>",
"     <li>",
"      Stool frequency can be reduced with antidiarrheal drugs.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"       Loperamide",
"      </a>",
"      was more effective than diphenoxylate for reducing urgency associated with incontinence and was associated with fewer central nervous system side effects in a double blind crossover trial that included 30 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/57\">",
"       57",
"      </a>",
"      ]. An additional benefit of loperamide is that it increases internal anal sphincter tone, and thereby improves rectal compliance [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anticholinergic agents (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/9/29846?source=see_link\">",
"       hyoscyamine",
"      </a>",
"      ) taken before meals may be helpful in patients who tend to have leakage of stools after eating.",
"     </li>",
"     <li>",
"      Patients who have stool impaction should be disimpacted and treated with a bowel regimen to prevent recurrent impaction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients who have incontinence related to mental dysfunction or physical debility may benefit from assistance with a regular defecation program and use of stool deodorants.",
"     </li>",
"     <li>",
"      Limited experience suggests that low doses of the tricyclic antidepressant",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"       amitriptyline",
"      </a>",
"      can improve symptoms in patients with idiopathic fecal incontinence [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/60\">",
"       60",
"      </a>",
"      ]. Its beneficial effect may be due to a decrease in the amplitude and frequency of rectal motor complexes and an increase in colonic transit time.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"       Phenylephrine",
"      </a>",
"      , a selective alpha 1 adrenergic agonist, has been studied for the treatment of fecal incontinence. When applied directly to the anal sphincter in gel form, phenylephrine increases anal sphincter tone and therefore holds greatest promise for patients who have an intact internal anal sphincter associated with low resting pressures [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The success of the above interventions is variable, depending upon the underlying cause of fecal incontinence and its severity. As a general rule, minor incontinence often improves with simple conservative measures while major incontinence may require additional measures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Biofeedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biofeedback therapy is a painless noninvasive means of cognitively retraining the pelvic floor and the abdominal wall musculature. Patients are guided to improve control of these muscles by electromyographic surface electrodes on an anal plug and an abdominal wall surface electrode. This technique is an established means of treating patients with urinary incontinence and urologic symptoms of pelvic dysfunction, and has also been used for more than 30 years in the treatment of fecal incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are three general mechanisms by which biofeedback may improve fecal incontinence:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Improved contraction of the striated muscles of the pelvic floor",
"     </li>",
"     <li>",
"      Enhancement of the ability to perceive rectal distension",
"     </li>",
"     <li>",
"      Improved coordination of the sensory and strength components that are required for continence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Improvement of incontinence with biofeedback has been described in multiple reports [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/63-67\">",
"     63-67",
"    </a>",
"    ], and has been recommended in a guideline issued by the American Gastroenterological Association for patients with fecal incontinence associated with structurally intact sphincter rings (ie, weakness of the EAS or decreased ability to perceive rectal distension because of nerve injury). The AGA technical review for anorectal testing techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/48\">",
"     48",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    . However, interpretation of these studies is limited since most have been retrospective, have not incorporated a control group, defined endpoints differently, were small, and had short follow-up. As a result, it is not surprising that rates of success have varied from 38 to as high as 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/68\">",
"     68",
"    </a>",
"    ]. A systematic review of controlled studies concluded that there was insufficient evidence to judge whether biofeedback is helpful for fecal incontinence or which patients are most likely to be helped [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, a NIH consensus statement concluded that biofeedback is effective in preventing and reversing some pregnancy-related fecal incontinence for the first year after delivery, but further research is needed on the long-term benefits of biofeedback in preventing fecal incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the largest and most rigorously designed prospective controlled studies to address the subject found no significant benefit compared with standard care (consisting of nine 40 to 60 minute sessions over three to six months with a specialist nurse who offered advice on a standard range of issues such as diet, fluids, techniques to improve evacuation, bowel training [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/70\">",
"     70",
"    </a>",
"    ], and titration of antidiarrheal medications) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/71\">",
"     71",
"    </a>",
"    ]. The overall improvement with biofeedback was 54 percent compared with 53 percent with standard care. These data appear to cast doubt on the effectiveness of biofeedback in the management of fecal incontinence. On the other hand, they also suggest that the conservative measures described above may be effective in more than one-half of patients.",
"   </p>",
"   <p>",
"    Thus, the role of biofeedback in the management of fecal incontinence is somewhat unsettled based upon the available evidence. Also unclear are the optimum protocol, equipment, and duration of treatment required to achieve a benefit. Nevertheless, a 2004 guideline issued by the American College of Gastroenterology characterizes it as \"safe and effective\" and recommends its use in patients with weak sphincters",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    impaired rectal sensation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/9\">",
"     9",
"    </a>",
"    ]. Similar recommendations have been proposed by others [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/68\">",
"     68",
"    </a>",
"    ], including the American Gastroenterological Association.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of surgical approaches to fecal incontinence have been described including direct sphincter repair, plication of the posterior part of the sphincter, anal encirclement, implantation of an artificial sphincter, and muscle transfer procedures with or without electrical stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. Colostomy may be the only option in patients with intractable symptoms who are not candidates for any other therapy, or in whom other treatments have failed.",
"   </p>",
"   <p>",
"    Many patients with a single sphincter tear from obstetrical trauma, and some with discrete damage from other types of injury such as after fistula surgery, can be cured by surgical repair. Anterior overlap repair of the external anal sphincter resolves symptoms in approximately 80 percent of patients with obstetric damage [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/35\">",
"     35",
"    </a>",
"    ]. The benefit is seen both in women who present soon after childbirth and those who present several years after the injury. In one report, approximately 50 percent of obstetric patients maintained satisfactory continence at five years postprocedure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/36\">",
"     36",
"    </a>",
"    ]. In another series of 47 patients who underwent anterior sphincter repair and were followed for more than five years, 60 percent had sustained clinical improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/74\">",
"     74",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9097?source=see_link\">",
"     \"Fecal incontinence related to pregnancy and vaginal delivery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When the anal sphincter muscles are irreversibly damaged, striated muscles such as the gracilis or gluteus muscle can be surgically \"wrapped\" around the anal canal to increase resting tone [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/75\">",
"     75",
"    </a>",
"    ]. The most tested of these operations is the gracilis neosphincter, which requires chronic electrical stimulation to maintain muscle contraction. The pacemaker device is not available in the United States (and thus the procedure is generally not available) but is available in some other countries.",
"   </p>",
"   <p>",
"    In a study of 52 patients treated with this approach, 73 percent were continent after a median follow-up of two years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/76\">",
"     76",
"    </a>",
"    ]. The procedure was associated with improved bowel frequency, ability to postpone defecation, less anxiety, and improved quality of life. Similar efficacy was found in another report of a multicenter trial that included 128 patients who underwent the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/73\">",
"     73",
"    </a>",
"    ]. However, 39 percent developed major wound complications, which were less likely in centers with the relatively greatest surgical experience.",
"   </p>",
"   <p>",
"    The long-term outcome of graciloplasty has not been well-defined but good outcomes appear to persist for up to five years in the majority of patients. A study with one of the longest periods of follow-up focused on 200 consecutive patients who were followed for a median of 261 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/77\">",
"     77",
"    </a>",
"    ]. The overall success rate was 72 percent with a higher rate reported (82 percent) in patients with fecal incontinence caused by trauma. Disturbed evacuation persisted in 16 percent. The median survival of the implantable pulse generator until battery expiration was 405 weeks.",
"   </p>",
"   <p>",
"    Rectal augmentation without use of an electrically stimulated gracilis neosphincter has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/78\">",
"     78",
"    </a>",
"    ]. The procedure involves longitudinal division of the anterior rectal wall followed by augmentation of the defect with an ileal patch with the goal of increasing rectal volume.",
"   </p>",
"   <p>",
"    Another alternative to the use of transplanted striated muscle is a synthetic sphincter device, which consists of silastic inflatable cuff, a valve that allows the cuff to deflate for a few minutes for the purpose of defecation, and a reservoir. This device might be best-suited for patients with anal leakage [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/35,79\">",
"     35,79",
"    </a>",
"    ]. A magnetic anal sphincter has also been developed that provides support to the anal sphincter, only opening when a sufficient level of force is generated during defecation. One retrospective study performed in a center with significant experience with the treatment of fecal incontinence found that patients treated with the magnetic anal sphincter had outcomes similar to those seen with the synthetic sphincter device [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/80\">",
"     80",
"    </a>",
"    ]. However, the number of patients in the study was small (n = 10 per group) and no randomized controlled trials are available.",
"   </p>",
"   <p>",
"    Colostomy has been used when all other treatments failed or were unsuitable [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Sacral nerve stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrical stimulation of the sacral nerve roots can restore continence in patients with structurally intact muscles. This approach appears to be particularly effective in patients with neurologic disorders and may be less costly than more invasive operations for fecal incontinence (eg, colostomy or dynamic graciloplasty) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/82,83\">",
"     82,83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An electrode inserted into the S3 sacral foramen provides low grade stimulation via an implanted stimulator [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/82-92\">",
"     82-92",
"    </a>",
"    ]. The mechanism of action is not entirely clear, but physiology studies in patients with sacral nerve stimulation have shown improvements in both resting and squeeze pressures of the anal sphincter and in rectal sensation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/88,93\">",
"     88,93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Experience with this approach is limited. A systematic review of three crossover studies suggested that sacral nerve stimulation can improve continence in selected individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/87\">",
"     87",
"    </a>",
"    ]. The authors also noted that temporary, percutaneous stimulation for a two-to-three week period was not always successful in identifying those in whom a permanent implant would be beneficial, suggesting that more studies are needed.",
"   </p>",
"   <p>",
"    The following illustrate the findings in the two available randomized trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized controlled trial compared sacral nerve stimulation (n = 60) to optimal medical therapy (n = 60) consisting of pelvic floor exercises, bulking agents, and dietary changes in patients with severe fecal incontinence [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/84\">",
"       84",
"      </a>",
"      ]. The permanent sacral nerve stimulator was placed into 54 of the 60 randomized patients who had demonstrated improvement during a temporary trial period. Use of the sacral nerve stimulator was associated with a significantly greater improvement in incontinence episodes and quality of life during 12 months of follow-up. In addition, 25 patients (47 percent) achieved \"perfect\" continence. Complications included pain at the implant site (6 percent), seroma (2 percent), and tingling in the vaginal region (9 percent). There were no septic complications requiring explantation.",
"     </li>",
"     <li>",
"      A double-blind multicenter study of 27 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/85\">",
"       85",
"      </a>",
"      ] randomized to on and off sacral nerve stimulation demonstrated a significant decrease in frequency of fecal incontinence episodes when the stimulator was on.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Observational series have echoed these positive results. In a prospective multicenter cohort of 120 patients who received implantation of a sacral nerve stimulator, 83 percent achieved greater than 50 percent reduction in incontinent episodes per week and 41 percent achieved 100 percent at 12 months. There were no adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/94\">",
"     94",
"    </a>",
"    ]. Benefit appears to occur in patients with or without anal sphincter defects [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/84,95\">",
"     84,95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A follow-up study, however, suggested that a significant number of patients will require surgical revision following stimulator implantation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/96\">",
"     96",
"    </a>",
"    ]. During a mean follow-up of 49 months, 36 of 87 patients (41 percent) who had undergone stimulator implantation required surgical revision. Reasons for revision included: infection (four patients), electrode displacement (two patients), electrode breakage (two patients), dysfunction due to an increase in impedance (four patients), pain with stimulation (seven patients), battery depletion (eight patients), and partial or total loss of clinical efficacy (nine patients).",
"   </p>",
"   <p>",
"    In April 2011, the FDA approved the sacral nerve stimulator (InterStim&reg;, Medtronics) for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.",
"   </p>",
"   <p>",
"    Posterior tibial nerve stimulation has also been demonstrated to produce short-term improvements in fecal incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/97-102\">",
"     97-102",
"    </a>",
"    ]. However, larger studies are needed to assess the optimal frequency and parameters of stimulation, and duration of treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H821580307\">",
"    <span class=\"h2\">",
"     Radiofrequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency is a procedure that involves delivering temperature-controlled radiofrequency energy (RFE) to the anorectal junction to create thermal lesions in the muscle while preserving mucosal integrity. RFE is a minimally invasive treatment for fecal incontinence that takes less than one hour to perform and is generally performed under local anesthesia and sedation.",
"   </p>",
"   <p>",
"    Only small nonrandomized studies have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/103-107\">",
"     103-107",
"    </a>",
"    ]. The largest study included 50 patients (43 women and 7 men) with incontinence at least once a week with unsatisfactory results to diet, biofeedback,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pharmacological therapy. After six months, the days with any fecal incontinence dropped from 10 to 7 in a 14-day period and improvement in the Cleveland Clinic Florida Fecal Incontinence score (CCF-FI) improved from 14.6 to 11.1. Anal ulceration occurred in two patients and one patient developed bleeding from a hemorrhoidal vein [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/106\">",
"     106",
"    </a>",
"    ]. In a prospective observational study of 19 patients with fecal incontinence treated with RFE, sustained modest improvements in scores of symptoms of fecal incontinence and quality of life were seen at five years after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/104\">",
"     104",
"    </a>",
"    ]. In contrast, one study of RFE in eight patients with fecal incontinence reported no improvement in symptoms after RFE at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effectiveness and safety of RFE remains to be determined by randomized trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Anal stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anal electrical stimulation involves daily home stimulation using an anal probe electrode. A sham-controlled trial suggested that it has, at best, only a modest benefit, possibly from increasing sensitization of the anal area [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Acticon incontinence device",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Acticon (TM) neosphincter (American Medical Systems, Inc, Minnetonka, MN) device consists of an occlusive cuff implanted around the anal canal, a pressure-regulating balloon implanted in the prevesical space, and a control pump with a septum port implanted in the labium or scrotum. The user is able to squeeze the control pump to permit defecation.",
"   </p>",
"   <p>",
"    The device is approved for the treatment of severe fecal incontinence. A multicenter, prospective, nonrandomized study evaluating this device included 112 patients (86 women) who underwent implantation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/109\">",
"     109",
"    </a>",
"    ]. Repeated surgery was required to revise the implant in 51 patients (46 percent), some of whom needed more than one revision. The device had to be removed in 41 patients (37 percent); however, it was reimplanted in seven. In patients with a functioning device, there was improvement in quality of life and anal continence. A successful outcome was observed in 53 percent of patients on an intention-to-treat basis. A controlled trial enrolling 14 patients suggested that it was more effective than medical therapy, although complications led to permanent explantation of the device in 30 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar results were demonstrated in a case series with long-term follow-up (mean follow-up 64 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/111\">",
"     111",
"    </a>",
"    ]. Of 52 patients who underwent implantation of the Acticon&trade; neosphincter for fecal incontinence, 26 (50 percent) required revisions after a mean of 58 months and 14 (27 percent) required definitive explantation after a mean of 15 months. There were significant improvements in both incontinence and quality-of-life scores in 35 patients (67 percent) with an activated device.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Procon incontinence device",
"    </span>",
"    &nbsp;&mdash;&nbsp;A novel system involving a rectally inserted balloon with a sensing device that alerts the user to an imminent bowel movement (Procon, AnaTech, El Paso, TX) had a beneficial effect in a pilot study of seven patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Injectable materials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several reports have described injection of materials to augment the function of the internal anal sphincter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Silicone biomaterial",
"    </span>",
"    &nbsp;&mdash;&nbsp;An injectable silicone biomaterial (PTP, Bioplastique) has been developed to augment the internal anal sphincter. The largest trial included 82 patients with severe fecal incontinence and a low anal resting pressure caused by internal anal sphincter dysfunction who were randomly assigned to injection with or without the aid of endoanal ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/113\">",
"     113",
"    </a>",
"    ]. The material was injected into the intersphincteric space and internal anal sphincter. Fecal incontinence improved significantly in both groups with up to 12 months of follow-up but to a greater extent in the group in whom injection was ultrasound guided. There were no serious complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Collagen injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intra-anal injection of collagen has been described but experience is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/114\">",
"     114",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h3\">",
"     Carbon-coated microbeads",
"    </span>",
"    &nbsp;&mdash;&nbsp;Submucosal injection of carbon-coated microbeads (Durasphere) improved minor incontinence in a pilot study of 33 patients but had no effect on quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14087204\">",
"    <span class=\"h3\">",
"     Dextranomer-hyaluronic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/26/31138?source=see_link\">",
"     dextranomer-hyaluronic acid",
"    </a>",
"    (Solesta&trade;) is used for the treatment of urinary incontinence and has been studied in patients with fecal incontinence. Studies suggest dextranomer-hyaluronic acid is effective for the treatment of fecal incontinence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial with 206 patients compared injection with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/26/31138?source=see_link\">",
"       dextranomer-hyaluronic acid",
"      </a>",
"      with sham injections of no substance [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/116\">",
"       116",
"      </a>",
"      ]. After six months of follow-up, 71 of 136 patients in the active treatment arm reported a 50 percent or greater reduction in incontinence episodes, compared with 22 of 70 patients (32 percent) in the sham arm. Two serious treatment-related adverse events were seen in the active treatment group: one patient developed a prostate abscess and one developed a rectal abscess. Both patients recovered with appropriate treatment.",
"     </li>",
"     <li>",
"      In a study of 34 patients who received four 1 mL injections of the gel just above the dentate line, treatment was associated with a greater than 50 percent decline in the median number of incontinence episodes at six and 12 months after treatment compared with baseline (10 and 9, respectively, versus 22) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/117\">",
"       117",
"      </a>",
"      ]. At six months, 15 patients (44 percent) were responders and, at 12 months, 19 patients (56 percent) were responders. There were no long-term side effects or adverse events reported.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In 2011,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/26/31138?source=see_link\">",
"     dextranomer-hyaluronic acid",
"    </a>",
"    gel (Solesta&trade;) was",
"    <a class=\"external\" href=\"file://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm259255.htm\">",
"     approved by the FDA",
"    </a>",
"    for the treatment of fecal incontinence in adult patients who have failed conservative therapy. Four 1 mL injections into the deep submucosa are given in the proximal part of the high pressure zone of the anal canal, about 5 mm above the dentate line. If the response is inadequate after a minimum of four weeks, a second treatment can be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H63546717\">",
"    <span class=\"h2\">",
"     Anal plugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anal plugs have been studied as a possible treatment for fecal incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/118-121\">",
"     118-121",
"    </a>",
"    ]. A meta-analysis looking at the use of anal plugs included four studies with 136 patients. It found that the plugs were difficult to tolerate (drop-out rates of 13 to 68 percent), with the majority of patients who dropped out doing so because of reasons related to the plug, such as discomfort [",
"    <a class=\"abstract\" href=\"UTD.htm?21/59/22458/abstract/122\">",
"     122",
"    </a>",
"    ]. In a minority of patients, the plugs appeared to improve fecal incontinence. Because anal plugs are often poorly tolerated, their use is limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/50/38690?source=see_link\">",
"       \"Patient information: Fecal incontinence (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?5/55/6006?source=see_link\">",
"       \"Patient information: Fecal incontinence (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The goal of treatment should be to restore continence and improve quality of life.",
"     </li>",
"     <li>",
"      A comprehensive history and physical examination can help provide clues as to the severity and type of incontinence and predisposing conditions (",
"      <a class=\"graphic graphic_table graphicRef74995 \" href=\"UTD.htm?25/38/26220\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testing should be guided by the clinical suspicion based upon the history and physical examination (",
"      <a class=\"graphic graphic_table graphicRef70231 \" href=\"UTD.htm?22/60/23500\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Diagnostic procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Supportive measures can be instituted in most patients. This may include avoiding foods or activities known to worsen symptoms, ritualizing bowel habits and improving perianal skin hygiene. Measures that can help improve hygiene include regular cleaning of the perianal skin after soiling, use of moist tissues and use of barrier creams (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/53/15187?source=see_link\">",
"       zinc oxide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/11/33969?source=see_link\">",
"       calamine lotion",
"      </a>",
"      ). Perianal fungal infections should be treated with a topical antifungal agent. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Medical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bulking agents (eg, fiber supplements) and antidiarrheal medications (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"       loperamide",
"      </a>",
"      ) can help to thicken the consistency of stool and thereby improve continence, although a benefit has not been clearly established and fiber also has the potential to increase stool volume and thereby worsen incontinence. A trial of fiber supplementation may be reasonable in patients who tend to have incontinence to liquid stools.",
"      <br/>",
"      <br/>",
"      Additional measures that can be helpful in patients residing in chronic care facilities include scheduled toileting and use of stool deodorants.",
"     </li>",
"     <li>",
"      Specific treatments (pharmacologic, biofeedback, implants and surgery) may each have a role in individual settings (",
"      <a class=\"graphic graphic_table graphicRef79705 graphicRef62138 \" href=\"UTD.htm?15/32/15885\">",
"       table 1A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/1\">",
"      Nelson R, Norton N, Cautley E, Furner S. Community-based prevalence of anal incontinence. JAMA 1995; 274:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/2\">",
"      Sangwan YP, Coller JA. Fecal incontinence. Surg Clin North Am 1994; 74:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/3\">",
"      Rothbarth J, Bemelman WA, Meijerink WJ, et al. What is the impact of fecal incontinence on quality of life? Dis Colon Rectum 2001; 44:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/4\">",
"      Landefeld CS, Bowers BJ, Feld AD, et al. National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med 2008; 148:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/5\">",
"      Lahr CJ. Evaluation and treatment of incontinence. Pract Gastroenterol 1988; 12:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/6\">",
"      Drossman DA, Funch-Jensen P, Janssens J, et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990; 3:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/7\">",
"      Thompson WG, Creed F, Drossman DA, et al. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992; 5:75.",
"     </a>",
"    </li>",
"    <li>",
"     Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed, American Psychiatric Association, Washington, DC 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/9\">",
"      Rao SS, American College of Gastroenterology Practice Parameters Committee. Diagnosis and management of fecal incontinence. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 2004; 99:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/10\">",
"      Macmillan AK, Merrie AE, Marshall RJ, Parry BR. The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature. Dis Colon Rectum 2004; 47:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/11\">",
"      Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/12\">",
"      Varma MG, Brown JS, Creasman JM, et al. Fecal incontinence in females older than aged 40 years: who is at risk? Dis Colon Rectum 2006; 49:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/13\">",
"      Perry S, Shaw C, McGrother C, et al. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut 2002; 50:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/14\">",
"      Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ 3rd. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992; 102:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/15\">",
"      Nelson R, Furner S, Jesudason V. Fecal incontinence in Wisconsin nursing homes: prevalence and associations. Dis Colon Rectum 1998; 41:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/16\">",
"      Bharucha AE, Zinsmeister AR, Locke GR, et al. Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology 2005; 129:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/17\">",
"      Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009; 137:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/18\">",
"      Markland AD, Goode PS, Burgio KL, et al. Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study. J Am Geriatr Soc 2010; 58:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/19\">",
"      Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol 1996; 91:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/20\">",
"      Sagar PM, Pemberton JH. Anorectal and pelvic floor function. Relevance of continence, incontinence, and constipation. Gastroenterol Clin North Am 1996; 25:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/21\">",
"      Shafik A, Shafik AA, El Sibai O, et al. Role of the rectosigmoidal junction in fecal continence: concept of the primary continent mechanism. Arch Surg 2006; 141:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/22\">",
"      Taylor BM, Beart RW Jr, Dozois RR, et al. The endorectal ileal pouch-anal anastomosis. Current clinical results. Dis Colon Rectum 1984; 27:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/23\">",
"      Sun WM, Read NW, Miner PB. Relation between rectal sensation and anal function in normal subjects and patients with faecal incontinence. Gut 1990; 31:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/24\">",
"      Fern&aacute;ndez-Fraga X, Azpiroz F, Malagelada JR. Significance of pelvic floor muscles in anal incontinence. Gastroenterology 2002; 123:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/25\">",
"      Oberwalder M, Connor J, Wexner SD. Meta-analysis to determine the incidence of obstetric anal sphincter damage. Br J Surg 2003; 90:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/26\">",
"      Bharucha AE, Zinsmeister AR, Locke GR, et al. Risk factors for fecal incontinence: a population-based study in women. Am J Gastroenterol 2006; 101:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/27\">",
"      Sultan AH, Kamm MA, Hudson CN, et al. Anal-sphincter disruption during vaginal delivery. N Engl J Med 1993; 329:1905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/28\">",
"      Fynes M, Donnelly V, Behan M, et al. Effect of second vaginal delivery on anorectal physiology and faecal continence: a prospective study. Lancet 1999; 354:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/29\">",
"      Faltin DL, Sangalli MR, Roche B, et al. Does a second delivery increase the risk of anal incontinence? BJOG 2001; 108:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/30\">",
"      Sze EH. Prevalence and severity of anal incontinence in women with and without additional vaginal deliveries after a fourth-degree perineal laceration. Dis Colon Rectum 2005; 48:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/31\">",
"      Mahony R, Behan M, O'Connell PR, O'Herlihy C. Effect of second vaginal delivery on anal function in patients at risk of occult anal sphincter injury after first forceps delivery. Dis Colon Rectum 2008; 51:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/32\">",
"      Wattchow DA, Rieger N. Faecal incontinence after vaginal delivery. Lancet 1999; 354:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/33\">",
"      McKenna DS, Ester JB, Fischer JR. Elective cesarean delivery for women with a previous anal sphincter rupture. Am J Obstet Gynecol 2003; 189:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/34\">",
"      Abramov Y, Sand PK, Botros SM, et al. Risk factors for female anal incontinence: new insight through the Evanston-Northwestern twin sisters study. Obstet Gynecol 2005; 106:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/35\">",
"      Kamm MA. Faecal incontinence. BMJ 1998; 316:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/36\">",
"      Malouf AJ, Norton CS, Engel AF, et al. Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma. Lancet 2000; 355:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/37\">",
"      Walker WA, Rothenberger DA, Goldberg SM. Morbidity of internal sphincterotomy for anal fissure and stenosis. Dis Colon Rectum 1985; 28:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/38\">",
"      Brisinda G, Maria G, Bentivoglio AR, et al. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med 1999; 341:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/39\">",
"      Rao SS, Read NW, Davison PA, et al. Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis. Gastroenterology 1987; 93:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/40\">",
"      Snooks SJ, Setchell M, Swash M, Henry MM. Injury to innervation of pelvic floor sphincter musculature in childbirth. Lancet 1984; 2:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/41\">",
"      Bharucha AE, Fletcher JG, Harper CM, et al. Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence. Gut 2005; 54:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/42\">",
"      Madoff RD, Williams JG, Caushaj PF. Fecal incontinence. N Engl J Med 1992; 326:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/43\">",
"      Coller JA. Clinical application of anorectal manometry. Gastroenterol Clin North Am 1987; 16:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/44\">",
"      Orkin BA, Sinykin SB, Lloyd PC. The digital rectal examination scoring system (DRESS). Dis Colon Rectum 2010; 53:1656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/45\">",
"      Barnett JL, Hasler WL, Camilleri M. American Gastroenterological Association medical position statement on anorectal testing techniques. American Gastroenterological Association. Gastroenterology 1999; 116:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/46\">",
"      Wald A. Colonic and anorectal motility testing in clinical practice. Am J Gastroenterol 1994; 89:2109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/47\">",
"      Jones MP, Post J, Crowell MD. High-resolution manometry in the evaluation of anorectal disorders: a simultaneous comparison with water-perfused manometry. Am J Gastroenterol 2007; 102:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/48\">",
"      Diamant NE, Kamm MA, Wald A, Whitehead WE. AGA technical review on anorectal testing techniques. Gastroenterology 1999; 116:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/49\">",
"      Rao SS, Patel RS. How useful are manometric tests of anorectal function in the management of defecation disorders? Am J Gastroenterol 1997; 92:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/50\">",
"      Sajid MS, Khatri K, Siddiqui MR, Baig MK. Endo-anal ultrasound versus endo-anal magnetic resonance imaging for the depiction of external anal sphincter pathology in patients with faecal incontinence: a systematic review. Magy Seb 2010; 63:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/51\">",
"      Saclarides TJ. Endorectal ultrasound. Surg Clin North Am 1998; 78:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/52\">",
"      Falk PM, Blatchford GJ, Cali RL, et al. Transanal ultrasound and manometry in the evaluation of fecal incontinence. Dis Colon Rectum 1994; 37:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/53\">",
"      Stoker J. Magnetic resonance imaging in fecal incontinence. Semin Ultrasound CT MR 2008; 29:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/54\">",
"      Lockhart ME, Fielding JR, Richter HE, et al. Reproducibility of dynamic MR imaging pelvic measurements: a multi-institutional study. Radiology 2008; 249:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/55\">",
"      Keating JP, Stewart PJ, Eyers AA, et al. Are special investigations of value in the management of patients with fecal incontinence? Dis Colon Rectum 1997; 40:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/56\">",
"      Cheetham M, Brazzelli M, Norton C, Glazener CM. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev 2003; :CD002116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/57\">",
"      Palmer KR, Corbett CL, Holdsworth CD. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 1980; 79:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/58\">",
"      Read M, Read NW, Barber DC, Duthie HL. Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci 1982; 27:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/59\">",
"      Wrenn K. Fecal impaction. N Engl J Med 1989; 321:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/60\">",
"      Santoro GA, Eitan BZ, Pryde A, Bartolo DC. Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum 2000; 43:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/61\">",
"      Cheetham MJ, Kamm MA, Phillips RK. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 2001; 48:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/62\">",
"      Engel BT, Nikoomanesh P, Schuster MM. Operant conditioning of rectosphincteric responses in the treatment of fecal incontinence. N Engl J Med 1974; 290:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/63\">",
"      Ko CY, Tong J, Lehman RE, et al. Biofeedback is effective therapy for fecal incontinence and constipation. Arch Surg 1997; 132:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/64\">",
"      Ryn AK, Morren GL, Hallb&ouml;&ouml;k O, Sj&ouml;dahl R. Long-term results of electromyographic biofeedback training for fecal incontinence. Dis Colon Rectum 2000; 43:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/65\">",
"      Guillemot F, Bouche B, Gower-Rousseau C, et al. Biofeedback for the treatment of fecal incontinence. Long-term clinical results. Dis Colon Rectum 1995; 38:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/66\">",
"      MacLeod JH. Management of anal incontinence by biofeedback. Gastroenterology 1987; 93:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/67\">",
"      Byrne CM, Solomon MJ, Young JM, et al. Biofeedback for fecal incontinence: short-term outcomes of 513 consecutive patients and predictors of successful treatment. Dis Colon Rectum 2007; 50:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/68\">",
"      Madoff RD, Parker SC, Varma MG, Lowry AC. Faecal incontinence in adults. Lancet 2004; 364:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/69\">",
"      Norton C, Hosker G, Brazzelli M. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev 2000; :CD002111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/70\">",
"      Norton C, Chelvanayagam S. Methodology of biofeedback for adults with fecal incontinence: a program of care. J Wound Ostomy Continence Nurs 2001; 28:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/71\">",
"      Norton C, Chelvanayagam S, Wilson-Barnett J, et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 2003; 125:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/72\">",
"      Christiansen J. Modern surgical treatment of anal incontinence. Ann Med 1998; 30:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/73\">",
"      Madoff RD, Rosen HR, Baeten CG, et al. Safety and efficacy of dynamic muscle plasty for anal incontinence: lessons from a prospective, multicenter trial. Gastroenterology 1999; 116:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/74\">",
"      Grey BR, Sheldon RR, Telford KJ, Kiff ES. Anterior anal sphincter repair can be of long term benefit: a 12-year case cohort from a single surgeon. BMC Surg 2007; 7:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/75\">",
"      Khaikin M, Wexner SD. Treatment strategies in obstructed defecation and fecal incontinence. World J Gastroenterol 2006; 12:3168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/76\">",
"      Baeten CG, Geerdes BP, Adang EM, et al. Anal dynamic graciloplasty in the treatment of intractable fecal incontinence. N Engl J Med 1995; 332:1600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/77\">",
"      Rongen MJ, Uludag O, El Naggar K, et al. Long-term follow-up of dynamic graciloplasty for fecal incontinence. Dis Colon Rectum 2003; 46:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/78\">",
"      Murphy J, Chan CL, Scott SM, et al. Rectal augmentation: short- and mid-term evaluation of a novel procedure for severe fecal urgency with associated incontinence. Ann Surg 2008; 247:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/79\">",
"      Vaizey CJ, Kamm MA, Gold DM, et al. Clinical, physiological, and radiological study of a new purpose-designed artificial bowel sphincter. Lancet 1998; 352:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/80\">",
"      Wong MT, Meurette G, Stangherlin P, Lehur PA. The magnetic anal sphincter versus the artificial bowel sphincter: a comparison of 2 treatments for fecal incontinence. Dis Colon Rectum 2011; 54:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/81\">",
"      Tan JJ, Chan M, Tjandra JJ. Evolving therapy for fecal incontinence. Dis Colon Rectum 2007; 50:1950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/82\">",
"      Gourcerol G, Gallas S, Michot F, et al. Sacral nerve stimulation in fecal incontinence: are there factors associated with success? Dis Colon Rectum 2007; 50:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/83\">",
"      Hetzer FH, Bieler A, Hahnloser D, et al. Outcome and cost analysis of sacral nerve stimulation for faecal incontinence. Br J Surg 2006; 93:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/84\">",
"      Tjandra JJ, Chan MK, Yeh CH, Murray-Green C. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum 2008; 51:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/85\">",
"      Leroi AM, Parc Y, Lehur PA, et al. Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg 2005; 242:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/86\">",
"      Rosen HR, Urbarz C, Holzer B, et al. Sacral nerve stimulation as a treatment for fecal incontinence. Gastroenterology 2001; 121:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/87\">",
"      Mowatt G, Glazener C, Jarrett M. Sacral nerve stimulation for faecal incontinence and constipation in adults. Cochrane Database Syst Rev 2007; :CD004464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/88\">",
"      Matzel KE, Stadelmaier U, Hohenfellner M, Gall FP. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet 1995; 346:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/89\">",
"      Jarrett ME, Matzel KE, Christiansen J, et al. Sacral nerve stimulation for faecal incontinence in patients with previous partial spinal injury including disc prolapse. Br J Surg 2005; 92:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/90\">",
"      Uluda O, Koch SM, van Gemert WG, et al. Sacral neuromodulation in patients with fecal incontinence: a single-center study. Dis Colon Rectum 2004; 47:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/91\">",
"      Matzel KE, Kamm MA, St&ouml;sser M, et al. Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet 2004; 363:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/92\">",
"      Rasmussen OO, Buntzen S, S&oslash;rensen M, et al. Sacral nerve stimulation in fecal incontinence. Dis Colon Rectum 2004; 47:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/93\">",
"      Kenefick NJ, Nicholls RJ, Cohen RG, Kamm MA. Permanent sacral nerve stimulation for treatment of idiopathic constipation. Br J Surg 2002; 89:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/94\">",
"      Wexner SD, Coller JA, Devroede G, et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg 2010; 251:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/95\">",
"      Boyle DJ, Knowles CH, Lunniss PJ, et al. Efficacy of sacral nerve stimulation for fecal incontinence in patients with anal sphincter defects. Dis Colon Rectum 2009; 52:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/96\">",
"      Faucheron JL, Voirin D, Badic B. Sacral nerve stimulation for fecal incontinence: causes of surgical revision from a series of 87 consecutive patients operated on in a single institution. Dis Colon Rectum 2010; 53:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/97\">",
"      George AT, Kalmar K, Sala S, et al. Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence. Br J Surg 2013; 100:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/98\">",
"      Shafik A, Ahmed I, El-Sibai O, Mostafa RM. Percutaneous peripheral neuromodulation in the treatment of fecal incontinence. Eur Surg Res 2003; 35:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/99\">",
"      Queralto M, Portier G, Cabarrot PH, et al. Preliminary results of peripheral transcutaneous neuromodulation in the treatment of idiopathic fecal incontinence. Int J Colorectal Dis 2006; 21:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/100\">",
"      Govaert B, Pares D, Delgado-Aros S, et al. A prospective multicentre study to investigate percutaneous tibial nerve stimulation for the treatment of faecal incontinence. Colorectal Dis 2010; 12:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/101\">",
"      Vitton V, Damon H, Roman S, et al. Transcutaneous posterior tibial nerve stimulation for fecal incontinence in inflammatory bowel disease patients: a therapeutic option? Inflamm Bowel Dis 2009; 15:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/102\">",
"      de la Portilla F, Rada R, Vega J, et al. Evaluation of the use of posterior tibial nerve stimulation for the treatment of fecal incontinence: preliminary results of a prospective study. Dis Colon Rectum 2009; 52:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/103\">",
"      Takahashi T, Garcia-Osogobio S, Valdovinos MA, et al. Radio-frequency energy delivery to the anal canal for the treatment of fecal incontinence. Dis Colon Rectum 2002; 45:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/104\">",
"      Takahashi-Monroy T, Morales M, Garcia-Osogobio S, et al. SECCA procedure for the treatment of fecal incontinence: results of five-year follow-up. Dis Colon Rectum 2008; 51:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/105\">",
"      Ruiz D, Pinto RA, Hull TL, et al. Does the radiofrequency procedure for fecal incontinence improve quality of life and incontinence at 1-year follow-up? Dis Colon Rectum 2010; 53:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/106\">",
"      Efron JE, Corman ML, Fleshman J, et al. Safety and effectiveness of temperature-controlled radio-frequency energy delivery to the anal canal (Secca procedure) for the treatment of fecal incontinence. Dis Colon Rectum 2003; 46:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/107\">",
"      Kim DW, Yoon HM, Park JS, et al. Radiofrequency energy delivery to the anal canal: is it a promising new approach to the treatment of fecal incontinence? Am J Surg 2009; 197:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/108\">",
"      Norton C, Gibbs A, Kamm MA. Randomized, controlled trial of anal electrical stimulation for fecal incontinence. Dis Colon Rectum 2006; 49:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/109\">",
"      Wong WD, Congliosi SM, Spencer MP, et al. The safety and efficacy of the artificial bowel sphincter for fecal incontinence: results from a multicenter cohort study. Dis Colon Rectum 2002; 45:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/110\">",
"      O'Brien PE, Dixon JB, Skinner S, et al. A prospective, randomized, controlled clinical trial of placement of the artificial bowel sphincter (Acticon Neosphincter) for the control of fecal incontinence. Dis Colon Rectum 2004; 47:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/111\">",
"      Wong MT, Meurette G, Wyart V, et al. The artificial bowel sphincter: a single institution experience over a decade. Ann Surg 2011; 254:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/112\">",
"      Giamundo P, Welber A, Weiss EG, et al. The procon incontinence device: a new nonsurgical approach to preventing episodes of fecal incontinence. Am J Gastroenterol 2002; 97:2328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/113\">",
"      Tjandra JJ, Lim JF, Hiscock R, Rajendra P. Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective. Dis Colon Rectum 2004; 47:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/114\">",
"      Stojkovic SG, Lim M, Burke D, et al. Intra-anal collagen injection for the treatment of faecal incontinence. Br J Surg 2006; 93:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/115\">",
"      Altomare DF, La Torre F, Rinaldi M, et al. Carbon-coated microbeads anal injection in outpatient treatment of minor fecal incontinence. Dis Colon Rectum 2008; 51:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/116\">",
"      Graf W, Mellgren A, Matzel KE, et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet 2011; 377:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/117\">",
"      Danielson J, Karlbom U, Sonesson AC, et al. Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence. Dis Colon Rectum 2009; 52:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/118\">",
"      Bond C, Youngson G, MacPherson I, et al. Anal plugs for the management of fecal incontinence in children and adults: a randomized control trial. J Clin Gastroenterol 2007; 41:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/119\">",
"      Norton C, Kamm MA. Anal plug for faecal incontinence. Colorectal Dis 2001; 3:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/120\">",
"      Pfrommer W, Holschneider AM, L&ouml;ffler N, et al. A new polyurethane anal plug in the treatment of incontinence after anal atresia repair. Eur J Pediatr Surg 2000; 10:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/121\">",
"      Van Winckel M, Van Biervliet S, Van Laecke E, Hoebeke P. Is an anal plug useful in the treatment of fecal incontinence in children with spina bifida or anal atresia? J Urol 2006; 176:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/59/22458/abstract/122\">",
"      Deutekom M, Dobben AC. Plugs for containing faecal incontinence. Cochrane Database Syst Rev 2012; 4:CD005086.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2561 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-F9050627AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22458=[""].join("\n");
var outline_f21_59_22458=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H40\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Rectosigmoid junction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Rectum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Internal anal sphincter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      External anal sphincter and puborectalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Dysfunction of the anal sphincters",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Vaginal delivery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Surgical trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Decreased rectal compliance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Impaired rectal sensation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Fecal impaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Idiopathic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Diagnostic procedures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Anorectal manometry",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Pudendal nerve terminal latency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Endorectal ultrasound and magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Defecography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Electromyography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Benefit of anorectal functional testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Biofeedback",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Sacral nerve stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H821580307\">",
"      Radiofrequency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Anal stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Acticon incontinence device",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Procon incontinence device",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Injectable materials",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Silicone biomaterial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Collagen injection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      - Carbon-coated microbeads",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14087204\">",
"      - Dextranomer-hyaluronic acid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H63546717\">",
"      Anal plugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2561\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2561|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?38/50/39712\" title=\"algorithm 1\">",
"      Fecal incontinence ACG",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2561|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/24/3461\" title=\"diagnostic image 1A\">",
"      Normal anal ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/47/14069\" title=\"diagnostic image 1B\">",
"      Anterior anal sphincter damage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2561|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/54/23394\" title=\"figure 1\">",
"      Continence mechanisms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2561|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/41/27292\" title=\"table 1A\">",
"      Mgmt fecal incontinence ACG I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/44/29387\" title=\"table 1B\">",
"      Mgmt fecal incontinence ACG II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/38/26220\" title=\"table 2\">",
"      Causes of fecal incontinence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/60/23500\" title=\"table 3\">",
"      Approach fecal incontinence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/3/21563\" title=\"table 4\">",
"      Anorec manom fecal incontinence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24985?source=related_link\">",
"      Diabetic autonomic neuropathy of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21735?source=related_link\">",
"      Endorectal endoscopic ultrasound in the evaluation of fecal incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9097?source=related_link\">",
"      Fecal incontinence related to pregnancy and vaginal delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?5/55/6006?source=related_link\">",
"      Patient information: Fecal incontinence (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/50/38690?source=related_link\">",
"      Patient information: Fecal incontinence (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_59_22459="Involving family and friends in pseudocyesis treatment";
var content_f21_59_22459=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70027&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70027&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Involving family and friends in treatment of pseudocyesis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Reducing negative influences from others",
"       </td>",
"       <td class=\"subtitle1\">",
"        Teaching others to assist with treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Educate others who support the patient's belief in pregnancy (eg, educate a boyfriend who insists patient must be pregnant because she has galactorrhea)",
"       </td>",
"       <td>",
"        Teach others how to encourage patient to accept treatment (eg, coaching spouse to explain that he is worried about patient and would like to come with her to see her doctor)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Help others reduce pressure on patient to become pregnant (eg, council the patient's mother who repeatedly tells patient that she is not a good wife unless she has a baby)",
"       </td>",
"       <td>",
"        Teach others how to respond therapeutically when patient says she is pregnant (eg, help them think of specific ways to show support apart from pregnancy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Help others reduce the secondary gain of pregnancy belief (eg, encourage family members to be solicitous of patient's needs without patient having to be \"pregnant\" to elicit that response from them)",
"       </td>",
"       <td>",
"        Improve communication (eg, help spouse communicate his frustrations directly and respectfully, instead of with avoidance)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22459=[""].join("\n");
var outline_f21_59_22459=null;
var title_f21_59_22460="Lung abscess in CMI defects";
var content_f21_59_22460=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Lung abscess microbiology in patients with cell-mediated immune defects",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Common",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Bacteria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pseudomonas aeruginosa",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Enterobacteriaceae",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Nocardia spp",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Anaerobic bacteria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Staphylococcus aureus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Mycobacteria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            M. tuberculosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            M. kansasii",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Fungi",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Cryptococcus spp",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Aspergillus spp",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Histoplasma capsulatum",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Uncommon",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Bacteria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Rhodococcus equi",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Legionella spp",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Mycobacteria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            M. avium complex",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Fungi",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Blastomyces dermatitidis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Pneumocystis jirovecii (formerly P. carinii)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22460=[""].join("\n");
var outline_f21_59_22460=null;
var title_f21_59_22461="Molecular markers in AML";
var content_f21_59_22461=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F88091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F88091&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Molecular markers in acute myeloid leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Approximate frequency in de-novo AML",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency in CN AML",
"       </td>",
"       <td class=\"subtitle1\">",
"        Strong associations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Not recorded with",
"       </td>",
"       <td class=\"subtitle1\">",
"        Outlook",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         NPM1",
"        </em>",
"       </td>",
"       <td>",
"        35 percent",
"       </td>",
"       <td>",
"        50 percent",
"       </td>",
"       <td>",
"        CN AML,",
"        <em>",
"         FLT3",
"        </em>",
"        -ITD,",
"        <em>",
"         FLT3",
"        </em>",
"        -TKD,",
"        <em>",
"         DNMT3A",
"        </em>",
"        ,",
"        <em>",
"         IDH1",
"        </em>",
"        ,",
"        <em>",
"         IDH2",
"        </em>",
"       </td>",
"       <td>",
"        <em>",
"         CEBPA",
"        </em>",
"        double mutant",
"       </td>",
"       <td>",
"        Favorable in patients with CN AML and in elderly patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         CEBPA",
"        </em>",
"       </td>",
"       <td>",
"        7 percent",
"       </td>",
"       <td>",
"        8 to 19 percent",
"       </td>",
"       <td>",
"        CN AML,",
"        <em>",
"         FLT3",
"        </em>",
"        -ITD",
"       </td>",
"       <td>",
"        <em>",
"         NPM1",
"        </em>",
"       </td>",
"       <td>",
"        Favorable in patients with CN AML (if biallelic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         FLT3",
"        </em>",
"        -ITD",
"       </td>",
"       <td>",
"        20 to 25 percent",
"       </td>",
"       <td>",
"        30 to 35 percent",
"       </td>",
"       <td>",
"        CN AML, APL, t(6;9),",
"        <em>",
"         NPM1",
"        </em>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Adverse in patients with CN AML; could vary with allelic burden; no clear effect in patients with APL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         FLT3",
"        </em>",
"        -TKD",
"       </td>",
"       <td>",
"        5 percent",
"       </td>",
"       <td>",
"        14 percent",
"       </td>",
"       <td>",
"        CN AML,",
"        <em>",
"         NPM1",
"        </em>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Controversial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         KIT",
"        </em>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        25 percent",
"       </td>",
"       <td>",
"        Core binding factor leukemias",
"       </td>",
"       <td>",
"        Most other karyotypes",
"       </td>",
"       <td>",
"        Adverse in adult patients with core binding factor leukemias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TET2",
"       </td>",
"       <td>",
"        8 to 12 percent",
"       </td>",
"       <td>",
"        23 percent",
"       </td>",
"       <td>",
"        Possibly CN AML",
"       </td>",
"       <td>",
"        <em>",
"         IDH1",
"        </em>",
"        ,",
"        <em>",
"         IDH2",
"        </em>",
"       </td>",
"       <td>",
"        Controversial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         DNMT3A",
"        </em>",
"       </td>",
"       <td>",
"        14 to 22 percent",
"       </td>",
"       <td>",
"        20 to 33 percent",
"       </td>",
"       <td>",
"        CN AML,",
"        <em>",
"         NPM1",
"        </em>",
"        ,",
"        <em>",
"         FLT3",
"        </em>",
"       </td>",
"       <td>",
"        Core binding factor leukemias,",
"        <em>",
"         CEBPA",
"        </em>",
"        ,",
"        <em>",
"         MLL",
"        </em>",
"        translocations",
"       </td>",
"       <td>",
"        Possibly adverse in patients with CN AML",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         IDH1",
"        </em>",
"        ,",
"        <em>",
"         IDH2",
"        </em>",
"       </td>",
"       <td>",
"        8 to 16 percent",
"       </td>",
"       <td>",
"        30 percent",
"       </td>",
"       <td>",
"        CN AML,",
"        <em>",
"         NPM1",
"        </em>",
"        ,",
"        <em>",
"         FLT3",
"        </em>",
"       </td>",
"       <td>",
"        <em>",
"         TET2",
"        </em>",
"        ,",
"        <em>",
"         WT1",
"        </em>",
"       </td>",
"       <td>",
"        Controversial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <em>",
"         ASXL1",
"        </em>",
"       </td>",
"       <td>",
"        5 to 30 percent",
"       </td>",
"       <td>",
"        About 10 percent",
"       </td>",
"       <td>",
"        Uncommon with",
"        <em>",
"         NPM1",
"        </em>",
"        and",
"        <em>",
"         FLT3",
"        </em>",
"       </td>",
"       <td>",
"        Possibly",
"        <em>",
"         CEBPA",
"        </em>",
"       </td>",
"       <td>",
"        Adverse in patients with CN AML and older patients; more common in older patients",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Changes of miRNAs 15, 16, 155, and 181 among others, have been reported. The prognostic effect varies and studies are needed to assess the individual miRNA families and their interactions with other mutations. Some studies have shown that overexpression of BAALC, MN1, and ERG genes is associated with poorer outcomes, but needs confirmation.",
"    <div class=\"footnotes\">",
"     AML: acute myeloid leukemia; CN AML: cytogenetically normal acute myeloid leukemia; ITD: internal tandem duplication; TKD: tyrosine kinase domain; APL: acute promyelocytic leukemia.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet 2013; 381:484. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22461=[""].join("\n");
var outline_f21_59_22461=null;
var title_f21_59_22462="Contents: Pediatric sports medicine";
var content_f21_59_22462=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric sports medicine",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric sports medicine",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Ankle injuries",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/20/31050\">",
"           Clinical features and management of ankle pain in the young athlete",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/23/14711\">",
"           Evaluation of foot and ankle pain in the young athlete",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Elbow injuries",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/25/22937\">",
"           Elbow injuries in the young athlete",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Exercise",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/31/43513\">",
"           Overview of aerobic exercise testing in children and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Heel and foot injuries",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/41/23190\">",
"           Clinical features and management of foot pain in the young athlete",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/6/28775\">",
"           Clinical features and management of heel pain in the young athlete",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/23/14711\">",
"           Evaluation of foot and ankle pain in the young athlete",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Knee injuries",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/9/5273\">",
"           Approach to the young athlete with acute knee pain or injury",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/34/29223\">",
"           Approach to the young athlete with chronic knee pain or injury",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/6/12392\">",
"           Osgood-Schlatter disease (tibial tuberosity avulsion)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/0/24581\">",
"           Patellar dislocations in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/50/28455\">",
"           Traumatic causes of acute knee pain and injury in the young athlete",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/61/4056\">",
"           Treatment of knee injuries in the young athlete",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Musculoskeletal injuries",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/62/8169\">",
"           Musculoskeletal injury in the young athlete: Overview of rehabilitation for nonoperative injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/46/44775\">",
"           Musculoskeletal injury in the young athlete: Overview of treatment principles for nonoperative injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/6/12392\">",
"           Osgood-Schlatter disease (tibial tuberosity avulsion)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neck injuries",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/25/41368\">",
"           Approach to the young athlete with neck pain or injury",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/28/15815\">",
"           Field care and evaluation of the young athlete with acute neck injury",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/8/23689\">",
"           Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/49/11033\">",
"           Overview of musculoskeletal neck injuries in the young athlete",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Nutrition",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/6/40040\">",
"           Calcium requirements in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/11/23735\">",
"           Dietary energy requirements in adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/14/4329\">",
"           Iron requirements and iron deficiency in adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/7/27769\">",
"           High altitude disease: Unique pediatric considerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/61/14298\">",
"           Overview of physical activity and strength training in children and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Physical examination",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/13/36058\">",
"           The preparticipation sports examination in children and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Wrist injuries",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/60/38855\">",
"           Causes of chronic wrist pain in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/43/32440\">",
"           Evaluation of wrist pain and injury in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/8/32905\">",
"           Overview of acute wrist injuries in children and adolescents",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-5B4AC38CF5-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f21_59_22462=[""].join("\n");
var outline_f21_59_22462=null;
var title_f21_59_22463="Lunge exercise";
var content_f21_59_22463=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F65588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F65588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lunge",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 259px; height: 331px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With tubing around waist, the patient should push off with one foot, lunge forward onto the other, and return. The legs are alternated, and the patient should advance with each lunge.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_59_22463=[""].join("\n");
var outline_f21_59_22463=null;
